(REVERSES | REVERSAL OF | REVERSE | REVERSED) OBESITY

/ Uncategorized / By
  1. Reversal of obesity by targeted ablation of adipose tissue
  2. Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
  3. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents
  4. Reversal of diet-induced obesity and diabetes in C57BL/6J mice
  5. Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats
  6. Leptin Activation of Corticosterone Production in Hepatocytes May Contribute to the Reversal of Obesity and Hyperglycemia in Leptin-Deficient ob/ob Mice
  7. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a β3-adrenoceptor agonist
  8. Trends in fatness and the origins of obesity
  9. Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture
  10. Reversal of Obesity-and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption….
  11. Mifepristone (RU 486), a blocker of type II glucocorticoid and progestin receptors, reverses a dietary form of obesity
  12. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy
  13. Myocardial fatty acid oxidation rates remain elevated in ob/ob mice despite reversal of obesity and diabetes by caloric restriction
  14. Specificity of Leptin Action on Elevated Blood Glucose Levels and Hypothalamic Neuropeptide Y Gene Expression in ob/ob Mice
  15. Body weight regulation in obese and obese-reduced rats.
  16. Inflammation and the IKKβ/IκB/NF-κB axis in obesity-and diet-induced insulin resistance
  17. Polycythemia of obesity: further studies of its mechanism and a report of two additional cases
  18. Brain responses to obesogenic diets and diet-induced obesity
  19. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue
  20. Hypothalamic obesity: the autonomic hypothesis and the lateral hypothalamus
  21. Role of Endoplasmic Reticulum Stress and c-Jun NH2-Terminal Kinase Pathways in Inflammation and Origin of Obesity and Diabetes
  22. Severe orthostatic hypotension following weight reduction surgery
  23. The role of beta3-adrenergic receptors in control of brown and white adipose tissues and of energy balance: Reversal of obesity by CL 316,243, a new beta3 …
  24. Strategies for the delivery of leptin to the CNS
  25. Mouse models of lipodystrophy: Key reagents for the understanding of the metabolic syndrome
  26. The liver in obesity and type 2 diabetes mellitus
  27. Effects of fasting and refeeding on blood pressure are determined by nutritional state, not by body weight change
  28. Maternal obesity is associated with younger age at obesity onset in US adolescent offspring followed into adulthood
  29. Thematic review series: adipocyte biology. Sympathetic and sensory innervation of white adipose tissue
  30. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity
  31. Using mouse models to dissect the genetics of obesity
  32. Energy balance in reversible obesity
  33. Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia
  34. Renal cell carcinoma following bariatric surgery
  35. Pathophysiologic changes of obesity
  36. Role of the autonomic nervous system in the development of ventromedial hypothalamic obesity
  37. Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle
  38. Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity
  39. The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity
  40. Brain somatic cross-talk: ghrelin, leptin and ultimate challengers of obesity
  41. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation
  42. Pathogenesis of type 2 diabetes mellitus
  43. Internal regulation and the evolution of normal growth as the basis for prevention of obesity in children
  44. A novel IKKβ inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance
  45. Obesity and alcoholic liver disease
  46. Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid–induced insulin resistance
  47. The growing problem of obesity in dogs and cats
  48. Drug Insight: the role of leptin in human physiology and pathophysiology—emerging clinical applications
  49. The cross cultural context of obesity: an INCLEN multicentre collaborative study
  50. Leptin: the link between adipose tissue and reproductive system
  51. Reduction of diet-induced obesity in rats with a herbal formulation
  52. Prohibitin: a potential target for new therapeutics
  53. Inflammation in obesity is a common link between defects in fatty acid metabolism and insulin resistance
  54. Increase in prevalence of obesity and diabetes and decrease in plasma cholesterol in a central Australian aboriginal community
  55. Obesity, past present and future
  56. Is there a metabolic rationale to support a weight loss programme to prevent diabetes?
  57. Five-year obesity incidence in the transition period between adolescence and adulthood: the National Longitudinal Study of Adolescent Health
  58. Pharmacology of thermogenic drugs
  59. Increased CD36 protein as a response to defective insulin signaling in macrophages
  60. Adipose stress-sensing kinases: linking obesity to malfunction
  61. Diabetes and the endocrine pancreas II
  62. Controlling Obesity: School, Work, and Leisure
  63. Reduced skeletal muscle inhibitor of κBβ content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training
  64. Hyperphagia and obesity following ventromedial hypothalamic lesions in rats with subdiaphragmatic vagotomy
  65. Effect of Intracerebroventricular Leptin on Cardiac Fructose-2, 6-Bisphosphate Content
  66. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome …
  67. The biology of white adipocyte proliferation
  68. Physical activity mediates a healthier body weight in the presence of obesity
  69. Traditional diets of the Pacific and coronary heart disease
  70. Gastric bypass surgery enables recovery of cardiac structure and function
  71. The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis
  72. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance
  73. The hypothalamic‐pituitary‐adrenal axis activity in obesity and the metabolic syndrome
  74. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety
  75. Insulin resistance: a phosphorylation-based uncoupling of insulin signaling
  76. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance
  77. Hyperinsulinemia in rats with hypothalamic obesity: effects of autonomic drugs and glucose
  78. in Obesity and Diabetes
  79. Regulation of 11β‐HSD Genes in Human Adipose Tissue: Influence of Central Obesity and Weight Loss
  80. Adrenal and gonadal function in obesity
  81. CCR2 modulates inflammatory and metabolic effects of high-fat feeding
  82. Nitrosative stress and pathogenesis of insulin resistance
  83. The genetics of human obesity
  84. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
  85. Neuropeptides, appetite regulation, and human obesity
  86. DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet
  87. Adipokines: molecular links between obesity and atheroslcerosis
  88. Leptin as a cardiac hypertrophic factor: a potential target for therapeutics
  89. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
  90. Adipokines: at the heart of the relationship between obesity and insulin resistance.
  91. The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance?
  92. Obesity: overview of prevalence, etiology, and treatment
  93. Monitoring Blood Glucose Levels in Female Mink During the Reproductive Cycle: The Prevention and Reversal of Hyperglycemia During the Nursing Period
  94. Adipokines, inflammation, and the endothelium in diabetes
  95. A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice
  96. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85α: the two sides of a coin
  97. Low-grade inflammation, obesity, and insulin resistance in adolescents
  98. Surgical management of obesity
  99. Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible
  100. Subclinical inflammation and obesity, diabetes and related disorders
  101. Optimal management of the morbidly obese patient SAGES appropriateness conference statement
  102. Dietary Cyanidin 3-O-β-D-Glucoside-Rich Purple Corn Color Prevents Obesity and Ameliorates Hyperglycemia in Mice
  103. Prediction: Death Rates for the Four Leading Cancers Will Be Halved by 2015
  104. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance
  105. Metabolic syndrome, hyperinsulinemia, and cancer
  106. Benefits of lifestyle modification in NAFLD
  107. Beta-3 adrenoceptor (beta-3AR) expression in leptin treated OB/OB mice
  108. Evidence for alteration of the vitamin D-endocrine system in obese subjects.
  109. PDK4: A factor in fatness?
  110. Pharmacological treatment of obesity: therapeutic strategies
  111. A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis
  112. Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells
  113. Neuroendocrine and metabolic effects of adipocyte-derived hormones
  114. Cellular inflammatory responses: novel insights for obesity and insulin resistance
  115. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease
  116. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
  117. Animal models of steatohepatitis
  118. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease
  119. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance
  120. Obesity-induced inflammatory changes in adipose tissue
  121. A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes?
  122. Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance
  123. Obesity and androgens: facts and perspectives
  124. Antidiabetic Effects of cis-9, trans-11–Conjugated Linoleic Acid May Be Mediated via Anti-Inflammatory Effects in White Adipose Tissue
  125. Endoplasmic reticulum stress and inflammation in obesity and type 2 diabetes
  126. Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1α: implications for metabolic disease
  127. Search for obesity drugs: targeting central and peripheral pathways
  128. Adipsin and an endogenous pathway of complement from adipose cells.
  129. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators
  130. Surgery for obesity: a review of the current state of the art and future directions
  131. A surgical rat model of human Roux-en-Y gastric bypass
  132. Regulation of energy balance in two models of reversible obesity in the rat.
  133. Type 2 diabetes: principles of pathogenesis and therapy
  134. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight
  135. The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus
  136. Comparison of short-term diet and exercise on insulin action in individuals with abnormal glucose tolerance
  137. Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics
  138. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian
  139. Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling
  140. Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus
  141. Inhibitors of preadipocyte replication: opportunities for the treatment of obesity
  142. Obesity and endothelial function
  143. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity
  144. Laparoscopic Roux-en-Y gastric bypass for recalcitrant gastroesophageal reflux disease in morbidly obese patients
  145. The evolving role of inflammation in obesity and the metabolic syndrome
  146. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver
  147. Transcriptional regulation of the GLUT4 gene: from PPAR-γ and FOXO1 to FFA and inflammation
  148. 7 Bariatric Surgery for Obesity
  149. Relation of endothelial cell function to erectile dysfunction: implications for treatment
  150. Adipose tissue macrophages
  151. Nonalcoholic fatty liver disease and the epidemic of obesity
  152. The Prevalence and Treatment of Obesity in Adolescence (Weight Control)
  153. Leptin directly stimulates thermogenesis in skeletal muscle
  154. Nonalcoholic fatty liver disease
  155. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone
  156. MCH−/− Mice Are Resistant to Aging-Associated Increases in Body Weight and Insulin Resistance
  157. Inflammation, stress, and diabetes
  158. Novel targets and therapeutic strategies for type 2 diabetes
  159. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes
  160. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance
  161. Insulin sensitizers may prevent metabolic inflammation
  162. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats
  163. Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance
  164. Effects of gonadectomy on glucocorticoid metabolism in obese Zucker rats
  165. Pathogenesis of non-alcoholic steatohepatitis: human data
  166. Oxidative inflammatory stress in obesity and diabetes
  167. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis
  168. Combined leptin actions on adipose tissue and hypothalamus are required to deplete adipocyte fat in lean rats: implications for obesity treatment
  169. Inflammation, atherosclerosis, and aspects of insulin action
  170. Hyperglycemia, maturity-onset obesity, and insulin resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes
  171. IKKβ/NF-κB activation causes severe muscle wasting in mice
  172. Increased insulin and leptin sensitivity in mice lacking acyl CoA: diacylglycerol acyltransferase 1
  173. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease
  174. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study
  175. Nonalcoholic steatohepatitis: what we know in the new millennium
  176. Pharmacology of thermogenic drugs13
  177. Energy balance and carcinogenesis: underlying pathways and targets for intervention
  178. Inhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
  179. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α
  180. 11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
  181. Effect of a β-3 agonist on food intake in two strains of rats that differ in susceptibility to obesity
  182. Tackling obesities: future choices-project report
  183. Role of Ser/Thr kinases in the uncoupling of insulin signaling
  184. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes
  185. Transplantation of pancreatic beta-cells prevents development of hypothalamic obesity in rats.
  186. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial
  187. Anti‐Inflammatory and Antidiabetic Roles of PPARγ
  188. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
  189. Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis
  190. Emerging pharmacological approaches to the treatment of obesity
  191. Differential effects of interleukin-6 and-10 on skeletal muscle and liver insulin action in vivo
  192. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study
  193. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences
  194. Increased glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db …
  195. Lifestyle modification and progressive renal failure
  196. Adipocyte-specific overexpression of FOXC2 prevents diet-induced increases in intramuscular fatty acyl CoA and insulin resistance
  197. Current knowledge in the neurophysiologic modulation of obesity
  198. Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity.
  199. Initial results with a stapled gastrojejunostomy for the laparoscopic isolated Roux-en-Y gastric bypass
  200. Role of energy charge and AMP-activated protein kinase in adipocytes in the control of body fat stores
  201. Regulated membrane transport of free fatty acids in adipocytes: role in obesity and non-insulin dependent diabetes mellitus.
  202. Effect of a short-term diet and exercise intervention on
  203. Recommended Childhood and Adolescent Immunization Schedule, United States, 2006
  204. Weight loss increases 11β-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue
  205. New approaches in the pharmacological treatment of obesity
  206. Leptin and the treatment of obesity: its current status
  207. Short-and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents
  208. Inflammation and insulin resistance
  209. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats
  210. Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-facp) rats
  211. Insulin signalling and the regulation of glucose and lipid metabolism
  212. Obesity-related differential gene expression in the visceral adipose tissue
  213. Aging up-regulates expression of inflammatory mediators in mouse adipose tissue
  214. Stéatohépatite non alcoolique: 2. Aspects physiopathologiques
  215. IKK-β links inflammation to obesity-induced insulin resistance
  216. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea
  217. Adipose tissue as source and target for novel therapies
  218. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial
  219. Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and inflammatory signals
  220. Keynote review: the adipocyte as a drug discovery target
  221. Aspirin inhibits serine phosphorylation of IRS-1 in muscle and adipose tissue of septic rats
  222. Effects of zinc deficiency and supplementation on plasma leptin levels in rats
  223. Obesity, inflammation, and insulin resistance
  224. Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice
  225. Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice
  226. Diabetes and obesity: part 1
  227. Molecular and genetic studies examining the inflammatory consequences of obesity
  228. Prevention of genetic fa/fa obesity with an ephedrine-methylxanthines thermogenic mixture
  229. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and …
  230. Obesity: Overview & Management
  231. Pathogenesis of steatohepatitis
  232. Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle intervention
  233. Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis
  234. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study
  235. Preventable chronic diseases among Indigenous Australians: the need for a comprehensive national approach
  236. Inflammatory mechanisms in diabetes: lessons from the β-cell
  237. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in growth hormone treated animals
  238. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings
  239. Type 2 diabetes and obesity in children and adolescents: experience from studies in Taiwanese population
  240. Advances in the understanding and treatment of nonalcoholic fatty liver disease
  241. Ceramides in insulin resistance and lipotoxicity
  242. Resistin-and obesity-associated metabolic diseases
  243. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes
  244. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research
  245. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes
  246. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives
  247. A primer on bariatric surgery: treatment of last resort for morbid obesity
  248. Anti-obesity and anti-tumor pro-apoptotic peptides are sufficient to cause release of cytochrome c from vesicles
  249. Obesity, insulin resistance, and renal function
  250. Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes
  251. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms
  252. Adipocytokines: mediators linking adipose tissue, inflammation and immunity
  253. Weapons of mass destruction: Pandemic lipotoxicity in the US
  254. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study
  255. New drug targets for type 2 diabetes and the metabolic syndrome
  256. Weapons of lean body mass destruction part II: Defending the heartland
  257. Effects of Subcutaneous Leptin Injections on Hypothalamic Gene Profiles in Lean and ob/ob Mice
  258. Diet-induced obesity and acute hyperlipidemia reduce IκBα levels in rat skeletal muscle in a fiber-type dependent manner
  259. Genetic variability affects the development of brown adipocytes in white fat but not in interscapular brown fats⃞
  260. Diabesity: an inflammatory metabolic condition
  261. Peroxisome proliferator-activated receptor-α deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic …
  262. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation
  263. Leptin: at the crossroads of energy balance and systemic inflammation
  264. Pathogenic role of inflammatory cytokines in obesity: from insulin resistance to diabetes mellitus
  265. Thiazolidinediones influence plasma steroids of male obese Zucker rats
  266. Loss of cyclin‐dependent kinase inhibitors produces adipocyte hyperplasia and obesity
  267. Beyond the scale: understanding mechanisms of weight gain and obesity in diabetes
  268. Adiponectin and hypertension: a putative link between adipocyte function and atherosclerotic risk?
  269. Sibutramine-dependent brown fat activation in rats: an immunohistochemical study
  270. 12: Does physical activity help weight loss in obesity?
  271. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels
  272. Heterogeneity of adipose tissue metabolism
  273. FINAL ACCEPTED VERSION
  274. The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans
  275. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm
  276. Prevalence, predisposition and prevention of type II diabetes
  277. Inflammation and metabolic disorders
  278. The role of glucocorticoid action in the pathophysiology of the metabolic syndrome
  279. Neurohumoral regulation of body weight gain
  280. Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-κB and IκB kinase pathway to regulate the release of proinflammatory cytokines from human adipose …
  281. Induction of heat shock proteins may combat insulin resistance
  282. Obesity in Later Childhood and Countermeasures
  283. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α
  284. 2 Steps for the Medical Evaluation of the Obese Patient
  285. Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses
  286. Exercise alone reduces insulin resistance in obese children independently of changes in body composition
  287. Evolutionary origins of insulin resistance: a behavioral switch hypothesis
  288. TLR4 links innate immunity and fatty acid–induced insulin resistance
  289. Improving effect of carteolol on bodyweight and carbohydrate and lipid metabolic responses in the OLETF rat
  290. Lifestyle of school children: representative survey in Metropolitan elementary Schools–Part One
  291. Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db …
  292. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models
  293. Are oxidative stress− activated signaling pathways mediators of insulin resistance and β-cell dysfunction?
  294. Can Hypertension Be Prevented? Is Salt Reduction Important in Hypertension? Presentaion made during the Eleventh International Interdisciplinary Conference on …
  295. PKC-mediated modulation of L-type calcium channels may contribute to fat-induced insulin resistance
  296. 11 [beta]-hydroxysteroid dehydrogenase type 1 in obesity
  297. Role of adipocytokines in metabolism and disease
  298. A longitudinal study of gross body composition and body conformation and their association with food and activity in a teen-age population: Views of teen-age subjects …
  299. New insights into the pathophysiology of gestational diabetes mellitus: possible role of human leukocyte antigen-G
  300. Factors influencing body weight regulation
  301. Inhibitor κB kinase is involved in the paracrine crosstalk between human fat and muscle cells
  302. Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1
  303. Adult female rats defend “appropriate” energy intake after adaptation to dietary energy
  304. Mechanisms of the antidiabetic effects of the β3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats
  305. Tumor necrosis factor (TNF) interferes with insulin signaling through the p55 TNF receptor death domain
  306. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo
  307. Innate immunity in the liver
  308. Contribution of sphingolipids to the pathogenesis of obesity
  309. Autoamplification of tumor necrosis factor-α: a potential mechanism for the maintenance of elevated tumor necrosis factor-α in male but not female obese mice
  310. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference
  311. Insulin receptor substrate proteins and diabetes
  312. Neuroendocrinology of insulin resistance: metabolic and endocrine aspects of adiposity
  313. Pathophysiology of nonalcoholic steatohepatitis
  314. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
  315. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects
  316. Interleukin-6 induces cellular insulin resistance in hepatocytes
  317. Les relations entre obésité, inflammation et insulinorésistance: acquisitions récentes
  318. Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-κB activation by …
  319. Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men
  320. An inflammatory cascade leading to hyperresistinemia in humans
  321. Steatosis in chronic hepatitis C: why does it really matter?
  322. Physiological roles of the leptin endocrine system: differences between mice and humans
  323. A sympathetic defense against obesity
  324. Sex steroids and leptin regulate 11β-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: sex specificities
  325. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins …
  326. Unexpected deposition of brown fat in mammary gland during postnatal development
  327. Uremic hyperleptinemia: Adaptive or maladaptive?
  328. Potential utility of natural polyphenols for reversing fat-induced insulin resistance
  329. Prostate cancer screening: is it possible to explain diametrically opposed views?
  330. Turning down insulin signaling
  331. Female rats do not exhibit free fatty acid–induced insulin resistance
  332. A clinical guide to pediatric weight management and obesity
  333. Lessons from animal models of NASH
  334. Fat, diabetes, and liver injury in chronic hepatitis C
  335. Molecular basis of insulin action
  336. Diabetic pregnancy in rats leads to impaired glucose metabolism in offspring involving tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 …
  337. Pioglitazone: the beginning of a new era for NASH?
  338. Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study
  339. Control of body weight: a physiologic and transgenic perspective
  340. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation
  341. Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro
  342. Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice
  343. Skeletal muscle and obesity
  344. SR59230A blocks β3-adrenoceptor-linked modulation of uncoupling protein-1 and leptin in rat brown adipocytes
  345. Adipose tissue remodeling and malfunctioning in obesity revealed by in vivo molecular imaging
  346. Muscle triglyceride and insulin resistance
  347. Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes
  348. Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition
  349. Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987–1998
  350. Cytokines and inflammatory recruitment in NASH: experimental and human studies
  351. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
  352. Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy
  353. Studies on the sympathetic efferent nerves of brown adipose tissue of lean and obese Zucker rats
  354. Antioxidants: do they have a role in the treatment of insulin resistance?
  355. Transcriptional control of brown fat determination by PRDM16
  356. AAV-mediated leptin receptor installation improves energy balance and the reproductive status of obese female Koletsky rats
  357. Transcriptional synergy and the regulation of Ucp1 during brown adipocyte induction in white fat depots
  358. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins
  359. Preclinical developments in type 2 diabetes
  360. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease
  361. The irresistible biology of resistin
  362. NEUROPEPTIDE, OPIOID RECEPTOR, AND BEHAVIORAL CHANGES FOLLOWING OBESITY-INDUCING VENTROMEDIAL HYPOTHALAMIC LESIONS …
  363. Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines
  364. Disordered lipid metabolism and the pathogenesis of insulin resistance
  365. Lifestyle modification and endothelial function in obese subjects
  366. White adipose tissue contributes to UCP1-independent thermogenesis
  367. Insulin resistance, inflammation, and the IKK/IκB/NF-κB pathway
  368. ALS/Lt: a new type 2 diabetes mouse model associated with low free radical scavenging potential
  369. Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms
  370. Mechanisms of the free fatty acid-induced increase in hepatic glucose production
  371. Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKβ
  372. Lipids and glucose in type 2 diabetes: what is the cause and effect?
  373. Type 1 diabetes is associated with increased cyclooxygenase-and cytokine-mediated inflammation
  374. Non-alcoholic fatty liver disease: current concepts and management strategies
  375. Insulin signaling pathways in time and space
  376. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells
  377. Adipsin and complement factor D activity: A link between the alternative complement pathway and the regulation of energy balance?
  378. Mechanisms of disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
  379. NASH as part of the metabolic (insulin resistance) syndrome
  380. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue
  381. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue
  382. Nutritional concerns in women’s primary care
  383. Energy metabolism in genetically fat and lean birds and mammals
  384. Insulin resistance, inflammation, and the ikk/ikb/nf-kb pathway
  385. Insulin resistance in NAFLD: Potential mechanisms and therapies
  386. Pathogenesis of type 2 diabetes
  387. The role of AEBP1 in sex-specific diet-induced obesity
  388. Mitochondrial dysfunction and type 2 diabetes
  389. Nitric oxide-induced downregulation of leptin production by 3T3-L1 adipocytes
  390. Uncoupling proteins
  391. Journals in Science and Medicine
  392. Metabolic and endocrine factors in regulation of nutrient balance
  393. Insulin resistance, inflammation, and the IKK/IкB/NF-кB pathway
  394. Aspirin and diabetes: inhibition of amylin aggregation by nonsteroidal anti-inflammatory drugs
  395. Energy balance and cancer
  396. IRS‐1 regulation in health and disease
  397. LXRs regulate the balance between fat storage and oxidation
  398. Tag Polymorphisms at the A20 (TNFAIP3) Locus Are Associated With Lower Gene Expression and Increased Risk of Coronary Artery Disease in Type 2 Diabetes
  399. Lipotoxicity: when tissues overeat
  400. Adiponectin: a key fat-derived molecule regulating inflammation
  401. The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X
  402. Physical activity and cardiovascular health in children
  403. Nuclear receptors versus inflammation: mechanisms of transrepression
  404. Future Pharmacotherapy for Obesity: Integration of Metabolism and Body Weight Regulation
  405. Fibrogenic impact of high serum glucose in chro nic hepatitis C
  406. The metabolic syndrome: role of skeletal muscle metabolism
  407. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo
  408. Inflammation and its relationship to insulin resistance, type 2 diabetes mellitus, and endothelial dysfunction
  409. Leptin and the regulation of the hypothalamic–pituitary–adrenal axis
  410. Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in …
  411. Inflammatory cytokines in acute renal failure
  412. Magic bullets melt fat
  413. PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity
  414. Psychosocial stress and cardiovascular diseases
  415. Long‐term use of appetite suppressant medication: Rationale and recommendations
  416. Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats
  417. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms
  418. Phenotypic diversity of the lung vasculature in experimental models of metastases
  419. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction
  420. Effect of a high or low ambient perinatal temperature on adult obesity in Osborne-Mendel and S5B/Pl rats
  421. The effect of tea polyphenols on chronic disease: obesity, the metabolic syndrome, and colon cancer
  422. Conformational studies on the pancreatic polypeptide hormone family
  423. Abscisic acid ameliorates glucose tolerance and obesity-induced inflammation
  424. The metabolic syndrome
  425. Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway
  426. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men
  427. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes
  428. The Apparent Increase in Insulin Sensitivity of Leptin-Treated Rats Appears to be Due to a Decrease in Blood Glucose Concentrations in Response to Fasting
  429. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-α
  430. Rat models of the metabolic syndrome
  431. Long-term multidisciplinary therapy decreases predictors and prevalence of metabolic syndrome in obese adolescents
  432. Palmitate-mediated downregulation of peroxisome proliferator–activated receptor-γ coactivator 1α in skeletal muscle cells involves MEK1/2 and nuclear factor-κB …
  433. Not the next tobacco: Defenses to obesity claims
  434. Obesity and nutrition
  435. Development of renal-targeted vectors through combined in vivo phage display and capsid engineering of adenoviral fibers from serotype 19p
  436. Drug Therapy for Insulin Resistance—a Look at the Future
  437. Adiponectin oligomers in human serum during acute and chronic exercise: relation to lipid metabolism and insulin sensitivity
  438. Palmitate induces tumor necrosis factor-α expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-κB activation
  439. Kinase-dependent pathways and the development of insulin resistance in hepatocytes
  440. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders
  441. Effect of high-fat diet on KKAy and ob/ob mouse liver and adipose tissue corticosterone and 11-dehydrocorticosterone concentrations
  442. Invited review: uncoupling proteins and thermoregulation
  443. Mechanisms of insulin resistance in humans and possible links with inflammation
  444. Development and evaluation of a nutrition curriculum to prevent obesity in inner-city teens
  445. Cardiac-specific overexpression of peroxisome proliferator–activated receptor-α causes insulin resistance in heart and liver
  446. Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus
  447. Fatty liver in the intensive care unit
  448. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells
  449. Increased glucose uptake promotes oxidative stress and PKC-δ activation in adipocytes of obese, insulin-resistant mice
  450. Monitoring blood glucose levels in female mink during the reproductive cycle: 2. Effects of short-term fish oil, chromium picolinate, and acetylsalicylic acid …
  451. Molecular and cellular aspects of insulin resistance: implications for diabetes
  452. Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man
  453. Outfoxing liver cancer with p19ARF tumor suppressor?
  454. β 3-adrenergic agonist up-regulates uncoupling proteins 2 and 3 in skeletal muscle of the mouse
  455. Non‐Alcoholic Fatty Liver Disease
  456. Direct vasoprotection by aspirin: a significant bonus to antiplatelet activity?
  457. Non-alcoholic fatty liver disease and insulin resistance
  458. Fatty acids, triglycerides, and glucose metabolism: recent insights from knockout mice
  459. Role of oxidative stress and inflammation in the origin of Type 2 diabetes–a paradigm shift
  460. The contribution of mitochondria to common disorders
  461. Serum concentrations of resistin-like molecules β and γ are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract …
  462. Reactive species, cellular repair and risk factors in the onset of type 2 diabetes mellitus: review and hypothesis
  463. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine
  464. Control of oxidative stress and metabolic homeostasis by the suppression of postprandial hyperglycemia
  465. Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid–induced inflammatory changes in the interaction between adipocytes and macrophages
  466. Salicylates targeting insulin resistance
  467. COMMENT: Genetic Variability in Insulin Action Inhibitor Ikkβ (IKBKB) Does Not Play a Major Role in the Development of Type 2 Diabetes
  468. Relationship between stress, inflammation and metabolism
  469. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the [beta] 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats
  470. Bibliography Current World Literature Vol 15 No
  471. 11β-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease
  472. Autoimmune hepatitis
  473. Bradykinin Augments Insulin-Stimulated Glucose Transport in Rat Adipocytes via Endothelial Nitric Oxide Synthase–Mediated Inhibition of Jun NH2-Terminal Kinase
  474. Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women
  475. Acute and chronic effects of leptin on skeletal muscle fatty acid metabolism
  476. Obesity-associated interleukin-6 contributes to hepatic insulin resistance in mice
  477. Kinome analysis reveals nongenomic glucocorticoid receptor-dependent inhibition of insulin signaling
  478. Feeding scallop shell powder induces the expression of uncoupling protein 1 (UCP1) in white adipose tissue of rats
  479. The macrophage at the crossroads of insulin resistance and atherosclerosis
  480. Molecular mechanisms of diabetic vasculopathy
  481. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle …
  482. Control of energy homeostasis: role of enzymes and intermediates of fatty acid metabolism in the central nervous system
  483. Central nervous system regulation of fat cell lipid mobilization: The role of the sympathetic nervous system
  484. Treatment of insulin resistance in diabetes mellitus
  485. Adiponectin and leptin: potential tools in the differential diagnosis of pediatric diabetes?
  486. An efficient 1H/31P double-resonance solid-state NMR probe that utilizes a scroll coil
  487. Short-term and long-term in vivo exposure to an ephedra-and caffeine-containing metabolic nutrition system does not induce cardiotoxicity in B6C3F1 mice
  488. Integration of the metabolic and cardiovascular effects of exercise
  489. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis
  490. Health Promotion and Genome in Japanese
  491. S-adenosyl methionine protects ob/ob mice from CYP2E1-mediated liver injury
  492. Sympathetic innervation of white adipose tissue and its regulation of fat cell number
  493. Old and new determinants in the regulation of energy expenditure
  494. Mechanisms underlying fat-induced hepatic insulin resistance
  495. Metabolic and cellular plasticity in white adipose tissue I: effects of β3-adrenergic receptor activation
  496. Primary prevention by nutrition intervention in infancy and childhood
  497. Insulin is an anti-inflammatory and anti-atherosclerotic hormone
  498. Separate and combined effects of ephedrine and caffeine on protein and lipid deposition in finishing pigs
  499. Agonist-induced activation releases peroxisome proliferator-activated receptor β/δ from its inhibition by palmitate-induced nuclear factor-κB in skeletal muscle cells
  500. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines
  501. Free fatty acid-induced insulin resistance in the obese is not prevented by rosiglitazone treatment
  502. Phosphorylation of fetuin-A, a physiological inhibitor of insulin action, regulated by insulin and leptin
  503. Acute and chronic effects of FR-149175, a β3-adrenergic receptor agonist, on energy expenditure in Zucker fatty rats
  504. Functional characterization of resistin, a novel adipokine
  505. Regulating insulin signaling and β-cell function through IRS proteins
  506. Role of cyclin-dependent kinase inhibitors in estrogen regulation of adipogenesis
  507. The effect of salicylates on insulin sensitivity
  508. Renal Cell Carcinoma: Overview
  509. Adipokine expression and secretion: a target for pharmacologic treatment
  510. Cells of the stroma-vascular fraction of human adipose tissue: characterization and function
  511. Modulation of insulin action
  512. Advanced-glycation end products in insulin-resistant states
  513. Molecular modeling of prohibitin domains
  514. Worsening of steatosis and fibrosis progression
  515. Pathophysiology of NASH: insulin resistance, free fatty acids and oxidative stress
  516. The hormone leptin reduces body weight. A mutant gene makes the mouse obese
  517. Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries
  518. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis
  519. Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes
  520. Mechanism of glucose intolerance in mice with
  521. Effects of pioglitazone on promoting energy storage, not expenditure, in brown adipose tissue of obese fa/fa Zucker rats: comparison to CL 316,243
  522. PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity
  523. Pioglitazone and sodium salicylate protect human β-cells against apoptosis and impaired function induced by glucose and interleukin-1β
  524. Myosin motor Myo1c and its receptor NEMO/IKK-γ promote TNF-α–induced serine307 phosphorylation of IRS-1
  525. Inflammatory markers and type 2 diabetes
  526. Effect of NPY in the hypothalamic paraventricular nucleus on uncoupling proteins 1, 2, and 3 in the rat
  527. Diversion colitis with a mucosal tear on endoscopic insufflation
  528. My scientific life: 40 years at the College de France
  529. The β3-adrenergic agonist CL316, 243 inhibits insulin signaling but not glucose uptake in primary human adipocytes
  530. Real time RT-PCR analysis of hypothalami from rodents treated centrally and peripherally with peptide hormones
  531. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
  532. Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-α induction of p38 and p42/p44 mitogen-activated protein …
  533. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic
  534. Tumour necrosis factor α decreases glucose-6-phosphatase gene expression by activation of nuclear factor κB
  535. Adipocyte differentiation induces dynamic changes in NF-κB expression and activity
  536. Body composition analysis during growth in children and adolescents
  537. The metabolic syndrome and stroke: potential treatment approaches
  538. Perspectives in animal health: old targets and new opportunities
  539. 25 Insulin Resistance Syndrome and Its Vascular Complications
  540. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
  541. Long term follow up of Helicobacter pylori induced gastric diffuse large B cell MALT lymphoma following eradication treatment alone
  542. Altered arterial concentrations of placental hormones during maximal placental growth in a model of placental insufficiency
  543. Association between Helicobacter felis—Induced Gastritis and Elevated Glycated Hemoglobin Levels in a Mouse Model of Type 1 Diabetes
  544. Neuropeptide and peripheral hormone crosstalk with adipocyte function
  545. Prevention of cardiovascular complications of diabetes mellitus by aspirin
  546. THE ANTI-INFLAMMATORY AND POTENTIAL ANTI-ATHEROGENIC EFFECT OF INSULIN
  547. Plasma resistin levels in asthmatics as a marker of disease state
  548. Selenium acts as an insulin-like molecule for the down-regulation of diabetic symptoms via endoplasmic reticulum stress and insulin signalling proteins in diabetes …
  549. Pharmacological studies of trimetoquinol analogs as human beta (3)-adrenergic receptor-selective agonists in vitro
  550. The aging pancreas, glucose tolerance and insulin action
  551. Correction of insulin resistance and the metabolic syndrome
  552. Endothelium, inflammation, and diabetes
  553. Does the Built Environment Influence Physical Activity?: Examining the Evidence–Special Report 282
  554. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis
  555. Mitochondrial uncoupling proteins in energy expenditure
  556. Therapy and clinical trials
  557. Prevention of fat-induced insulin resistance by salicylate
  558. Molecular Biology and Immunology in Hepatology. Advances in the Treatment of Intractable Liver Diseases: Edited by T Tsuji, T Higashi, M Zeniya, et al. Amsterdam …
  559. Hormonal therapy for late-onset depression: The case for growth hormone
  560. ASSESSMENT OF RISK FACTOR IN PATIENTS WITH ISCHEMIC HEART DISEASE IN BASRAH (HOSPITAL BASED STUDY)
  561. Gut: first published as 10.1136/gut. 52.9. 1386 on 11 August 2003. Downloaded from
  562. Colorectal Cancer: MP de Leon. Berlin: Springer, 2002,£ 70.00, pp 303. ISBN 3-540-43047-4
  563. Irritable Bowel Syndrome: Diagnosis and Treatment: Edited by M Camilleri, RC Spiller. Philadelphia: WB Saunders,£ 49.99, pp 193. ISBN 0702026557.
  564. Patents in Targets and Drugs for Insulin Resistance: Correlation with Inflammatory Mediators
  565. Treating insulin resistance: future prospects
  566. Transgenic Models of Impaired Insulin Signaling
  567. Insulin resistance, hypertension and endothelial dysfunction
  568. Molecular imaging of the transcription factor NF-κB, a primary regulator of stress response
  569. The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging …
  570. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle
  571. Metabolic effects of aminophylline in rats
  572. Adult stem cells for cardiovascular diseases: the adipose tissue potential
  573. Homogeneous Assays for Cellular Protein Degradation Using β-Galactosidase Complementation: NF-κB/IκB Pathway Signaling
  574. A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus?
  575. Mitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment
  576. Investigation of the alternative pathway of complement in the biology of white and brown adipocytes
  577. Exercise, MAPK, and NF-κB signaling in skeletal muscle
  578. Effectiveness of a Christian faith-based program for weight loss
  579. Interaction of the hypothalamic-pituitary-adrenal axis with the serotoninergic anorectic D-Fenfluramine
  580. Increased in vivo phosphorylation of insulin receptor at serine 994 in the liver of obese insulin-resistant Zucker rats
  581. Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats
  582. Glucocorticoid administration: Studies on weight regulation and metabolic implications
  583. Role of insulin resistance and insulin secretory dysfunction in the pathogenesis of type 2 diabetes mellitus: lessons from cross-sectional, prospective, and longitudinal …
  584. The relationship between high-fat feeding, insulin resistance, and TNF-α gene expression in growing rats
  585. Modeling drug action in the mouse with knockouts and RNA interference
  586. β1 to β3 Switch in Control of Cyclic Adenosine Monophosphate during Brown Adipocyte Development Explains Distinct β-Adrenoceptor Subtype Mediation of …
  587. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism
  588. Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels
  589. Celecoxib Decreases Fatty Acid Synthase Expression via Down-Regulation of c-Jun N-Terminal Kinase-1
  590. The metabolic and molecular regulation of adipose triglyceride lipase
  591. Short-term lifestyle intervention significantly increases fasting adiponectin and induces a decline in serum adiponectin during oral glucose tolerance test, without …
  592. Inflammation and the development of pancreatic cancer
  593. Aspirin and diabetes
  594. Changes in feeding behavior and metabolism associated with the addition of tallow to the diet of lactating sows
  595. PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling
  596. Informed decision-making on sympathomimetic use in sport and health
  597. State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective
  598. Amelioration of glucose tolerance by hepatic inhibition of nuclear factor κB in db/db mice
  599. Antioxidants in diabetic complications and insulin resistance
  600. Molecular modifications induced by physical exercise: a significant role in disease prevention
  601. Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non–platelet-mediated effects
  602. IRS proteins and the common path to diabetes
  603. Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones
  604. Syndromes of Severe Insulin Resistance (SSIRs)
  605. Localization of thermogenesis induced by single infusion of ephedrine in dog
  606. Nonalcoholic Fatty Liver Diseases: Clinical and Pathophysiological Features
  607. Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors
  608. Phage display technology: applications and innovations
  609. Suppression of DGAT2 Expression Improves Hepatic Steatosis and Prevents Fat Induced Insulin Resistance
  610. Timp3 deficiency in insulin receptor–haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-α
  611. Mechanism of the alcohol cyclic pattern: role of catecholamines
  612. Impact of trans-10, cis-12 conjugated linoleic acid on interleukin (IL)-6 and IL-8 and adipogenic genes in cultures of human adipose tissue explants
  613. IL6 genotypes and colon and rectal cancer
  614. STAT‐3 and the liver: A new station on our way to understand diabetes?
  615. Functional anatomy of the ‘Adipose Organ’
  616. Molecular basis of coordination of adipocyte metabolic and inflammatory responses
  617. Age-and sex-related reference values for serum insulin concentration and its biological determinants in a French healthy population. The STANISLAS cohort
  618. Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat type 2 diabetes
  619. Ras-Raf signaling needs prohibitin
  620. Cell Signaling Properties of a-Lipoic Acid: Implications in Type 2 Diabetes
  621. an unexpected virus–host interaction–the hepatitis C virus‐diabetes link
  622. Comparison of isoenergetic aerobic versus aerobic plus resistance exercise program during a weight loss program
  623. Independent Associations between Psychosocial Constructs and C-Reactive Protein among Healthy Women
  624. Suppressor of Cytokine Signaling
  625. Angiogenesis: an organizing principle for drug discovery?
  626. Lipid metabolism and therapy
  627. Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells
  628. Leptin regulation of glucose homeostasis
  629. Tumor necrosis factor α produces insulin resistance in skeletal muscle by activation of inhibitor κB kinase in a p38 MAPK-dependent manner
  630. Real-time RT-PCR and proteomic analysis of adipose tissue from ob/ob mice treated with leptin
  631. Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance
  632. A bifunctional targeted peptide that blocks HER-2 tyrosine kinase and disables mitochondrial function in HER-2-positive carcinoma cells
  633. The role of GSK3 in glucose homeostasis and the development of insulin resistance
  634. The relationship of the Diet Quality Index to prevalence of overweight in black and white adolescent girls: an examination of data from the National Heart, Lung, and …
  635. On endothelial function in type 2 diabetic patients with coronary artery disease
  636. Small rat islets are superior to large islets in in vitro function and in transplantation outcomes
  637. CLAUDIA MENZAGHI, NATTACHET PLENGVIDHYA, XIAOWEI MA, JAMES H. WARRAM
  638. Type 2 diabetes impairs interleukin-4 function in macrophages and amplifies the brain-based neuroimmune response
  639. NF-κB and the regulation of hematopoiesis
  640. Insulin Signalling and Regulation of Protein kinase B in Adipocytes
  641. Stress and Type 2 diabetes
  642. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
  643. Tumor angiogenesis: feeding the beast
  644. The polycystic ovary syndrome: some pathophysiological, diagnostical and therapeutical aspects
  645. Insulin Resistance
  646. Frank L. Greenway
  647. Apolipoprotein A-IV is regulated by nutritional and metabolic stress: involvement of glucocorticoids, HNF-4α, and PGC-1αs⃞
  648. Temperature-dependent effects of ephedrine in the cold
  649. Inflammatory Response and Oxidative Stress in Rats Selected for Intrinsic Aerobic Endurance Capacity
  650. New developments in NF-KB
  651. Bibliography Current World Literature Vol 5 No 4 July 2002
  652. Nutrition and vascular function.
  653. Pi 3-kinase and its up-and down-stream modulators as potential targets for the treatment of type II diabetes
  654. Fitness and the Elderly
  655. Nuclear factor-κB: its role in health and disease
  656. Transgenic expression of viral transcription factors leads to metabolic syndrome in mice
  657. Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline
  658. The Selenium Significantly Activated the ER Stress Signaling Pathway in the Diabetes-Susceptible NOD Mice
  659. The Impact The Impact of the Built Environment the Built Environment the Built Environment on the Health of the Population of the Population of the Population …
  660. Effects of acetylsalicylic acid on experimental atherogenesis induced in rabbits
  661. Hypoxia amplifies the proliferative capacity of distal human pulmonary artery smooth-muscle cells
  662. Therapy and clinical trials
  663. The Prohibitins: emerging roles in diverse functions
  664. Liza Makowski, Ph. D., MM
  665. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention …
  666. Gliclazide protects 3T3L1 adipocytes against insulin resistance induced by hydrogen peroxide with restoration of GLUT4 translocation
  667. Effects of caffeine and exercise on the development of bone: a densitometric and histomorphometric study in young Wistar rats
  668. Use of cell permeable NBD peptides for suppression of inflammation
  669. Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative action
  670. Effect of Huanglian Jiedu Decoction on Glucose Transporter 4 Expression in Adipose and Skeletal Muscle Tissues of Insulin Resistant Rats.
  671. Vitamin A and beta (3) adrenergic regulation of leptin and UCP1 expression: Role in energy homeostasis and senescence
  672. Plasma arachidonic acid influences insulin-stimulated glucose uptake in healthy adult women
  673. Induction of multidrug resistance proteins MRP1 and MRP3 and γ-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human …
  674. Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies
  675. IKK-2/NF-κB-DEPENDENT TRANSCRIPTION
  676. Design and construction of targeted AAVP vectors for mammalian cell transduction
  677. Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids
  678. NF-κB pathway in metabolic/endocrine diseases
  679. Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes
  680. Prohibitin binds to C3 and enhances complement activation
  681. Screening of Peptide‐Displaying Phage Libraries to Identify Short Peptides Mimicking Carbohydrates
  682. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy
  683. Vascular targeting: recent advances and therapeutic perspectives
  684. Future targets in the treatment of type 2 diabetes
  685. Molecular profiling of heart endothelial cells
  686. Gene expression of 11β-hydroxysteroid dehydrogenase type 1 and type 2 in the kidneys of insulin-dependent diabetic rats
  687. Effect of castration on acetyl salicylic acid metabolism in rabbits
  688. Lipoic acid in multiple sclerosis: a pilot study
  689. Long-term effects of recombinant human insulin-like growth factor I treatment on glucose and lipid metabolism and the growth of a patient with congenital generalized …
  690. Optimization of anti-tumor necrosis factor-α single chain Fv displayed on phages for creation of functional antibodies
  691. Inhibition of translation and insulin signaling by p21-activated protein kinase 2 (Pak2)
  692. Roles of AMPK in the regulation of cardiac metabolism and cell death
  693. Oxidative stress induces insulin resistance by activating the nuclear factor-κB pathway and disrupting normal subcellular distribution of phosphatidylinositol 3 …
  694. Prevention of the Angiogenic Switch in Human Breast
  695. The changes of fructos-2, 6-bisphosphate level in transgenic mice causing cardiomyopathy
  696. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver
  697. Nonalcoholic steatohepatitis: pathogenesis and treatment
  698. Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis
  699. Inhibition of IκB kinase by a new class of retinoid-related anticancer agents that induce apoptosis
  700. Orientation and Helical Conformation of a Tissue-specific Hunter-killer Peptide in Micelles
  701. Treatment of hypoxia‐induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease
  702. Prevention of the Angiogenic Switch in Human Breast Cancer
  703. Detecting type 2 diabetes by a single post-challenge blood sample
  704. Leukemia targeting ligands isolated from phage display peptide libraries
  705. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction
  706. Comprehensive Development Program of Hunter-Killer Peptides for Prostate Cancer
  707. Insulin and cellular stress induced glucose uptake in 3T3-L1 adipoc tes
  708. Opportunities for the treatment of inflammation in cardiovascular disease
  709. T regulatory cell based immunotherapy for the treatment of cancer
  710. Metabolic Effects of Antiproliferative Agents
  711. Techniques to decipher molecular diversity by phage display
  712. Cyclooxygenase-2 (PTGS2) inhibitors augment the rate of hexose transport in L6 myotubes in an insulin-and AMPKα-independent manner
  713. Ceramida como mediador de la resistencia a insulina producida por el factor de necrosis tumoral alfa en adipocitos marrones
  714. Proteomic identification and functional characterization of prohibitin 1 and 2 in T cell activation, expansion, survival and disease
  715. Iron in Chronic Liver Disease
  716. antibody by ELISA. Although control peptides did not bind to anti-TNF-a antibody, this synthetic peptide con-taining TNF-o fragment peptide dose-dependently …
  717. Identification of Molecular Receptors for Therapeutic Targeting in Prostate Cancer
  718. Ligand-directed targeting of malignant gliomas
  719. Proteomanalyse humaner Glatiramerazetat und Myelin basisches Protein spezifischer T-Zell Linien von MS-Patienten und gesunden Kontrollpersonen
  720. Angiogenesis Research to Improve Therapies for Vascular Leak Syndromes, Intra-Abdominal Adhesions, and Arterial Injuries
  721. Influence of calorie restriction on insulin signalling and glucose transport in skeletal muscle of rats
  722. The development of genetically-targeted adenoviral vectors for in vivo delivery to the heart
  723. Prevention and reversal of obesity and glucose intolerance in mice by DHA derivatives
  724. Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice
  725. Childhood obesity
  726. Predictors of chronic disease at midlife and beyond-the health risks of obesity
  727. Food reward functions as affected by obesity and bariatric surgery
  728. Inflammation in obesity-related diseases
  729. Chronic administration of brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reverses obesity induced by high-fat diet
  730. Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass
  731. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity
  732. Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation
  733. Obesity and CKD: how to assess the risk?
  734. Risks and management of obesity in pregnancy: current controversies
  735. Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia
  736. Brown adipose tissue and seasonal variation in humans
  737. Vascular targeting of adipose tissue as an anti-obesity approach
  738. Applying Brainpower to Obesity
  739. Changes in adiposity status from childhood to adolescence: A 6-year longitudinal study in Portuguese boys and girls
  740. Differential effects of calorie restriction and exercise on the adipose transcriptome in diet-induced obese mice
  741. n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet
  742. Mechanical stimulation of mesenchymal stem cell proliferation and differentiation promotes osteogenesis while preventing dietary‐induced obesity
  743. Normalization of obesity-associated insulin resistance through immunotherapy
  744. A putative role for apelin in the etiology of obesity
  745. The effect of obesity on sperm disorders and male infertility
  746. Prevention of obesity in preschool children
  747. Response of fractional synthesis rate (FSR) of fibrinogen, concentration of D‐dimer and fibrinolytic balance to physical activity‐based intervention in obese …
  748. Association between obesity and atopic dermatitis in childhood: a case-control study
  749. Obesity-Induced Inflammation and Insulin Resistance
  750. Obesity and Related Co-Morbid Conditions–A Retrograde Study
  751. Changing the future of obesity: science, policy, and action
  752. Adipokines in obesity
  753. A potential role for insulin in management of the metabolic syndrome
  754. “Liking” and “wanting” of sweet and oily food stimuli as affected by high-fat diet-induced obesity, weight loss, leptin, and genetic predisposition
  755. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration
  756. Brain sites capable of eliciting short-day responses in the Siberian hamster
  757. Food deprivation-induced changes in body fat mobilization after neonatal monosodium glutamate treatment
  758. Fibroblast growth factor 21 corrects obesity in mice
  759. Randomized trial on the effects of a 7-d low-glycemic diet and exercise intervention on insulin resistance in older obese humans
  760. Inflammation and adipose tissue macrophages in lipodystrophic mice
  761. Diacerhein improves glucose tolerance and insulin sensitivity in mice on a high-fat diet
  762. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells
  763. Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high …
  764. Insulin resistance, inflammation, and non-alcoholic fatty liver disease
  765. A highly saturated fat-rich diet is more obesogenic than diets with lower saturated fat content
  766. In vivo imaging of obesity-induced inflammation in adipose tissue
  767. Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway
  768. “Control” laboratory rodents are metabolically morbid: why it matters
  769. Weight regain after Roux-en-Y: a significant 20% complication related to PYY
  770. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress
  771. Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta
  772. Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice
  773. High-fat diet-induced obesity in animal models
  774. Mechanism for improved insulin sensitivity after gastric bypass surgery
  775. Salsalate improves glycemia and inflammatory parameters in obese young adults
  776. Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
  777. Ciliary neurotrophic factor stimulates muscle glucose uptake by a PI3-kinase–dependent pathway that is impaired with obesity
  778. Adipose tissue as an endocrine organ
  779. Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKβ
  780. Adipose Tissue Secreted Factors in Specific Populations and Metabolic States: Implications for Energy Balance and Metabolic Health
  781. REIN on obesity, proteinuria and CKD
  782. Endoscopic solutions for weight loss
  783. How young for bariatric surgery in children?
  784. Bariatric surgery
  785. Obesity in children. Part 2: Prevention and management
  786. Obesity surgery and gut–brain communication
  787. Gastric bypass up-regulates insulin signaling pathway
  788. Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity
  789. Angiogenesis and obesity
  790. Laminitis and the equine metabolic syndrome
  791. Diet-induced obesity alters protein synthesis: tissue-specific effects in fasted versus fed mice
  792. An intact dorsomedial hypothalamic nucleus, but not the subzona incerta or reuniens nucleus, is necessary for short-day melatonin signal-induced responses in …
  793. Emerging role of adipose tissue hypoxia in obesity and insulin resistance
  794. 3 The Role of Obesity in
  795. Childhood obesity: Treatment or prevention
  796. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease
  797. Oxidative stress and inflammation as therapeutic targets for high-fat diet-induced metabolic diseases
  798. Bariatric surgery in young massively obese diabetic patients
  799. Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance
  800. Inflammatory links between obesity and metabolic disease
  801. Inflammatory mechanisms in the regulation of insulin resistance
  802. Inflammatory concepts of obesity
  803. The influence of pediatric resident counseling on limiting sugar-sweetened drinks in children
  804. Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea
  805. Contrasting effects of leptin on food anticipatory and total locomotor activity
  806. Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids
  807. Adipokines: the missing link between insulin resistance and obesity
  808. Insulin sensitivity: modulation by nutrients and inflammation
  809. Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation*[S]
  810. Dysregulation of glucocorticoid metabolism in murine obesity: comparable effects of leptin resistance and deficiency
  811. Obesity, adipogenesis and insulin resistance
  812. Maternal obesity, inflammation, and fetal skeletal muscle development
  813. Obesity: New Mechanisms and Translational Paradigms
  814. Effects of rosiglitazone on intramyocellular lipid accumulation in Psammomys obesus
  815. Endoscopic visceral fat removal as therapy for obesity and metabolic syndrome: a sham-controlled pilot study (with video)
  816. Integrative and Translational Physiology: Integrative Aspects of Energy Homeostasis and Metabolic Diseases:“Liking” and “wanting” of sweet and oily food …
  817. The energy balance equation: looking back and looking forward are two very different views
  818. Inflammation and insulin resistance
  819. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance
  820. Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat
  821. Is adipose tissue metabolically different at different sites?
  822. Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity
  823. PPAR γ is highly expressed in F4/80hi adipose tissue macrophages and dampens adipose-tissue inflammation
  824. The role and therapeutic potential of prohibitin in disease
  825. Maternal obesity promotes a proinflammatory signature in rat uterus and blastocyst
  826. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment
  827. Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue
  828. Pathogenesis of non-alcoholic fatty liver disease
  829. n-3 PUFA: bioavailability and modulation of adipose tissue function: Symposium on ‘Frontiers in adipose tissue biology’
  830. Overweight, obesity, and related diseases
  831. Metabolic Mechanisms of Muscle Insulin Resistance
  832. Pigment epithelium-derived factor contributes to insulin resistance in obesity
  833. Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice
  834. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse
  835. Obesity, inflammation, and atherosclerosis
  836. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
  837. Bariatric surgery: a review of the available procedures and complications for the emergency physician
  838. 45Obesity, insulin resistance and free fatty acids
  839. Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation
  840. Adipokines in Obesity
  841. Hunter− killer peptide (HKP) for targeted therapy
  842. TNF-α and adipocyte biology
  843. Role of childhood obesity in atopic dermatitis
  844. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases
  845. Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction
  846. c-Jun N-terminal kinase pathways in diabetes
  847. The clinical implications of blood adiponectin in cardiometabolic disorders
  848. Adipokine Signaling: Implications for Obesity
  849. EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet–fed mice
  850. Food intake during the normal activity phase prevents obesity and circadian desynchrony in a rat model of night work
  851. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice
  852. Hypothalamic control of energy and glucose metabolism
  853. Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery
  854. Food reward, hyperphagia, and obesity
  855. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases
  856. Therapeutic approaches to target inflammation in type 2 diabetes
  857. Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: involvement of antiadipogenic mechanism and extracellularly regulated …
  858. Investigation of nuclear factor-κB inhibitors and interleukin-10 as regulators of inflammatory signalling in human adipocytes
  859. Biomechanical promotion of mesenchymal stem cell proliferation as a countermeasure to the development of obesity and osteoporosis
  860. Maternal obesity-impaired insulin signaling in sheep and induced lipid accumulation and fibrosis in skeletal muscle of offspring
  861. Beneficial effects of IKKε-deficiency on body weight and insulin sensitivity are lost in high fat diet-induced obesity in mice
  862. Surgery for obesity
  863. Integrating Role of Adipose Tissue Secretory Functions in Response to Dietary and Pharmacological Treatments
  864. Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice
  865. Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes: Involvement of Nuclear Factor-κB and c-Jun NH2-Terminal Kinase Pathways
  866. Outcomes of bariatric surgery in adolescents
  867. Tenomodulin gene and obesity-related phenotypes
  868. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery
  869. Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study
  870. Morphological and immunohistochemical features of brown adipocytes and preadipocytes in a case of human hibernoma
  871. Analysis of the involvement of α2-AMPK in the beneficial effects of n-3 polyunsaturated fatty acids on obesity-associated metabolic derangements
  872. Effect of aspirin on the expression of hepatocyte NF-κB and serum TNF-α in streptozotocin-induced type 2 diabetic rats
  873. Angiogenesis and development of adipose tissue
  874. siRNA-mediated reduction of inhibitor of Nuclear Factor-κB Kinase prevents Tumor Necrosis Factor-α–induced insulin resistance in human skeletal muscle
  875. JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
  876. Obesity in neurobiology
  877. Lipopolysaccharide, high glucose and saturated fatty acids induce endoplasmic reticulum stress in cultured primary human adipocytes: Salicylate alleviates this stress
  878. Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses
  879. Chemerin, a novel adipokine in the regulation of angiogenesis
  880. The Association between Obesity, Cognition, and Visual Function
  881. The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis
  882. Tissular Tregs: A unique population of adipose-tissue-resident Foxp3+ CD4+ T cells that impacts organismal metabolism
  883. Bariatric surgery to correct morbid obesity also ameliorates atherosclerosis in patients with type 2 diabetes mellitus
  884. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
  885. The renin angiotensin system and the metabolic syndrome
  886. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models
  887. Molecular mechanisms of obesity and diabetes: at the intersection of weight regulation, inflammation, and glucose homeostasis
  888. Adipose inflammation: cause or consequence of obesity-related insulin resistance
  889. Up-regulation of Toll-like receptor 4/nuclear factor-κB signaling is associated with enhanced adipogenesis and insulin resistance in fetal skeletal muscle of obese …
  890. Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease [S]
  891. Intestinal microbiota during infancy and its implications for obesity
  892. Lifestyle of hungarian adolescents–observations among metropolitan secondary school students
  893. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies
  894. Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases
  895. Inflammatory cytokines and metabolic risk factors during growth and maturation: influence of physical activity
  896. Large size cells in the visceral adipose depot predict insulin resistance in the canine model
  897. Cardiac lipotoxic effects of obesity
  898. Leptin is essential in maintaining normal vascular compliance independent of body weight
  899. Macrophage-mediated inflammation in metabolic disease
  900. Low birth weight and markers of inflammation and endothelial activation in adulthood: the ARIC study
  901. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease
  902. Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages
  903. Lipid ratio useful indicator in predicting risk of myocardial infarction in elderly normolipidemic patients: a report from a multi center study
  904. Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models
  905. Progressive dementia associated with ataxia or obesity in patients with Tropheryma whipplei encephalitis
  906. The adipocyte as an endocrine cell
  907. Brown adipose tissue in morbidly obese subjects
  908. Bariatric surgery in adolescents
  909. Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal …
  910. Solidago chilensis Meyen hydroalcoholic extract reduces JNK/IκB pathway activation and ameliorates insulin resistance in diet-induced obesity mice
  911. The Role of Obesity in Insulin Resistance: Epidemiological and Metabolic Aspects
  912. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
  913. The role of inflammatory cytokines in diabetes and its complications
  914. Inflammatory lipid mediators in adipocyte function and obesity
  915. NF-κB, inflammation, and metabolic disease
  916. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation
  917. Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of …
  918. Early insulin sensitivity after restrictive bariatric surgery, inconsistency between HOMA-IR and steady-state plasma glucose levels
  919. The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication
  920. The role of cytokines in non-alcoholic fatty liver disease
  921. Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children
  922. Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPARγ−/−, PPARδ−/−, PPARγδ−/−, or LXRαβ−/− bone marrow
  923. Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women
  924. Insulin resistance associated to obesity: the link TNF-alpha
  925. Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue
  926. Nature or nurture?: focus on “Preadipocyte transplantation: an in vivo study of direct leptin signaling on adipocyte morphogenesis and cell size”
  927. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy …
  928. The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity
  929. Xanthones from mangosteen prevent lipopolysaccharide-mediated inflammation and insulin resistance in primary cultures of human adipocytes
  930. Metabolic impact of estrogen signalling through ERalpha and ERbeta
  931. A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys
  932. Hypoxia-inducible factor 1α induces fibrosis and insulin resistance in white adipose tissue
  933. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
  934. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity
  935. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet–induced adipose tissue inflammation coincident with improved glucose homeostasis
  936. Effects of systemic inflammation on insulin sensitivity in horses and inflammatory cytokine expression in adipose tissue
  937. The multiple facets of the fat tissue
  938. 11β-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds
  939. Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations
  940. Determinants of brown adipocyte development and thermogenesis
  941. The protein kinase IKKɛ regulates energy balance in obese mice
  942. Endoplasmic reticulum stress and inflammation in obesity and diabetes
  943. Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRβ …
  944. Bofutsushosan, an oriental herbal medicine, attenuates the weight gain of white adipose tissue and the increased size of adipocytes associated with the increase in …
  945. Using gene expression signatures to dissect insulin resistance subtypes
  946. Structure–effect relation of C18 long-chain fatty acids in the reduction of body weight in rats
  947. Down-regulation of peroxisome proliferator-activated receptor γ coactivator-1α expression in fatty acid-induced pancreatic betacell apoptosis involves nuclear factor …
  948. Limited weight loss or simply no weight gain following lifestyle-only intervention tends to redistribute body fat, to decrease lipid concentrations, and to improve …
  949. Effects of n-3 polyunsaturated fatty acids, rosiglitazone, low caloric diet and environmental pollutants: obesity and related disorders
  950. Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet
  951. Novel fat depot–specific mechanisms underlie resistance to visceral obesity and inflammation in 11β-hydroxysteroid dehydrogenase type 1–deficient mice
  952. Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity
  953. Type 2 diabetes as an inflammatory disease
  954. Luteolin inhibits inflammatory response and improves insulin sensitivity in the endothelium
  955. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue
  956. Role of mitochondrial dysfunction in insulin resistance
  957. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity
  958. Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and β-cell dysfunction …
  959. Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes
  960. Anthropometric indicators of obesity and their link to lifestyle and cardiovascular risk in Colorado firefighters
  961. Adipokines in health and disease
  962. Getting the message across: mechanisms of physiological cross talk by adipose tissue
  963. Maternal obesity markedly increases placental fatty acid transporter expression and fetal blood triglycerides at midgestation in the ewe
  964. ROLE OF HIGH DOSE ASPIRIN IN MODULATING HYPERLIPIDEMIA AND HYPERGLYCEMIA
  965. Suppressing inflammation: a novel approach to treating the metabolic syndrome
  966. Activation of peroxisome proliferator-activated receptor-δ by GW501516 prevents fatty acid-induced nuclear factor-κB activation and insulin resistance in skeletal …
  967. Metformin Improves Insulin Signaling in Obese Rats via Reduced IKK Action in a Fiber-Type Specific Manner
  968. Polymethoxyflavones Activate Ca2+-Dependent Apoptotic Targets in Adipocytes
  969. Adipose tissue development, structure and function
  970. Increased whole-body and sustained liver cortisol regeneration by 11β-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for …
  971. Cholesterol’s decoupling effect on membrane partitioning and permeability revisited: Is there anything beyond Fick’s law of diffusion?
  972. Uncoupling protein 1 expression and high-fat diets
  973. Fats and fatty acid requirements for adults
  974. Diet-induced obesity increases NF-κB signaling in reporter mice
  975. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats
  976. Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways
  977. Vascular endothelial growth factor haplotypes associated with childhood obesity
  978. Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options
  979. Regulation by chronic-mild stress of glucocorticoids, monocyte chemoattractant protein-1 and adiposity in rats fed on a high-fat diet
  980. Antidiabetic Properties of Zinc-α2-Glycoprotein in ob/ob Mice
  981. Dissociation between skeletal muscle inhibitor-κB kinase/nuclear factor-κB pathway activity and insulin sensitivity in nondiabetic twins
  982. The effect of aspirin on atherogenic diet‐induced diabetes mellitus
  983. The obesity phenotype in children with asthma
  984. Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity
  985. Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-κB pathway in rat aorta
  986. Fighting fat with fat: the expanding field of adipose stem cells
  987. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in …
  988. Immune Modulation of Metabolism: The Role of Macrophages, NKT Cells and Dendritic Cells in the Development of the Metabolic Disturbances of Obesity
  989. Metabolic syndrome: from epidemiology to systems biology
  990. Oxidative stress and the etiology of insulin resistance and type 2 diabetes
  991. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
  992. The efficiency of cellular energy transduction and its implications for obesity
  993. Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders
  994. Transdifferentiation properties of adipocytes in the adipose organ
  995. High-fat diet induces Ikkβ and reduces insulin sensitivity in rats with low running capacity
  996. Lipid-induced insulin resistance is prevented in lean and obese myotubes by AICAR treatment
  997. Low-grade inflammation and the metabolic syndrome in children and adolescents
  998. Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the …
  999. Energetický metabolismus inbredních myších linií a jeho ovlivnění dietou
  1000. Central adiposity, systemic inflammation, and the metabolic syndrome
  1001. Palmitate-induced skeletal muscle insulin resistance does not require NF-κB activation
  1002. Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats
  1003. Obesity-Associated Inflammation And Its Role In Insulin Resistance
  1004. TNF-α and ghrelin: opposite effects on immune system, metabolism and mental health
  1005. Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine–choline-deficient diet
  1006. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERα-deficient mice
  1007. IκB kinase β (IKKβ/IKK2/IKBKB)—A key molecule in signaling to the transcription factor NF-κB
  1008. Inflammatory biomarkers associated with obesity and insulin resistance: a focus on lipocalin-2 and adipocyte fatty acid-binding protein
  1009. Role of stearoyl-CoA desaturase in human metabolic disease
  1010. Insights into the pathogenesis of NAFlD: The role of metabolic and pro-inflammatory mediators.
  1011. Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity
  1012. Deficiency of haematopoietic-cell-derived IL-10 does not exacerbate high-fat-diet-induced inflammation or insulin resistance in mice
  1013. Pathogenic perspectives for the role of inflammation in diabetic nephropathy
  1014. IKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance
  1015. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
  1016. Chronic kidney disease: importance of early diagnosis, immediate referral and structured interdisciplinary approach to improve outcomes in patients not yet on …
  1017. Salsalate attenuates free fatty acid–induced microvascular and metabolic insulin resistance in humans
  1018. 11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in type 2 diabetes mellitus and obesity
  1019. Dietary Energy Balance, Calorie Restriction, and Cancer Prevention
  1020. SPARC functions as an inhibitor of adipogenesis
  1021. Cellular Remodeling during the Growth of the Adipose Tissue
  1022. Adipose tissue macrophages: a piece of the PAI of metabolic syndrome
  1023. Substance P (SP)-neurokinin-1 receptor (NK-1R) alters adipose tissue responses to high-fat diet and insulin action
  1024. Inhibitory effect on protein kinase Cθ by Crocetin attenuates palmitate-induced insulin insensitivity in 3T3-L1 adipocytes
  1025. In vivo and in vitro application of black soybean peptides in the amelioration of endoplasmic reticulum stress and improvement of insulin resistance
  1026. IκB kinase ε: A potential therapeutic target for obesity (and nonalcoholic fatty liver disease)?
  1027. Dietary bitter melon seed increases peroxisome proliferator-activated receptor-γ gene expression in adipose tissue, down-regulates the nuclear factor-κB expression …
  1028. Therapeutic prospects of metabolically active brown adipose tissue in humans
  1029. 14 The Link Between Esophageal Cancer and Morbid Obesity
  1030. Feed-forward signaling of TNF-α and NF-κB via IKK-β pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice
  1031. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine …
  1032. Vascular and endothelial regeneration
  1033. A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity
  1034. Development of obesity-induced inflammation and insulin resistance: The role of adipose tissue, fatty acids, and toll-like receptors
  1035. HSP and diabetes
  1036. Brown fat biology and thermogenesis
  1037. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD
  1038. Articles in PresS. J Appl Physiol (January 13, 2011). doi: 10.1152/japplphysiol. 00541.2010
  1039. The role of the TWEAK/Fn14 signaling pathway in inflammatory and metabolic responses to diet-induced obesity
  1040. The presence and role of brown fat in adult humans
  1041. NATURE AND MECHANISMS OF INSULIN RESISTANCE–ROLE OF ADIPOKINES IN ETIOLOGY AND PATHOGENESIS
  1042. Transcriptional control of brown adipocyte development and physiological function—of mice and men
  1043. Fat Treg cells: a liaison between the immune and metabolic systems
  1044. Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight
  1045. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects
  1046. Lipid chaperones and metabolic inflammation
  1047. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice
  1048. Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse
  1049. The impact of myeloid cell-restricted insulin receptor deficiency on obesity-induced insulin resistance
  1050. β3-Adrenoceptor ligand development history through patent review
  1051. Brown adipose tissue in humans is activated by elevated plasma catecholamines levels and is inversely related to central obesity
  1052. The relationship between patients’ serum glucose levels and metabolically active brown adipose tissue detected by PET/CT
  1053. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress
  1054. THP-1 Macrophages and SGBS Adipocytes – A New Human in vitro Model System of Inflamed Adipose Tissue
  1055. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis
  1056. A European evidence-based guideline for the prevention of type 2 diabetes
  1057. The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity
  1058. The cost-effectiveness of child obesity intervention
  1059. Maternal obesity induces sustained inflammation in both fetal and offspring large intestine of sheep
  1060. Chronic treatment with the cannabinoid 1 antagonist rimonabant altered vasoactive cyclo-oxygenase-derived products on arteries from obese Zucker rats
  1061. Aspirin use and risk of type 2 diabetes in apparently healthy men
  1062. Rein, tissu adipeux, adipocytes–quelles nouveautés?
  1063. Role of NF-κB in the pathogenesis of diabetes and its associated complications
  1064. Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology
  1065. The peroxide dilemma: opposing and mediating insulin action
  1066. Analysis of knockout mice suggests a role for VGF in the control of fat storage and energy expenditure
  1067. RNAi-based therapeutic strategies for metabolic disease
  1068. Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology
  1069. Serum adiponectin levels are inversely correlated with insulin resistance in obese men with type 2 diabetes
  1070. Adipose tissue: development, anatomy and functions
  1071. Articles in PresS. Am J Physiol Endocrinol Metab (October 19, 2010). doi: 10.1152/ajpendo. 00219.2010
  1072. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung
  1073. Inflammation as a factor of the pathogenesis of insulin resistance and type 2 diabetes
  1074. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits
  1075. Visfatin and adiponectin levels in children: relationships with physical activity and metabolic parameters
  1076. aging and Alzheimer’s disease through the biological mechanisms behind obesity and type II diabetes. May 2013 Health IN PRESS
  1077. TLR4 and insulin resistance
  1078. Obesity and Asthma
  1079. Fitness level and body composition are associated with inflammation in non-obese children
  1080. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans
  1081. Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells
  1082. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study
  1083. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes
  1084. SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins
  1085. Lipid signalling in disease
  1086. Homocysteine upregulates resistin production from adipocytes in vivo and in vitro
  1087. Pharmacological characterization of a small molecule inhibitor of c-Jun kinase
  1088. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women
  1089. Gene expression profiles of diabetic mice treated with whole body hyperthermia: A high-density DNA microarray analysis
  1090. Role of the adipocyte-specific NF-κB activity in the regulation of IP-10 and T cell migration
  1091. Gut Microbes, Immunity, and Metabolism
  1092. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice
  1093. The multi-systemic nature of diabetes mellitus: Genotype or phenotype?
  1094. Neonatal overfeeding induced by small litter rearing causes altered glucocorticoid metabolism in rats
  1095. Preliminary Studies Investigating a Potential Role of an Intestinal Bacterium in the Development of Diet-Induced Obesity
  1096. Muscle-specific IRS-1 Ser→ Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle
  1097. 1 5 Insulin Resistance and Inhibitors of
  1098. The Role of Adipose Tissue Vasculature in Energy Balance.
  1099. Is there a relationship between insulin resistance and frailty syndrome?
  1100. Kupffer cell activation is a causal factor for hepatic insulin resistance
  1101. Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice
  1102. Lipid induced overexpression of NF-κB in skeletal muscle cells is linked to insulin resistance
  1103. Potential role of salicylates in type 2 diabetes
  1104. Loss of Stearoyl-CoA desaturase-1 attenuates adipocyte inflammation: effects of adipocyte-derived oleate
  1105. The implication of brown adipose tissue for humans
  1106. Cancer Prevention from a Biologist’s Perspective
  1107. To be or not to be fat: a novel role of Jak/Stat pathway in brown fat development and preventing obesity
  1108. The Role of Fatty Acids on Toll-like Receptor 4 Regulation of Substrate Metabolism with Obesity
  1109. The genetics of brown adipose tissue
  1110. Local metabolism of glucocorticoids in Prague hereditary hypertriglyceridemic rats–Effect of hypertriglyceridemia and gender
  1111. Long-term effect of lifestyle intervention on adiposity, metabolic parameters, inflammation and physical fitness in obese children: a randomized controlled trial
  1112. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes
  1113. Reversible physiological transdifferentiation in the adipose organ: symposium on ‘frontiers in adipose tissue biology’
  1114. Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure
  1115. Dog obesity, dog walking, and dog health
  1116. NF-κB in aging and disease
  1117. Effects of a structured exercise program on insulin resistance, inflammatory markers and physical fitness in obese Korean children
  1118. Distributed forebrain sites mediate melatonin-induced short-day responses in Siberian hamsters
  1119. Adiponectin, leptin, the adiponectin/leptin ratio, and physical fitness in children and young adults
  1120. Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: is there a role for adipose tissue and liver?
  1121. Over-the-counter analgesics normalize blood glucose and body composition in mice fed a high fat diet
  1122. FEDERICO II
  1123. Insulin resistance induced by tumor necrosis factor-α in myocytes and brown adipocytes
  1124. Salicylates increase insulin secretion in healthy obese subjects
  1125. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis
  1126. Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences
  1127. Aerobic training reverses high-fat diet-induced pro-inflammatory signalling in rat skeletal muscle
  1128. Effect of the dietary fat quality on insulin sensitivity
  1129. Energy Balance and Cancer Risk: Metabolic and Molecular Studies
  1130. Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal …
  1131. Fat Cell–Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism
  1132. Role of PPARγ in renoprotection in type 2 diabetes: molecular mechanisms and therapeutic potential
  1133. High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes
  1134. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway
  1135. Skeletal muscle stem cells: effects of aging and metabolism on muscle regenerative function
  1136. Altered estrogen receptor expression in skeletal muscle and adipose tissue of female rats fed a high-fat diet
  1137. Phosphorylation of IRS proteins, insulin action, and insulin resistance
  1138. Counter-modulation of fatty acid-induced pro-inflammatory nuclear factor κB signalling in rat skeletal muscle cells by AMP-activated protein kinase
  1139. Nutrient intake, physical activity, and CVD risk factors in children: Project HeartBeat!
  1140. 15 Insulin Resistance and Inflammatory Signaling Pathways Modulated by High-Fat Diet
  1141. Macrophage infiltration and cytokine release in adipose tissue: angiogenesis or inflammation?
  1142. 2009 World Congress on the Insulin Resistance Syndrome: Cardiovascular Disease Concepts
  1143. The role of peroxisome proliferator-activated receptor β/δ on the inflammatory basis of metabolic disease
  1144. Ankle stiffness in postmenopausal women: influence of hormone therapy and menopause nature
  1145. Adipose triglyceride lipase-null mice are resistant to high-fat diet–induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation
  1146. The role of ATF-2 family transcription factors in adipocyte differentiation: antiobesity effects of p38 inhibitors
  1147. Ligands of Adipose Stem Cell Receptors Isolated by High-Throughput Combinatorial Peptide Library Screening
  1148. 15 Insulin Resistance
  1149. Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease
  1150. Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging
  1151. 8 Glucocorticoids as
  1152. Inflammatory signaling in skeletal muscle insulin resistance: green signal for nutritional intervention?
  1153. Activation of Fas (CD95) in adipocytes contributes to high fat diet-induced insulin-resistance
  1154. Molecular mechanisms of insulin resistance in chronic hepatitis C
  1155. Mathematical modeling of preadipocyte fate determination
  1156. Sleeve gastrectomy relieves steatohepatitis in high-fat-diet-induced obese rats
  1157. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy
  1158. Lipoic acid increases heat shock protein expression and inhibits stress kinase activation to improve insulin signaling in skeletal muscle from high-fat-fed rats
  1159. NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance
  1160. Macrophage-conditioned medium inhibits adipocyte differentiation
  1161. Activin in glucose metabolism
  1162. Stakeholder Perceptions of the Bariatric Care Pathway on the Wirral
  1163. Paradoxically high adiponectin in obese 16-year-old girls protects against appearance of the metabolic syndrome and its components seven years later
  1164. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity
  1165. Preventive gerontology: Strategies for optimizing health across the life span
  1166. 8 Combinatorial Mapping
  1167. Renal cell carcinoma: Overview
  1168. Downregulation of genes involved in NFκB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin …
  1169. Therapeutic potential of peroxisome proliferators–activated receptor-α/γ dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes
  1170. Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat
  1171. EFFECT OF ASPIRIN PRETREATMENT IN STREPTOZOTOCINE INDUCED TYPE-II DIABETIC RATS
  1172. The metabolic syndrome. Part II: its mechanisms of development and its complications
  1173. Protective effect of aspirin in relation to IGF-1 in streptozotocin induced type-II diabetic rats
  1174. Phage display technology for stem cell delivery and systemic therapy
  1175. Exercise maintains euglycemia in association with decreased activation of c-Jun NH2-terminal kinase and serine phosphorylation of IRS-1 in the liver of ZDF rats
  1176. Plasma adiponectin does not correlate with insulin resistance and cardiometabolic variables in nondiabetic Asian Indian teenagers
  1177. Transcription Factor 7–like 2 Polymorphism and Colon Cancer
  1178. Anti-obesity effects of resveratrol, black tea extract and caffeine in mice
  1179. CD40L induces inflammation and adipogenesis in adipose cells–a potential link between metabolic and cardiovascular disease
  1180. Identification of targeting peptides for ischemic myocardium by in vivo phage display
  1181. Estrogen-regulated prohibitin is required for mouse uterine development and adult function
  1182. Adipose Tissue Biology: An Update Review
  1183. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications
  1184. Nutrient regulation of energy metabolism in relation to obesity and type 2 diabetes
  1185. Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes
  1186. Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 …
  1187. Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT)
  1188. The immune response attenuates growth and nutrient storage in Drosophila by reducing insulin signaling
  1189. Angiogenesis in the metabolic syndrome
  1190. Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension
  1191. Neurodegeneration in an animal model of Parkinson’s disease is exacerbated by a high-fat diet
  1192. Reversible transdifferentiation in the adipose organ
  1193. A Pediatric Perspective on Exercise Medicine
  1194. Differential metabolic effects in white and brown adipose tissue by conjugated linoleic acid elicit lipodystrophy-associated hepatic insulin resistance
  1195. Targeted inactivation of MLL3 histone H3–Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis
  1196. Tumor necrosis factor-like weak inducer of apoptosis attenuates the action of insulin in hepatocytes
  1197. Maternal obesity, inflammation and insulin resistance in skeletal muscle of fetal sheep
  1198. Vitamin C inhibits leptin secretion and some glucose/lipid metabolic pathways in primary rat adipocytes
  1199. SH2B1 regulates insulin sensitivity and glucose homeostasis by multiple mechanisms
  1200. Caloric Restriction in Leptin Deficiency Does Not Correct Myocardial Steatosis: Failure to 1 Normalize PPARα/PGC1α and Thermogenic Glyecrolipid/Fatty Acid …
  1201. Insulin induced phosphorylation of prohibitin at tyrosine114 recruits Shp1
  1202. The interleukin-11 receptor α as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples
  1203. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats
  1204. Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet
  1205. Lycopene prevents development of steatohepatitis in experimental nonalcoholic steatohepatitis model induced by high-fat diet
  1206. Diabetes and apoptosis: liver
  1207. Role of Tyk2 in the Development of Beige Cells
  1208. Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes
  1209. Genetic characterization of the St. Kitts-origin vervet monkey (Chlorocebus aethiops ssp.) as a model of polygenic obesity
  1210. A Novel Role for Fetuin-A in the Pathophysiology of Glucocorticoid-Mediated Insulin Resistance
  1211. Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes
  1212. Age and sex differences in fat distribution in non-obese Japanese children
  1213. Role of inflammation in diabetic nephropathy
  1214. Skeletal muscle inflammation is not responsible for the rapid impairment in adiponectin response with high-fat feeding in rats
  1215. Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells
  1216. Central melanocortin stimulation increases phosphorylated perilipin A and hormone-sensitive lipase in adipose tissues
  1217. Perspective: chronic obstructive pulmonary disease and obesity: more than adipose tissue mass matters
  1218. Aspirin use, body mass index, physical activity, plasma C-peptide, and colon cancer risk in US health professionals
  1219. Salsalate Efficacy in Blood Glucose Level Reduction in Diabetes
  1220. Association of visceral adiposity with increased intrarenal artery resistive index in HIV-1-infected patients receiving highly active antiretroviral therapy
  1221. Articles in PresS. Am J Physiol Endocrinol Metab (March 3, 2009). doi: 10.1152/ajpendo. 00015.2009
  1222. Reduction in inflammatory gene expression in skeletal muscle from Roux-en-Y gastric bypass patients randomized to omentectomy
  1223. Salicylate blocks lipolytic actions of tumor necrosis factor-α in primary rat adipocytes
  1224. Roles of NF-κB in health and disease: mechanisms and therapeutic potential
  1225. A Predominant Role for Parenchymal c-Jun Amino Terminal Kinase (JNK) in the Regulation of
  1226. TRANSDIFFERENTIATION 4
  1227. A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis
  1228. Tenomodulin, serum amyloid A and the serum amyloid A receptor selenoprotein S–implications for metabolic disease
  1229. Deposition Eliciting Insulin Resistance
  1230. A gene expression signature for insulin resistance
  1231. Nitrosative modifications of protein and lipid signaling molecules by reactive nitrogen species
  1232. Role of the TLR signaling molecule TRIF in β-cell function and glucose homeostasis
  1233. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers
  1234. Altered nuclear factor-kappaB inducing kinase expression in insulin-resistant mice
  1235. Analysis of Main Proteins Associated with Lipid Droplets from Peri-Adrenal Adipose Tissue of Patients with Cushing’s Syndrome
  1236. Astragalus polysaccharides decreased the expression of PTP1B through relieving ER stress induced activation of ATF6 in a rat model of type 2 diabetes
  1237. Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients
  1238. Phage library-screening: a powerful approach for generation of targeting-agents specific for normal pancreatic islet-cells and islet-cell carcinoma in vivo
  1239. Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption
  1240. Articles in PresS. Physiol Genomics (November 16, 2010). doi: 10.1152/physiolgenomics. 00115.2010
  1241. Taurine alleviates dyslipidemia and liver damage induced by a high-fat/cholesterol-dietary habit
  1242. A central role for hepatocyte growth factor in adipose tissue angiogenesis
  1243. Antiobesity effect of allenic carotenoid, fucoxanthin
  1244. Effect of Voluntary Exercise and Diet on the Unfolded Protein Response in the Brain of Mice
  1245. Transcriptional Control of Gene Expression in Different Adipose Tissue Depots
  1246. Local activation of the IκK-NF-κB pathway in muscle does not cause insulin resistance
  1247. Identification of a novel peptide ligand targeting visceral adipose tissue via transdermal route by in vivo phage display
  1248. LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications
  1249. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial
  1250. IFATS collection: Combinatorial peptides identify α5β1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells
  1251. Caloric restriction in leptin deficiency does not correct myocardial steatosis: Failure to normalize PPARα/PGC1α and thermogenic glycerolipid/fatty acid cycling
  1252. Reactive oxygen species production is increased in the peripheral blood monocytes of obese patients
  1253. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery
  1254. Adrenocorticotropin
  1255. Extracellular high dosages of adenosine triphosphate induce inflammatory response and insulin resistance in rat adipocytes
  1256. for Heart and Vascular Metabolism
  1257. Role of inhibitory κB kinase and c-Jun NH2-terminal kinase in the development of hepatic insulin resistance in critical illness diabetes
  1258. Role of inflammation and endothelial dysfunction of coronary arterioles in type 2 diabetes
  1259. Pathophysiology of NASH
  1260. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis
  1261. Metabolic syndrome and inflammation
  1262. Involvement of inducible nitric oxide synthase in hydroxyl radical-mediated lipid peroxidation in streptozotocin-induced diabetes
  1263. Genetic Analysis of Adipose Lineage and Development
  1264. Effects of salsalate therapy on recovery from vascular injury in female Zucker fatty rats
  1265. Bibliography Current World Literature Vol 19 No 5 September 2010
  1266. Stakeholder perceptions of the CHANGES weight management service
  1267. Prenatal hypoxia independent of undernutrition promotes molecular markers of insulin resistance in adult offspring
  1268. Bifurcation of in vivo hepatic energy metabolism and glucose production in insulin resistance and diabetes
  1269. Homing peptides as targeted delivery vehicles
  1270. Inhibition of the Nuclear Factor-κB Pathway Prevents Beta Cell Failure and Diet Induced Diabetes in Psammomys obesus
  1271. Advances in Laminitis, Part II, An Issue of Veterinary Clinics: Equine Practice
  1272. The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation
  1273. Fish oil rich diet in comparison to saturated fat rich diet offered protection against lipopolysaccharide-induced inflammation and insulin resistance in mice
  1274. Vigorous physical activity and cytokines in adolescents
  1275. Genistein modulates NF-κB-associated renal inflammation, fibrosis and podocyte abnormalities in fructose-fed rats
  1276. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease
  1277. Interaction of bacteriophages with animals
  1278. Insulin Resistance and Inhibitors of the Insulin Receptor Tyrosine Kinase
  1279. Enhanced glycogen metabolism in adipose tissue decreases triglyceride mobilization
  1280. Lessons in initiating insulin in clinical practice
  1281. An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells
  1282. Effects of exercise training and diet on lipid kinetics during free fatty acid-induced insulin resistance in older obese humans with impaired glucose tolerance
  1283. Reduction of hepatic CEACAM1 levels: an early mechanism of insulin resistance induced by high-fat diet
  1284. A new era for brown adipose tissue: New insights into brown adipocyte function and differentiation
  1285. Erhöhte Expression von proinflammatorischen Zytokinen im Fettgewebe von adipösen Patienten mit chronischer Niereninsuffizienz
  1286. Components of Metabolic Syndrome
  1287. Local metabolism of glucocorticoids in female Prague hereditary hypertriglyceridemic rats
  1288. When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders
  1289. Activation of Inflammatory pathways impairs insulin signaling in obese Zucker rat skeletal muscle
  1290. Effects of rosiglitazone on inflammation in Otsuka Long-Evans Tokushima Fatty rats
  1291. Toll-like receptor signalling induced by endurance exercise
  1292. Mitochondrial–nuclear communication by prohibitin shuttling under oxidative stress
  1293. Metabolic Characterization of Human FOXC2 in Adipose Tissue
  1294. Cytokines, growth mediators and physical activity in children during puberty
  1295. Studies examining the function of adipose tissue macrophages
  1296. Localization of prohibitin in the nuclear matrix and alteration of its expression during differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid
  1297. Caloric restriction in leptin deficiency does not correct
  1298. Exercise and Type 2 Diabetes in Youth
  1299. Osteopontin knockout abates high fat diet-induced insulin resistance and adipose tissue inflammation
  1300. Aspirin and diabetes mellitus: revisiting an old player
  1301. The Novel Role of Interleukin-1 Receptor-Associated Kinase 1 in the Signaling Process Controlling Innate Immunity and Inflammation
  1302. Prohibitin and mitochondrial biology
  1303. High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKKα/β phosphorylation and decreases PI-3 kinase activity in muscle
  1304. Specificity of insulin signalling in human skeletal muscle as revealed by small interfering RNA
  1305. The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning
  1306. Characteristics of Bariatric Surgery Patients Lost to Follow-Up
  1307. Towards understanding the roles of prohibitins, multi-functional regulator proteins
  1308. Gut-liver interaction in triglyceride-rich lipoprotein metabolism
  1309. Articles in PresS. Am J Physiol Endocrinol Metab (August 23, 2011). doi: 10.1152/ajpendo. 00185.2011
  1310. Confirmation of top polymorphisms in hypertension genome wide association study among Han Chinese
  1311. An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment
  1312. A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and …
  1313. Methodological and Clinical Studies on Insulin Resistance in Childhood
  1314. β3-Adrenergic Signaling Acutely Down Regulates Adipose Triglyceride Lipase in Brown Adipocytes
  1315. Effect of the dietary fat quality on insulin sensitivity
  1316. Therapeutic Strategies for the Treatment of Insulin Resistance in Various Metabolic Disease States
  1317. Dietary α-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E–deficient and apolipoprotein E/low-density lipoprotein receptor …
  1318. 15 Exercise and Type 2 Diabetes in Youth
  1319. Aryl hydrocarbon receptor deficiency enhances insulin sensitivity and reduces PPAR-α pathway activity in mice
  1320. Evidence for increased risk of prediabetes in the uremic patient
  1321. A proposed scoring system for quantification of metabolic syndrome severity
  1322. Biochemical Evaluation of Serum Adiponectin Level in Egyptian Breast Cancer Patients before and after Treatment
  1323. NF-κB activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditions
  1324. Leucine-induced Impairment of Insulin Sensitivity in Skeletal Muscle of Healthy Rats is Reversible
  1325. New Trends of Diabetes Therapy type II of the Animal Model
  1326. Objectively measured physical activity is negatively associated with plasma adiponectin levels in minority female youth
  1327. The Renin-Angiotensin System and the Neuroendocrine Regulation of Energy Balance
  1328. Salicylates increase insulin secretion in healthy obese
  1329. Hypoxia-Inducible Factor
  1330. Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic β-or α-cells in vivo
  1331. IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice
  1332. Chronically Elevated Glucocorticoids in Conjunction with a High Fat Diet: A Model of Non Alcoholic Fatty Liver Disease
  1333. Estrogen and Glucocorticoid Metabolism
  1334. Lipid metabolism
  1335. Voluntary exercise ameliorates the progression of atherosclerotic lesion formation via anti-inflammatory effects in apolipoprotein E-deficient mice
  1336. Evaluation of polyunsaturated fatty acid uptake, distribution, and incorporation into specific muscle types
  1337. Molecular mechanisms of hepatic insulin resistance following injury
  1338. Distinct functions of autophagy kinases ULK1 and ULK2 in adipogenesis and adipocyte metabolism
  1339. Articles in PresS. J Appl Physiol (January 29, 2009). doi: 10.1152/japplphysiol. 91210.2008
  1340. Effect of the Transcendental Meditation Program and Health Education on Allostatic Load: Promoting Normal Aging
  1341. Zinc-finger Protein Mcpip In Cell Death And Differentiation
  1342. Prohibitin inhibits tumor necrosis factor alpha–induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin α3 expression
  1343. Sweet heart–contributions of metabolism in the development of heart failure in diabetes mellitus
  1344. Amelioration of glucose intolerance by the synthetic androstene HE3286: link to inflammatory pathways
  1345. Epigenetic Dysregulation in Aging and Cancer
  1346. Alteration in body composition in the portacaval anastamosis rat is mediated by increased expression of myostatin
  1347. Chronic inflammation in the metabolic syndrome: emphasis on adipose tissue
  1348. Temporal Mechanisms by which a High Fat-diet Induces Skeletal Muscle Insulin Resistance
  1349. Insulin action
  1350. Fish oil consumption prevents glucose intolerance and hypercorticosteronemy in footshock-stressed rats
  1351. Oxidative stress in type 2 diabetes mellitus
  1352. The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and β-cell dysfunction in overweight and …
  1353. Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility
  1354. Role of the IKKβ/NF-κB inflammatory pathway, free fatty acids, and adiposity in insulin resistance in Hispanic Americans
  1355. Diabetes mellitus: metabolic effects and oxidative stress
  1356. Inflammation and NF-κB in Alzheimer’s disease and diabetes
  1357. Regulation of PGC-1 alpha in white adipose tissue by exercise
  1358. Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency
  1359. 100 questions & answers about diabetes
  1360. Cellular and Molecular Mechanisms Associated with Salicylate Inhibition of Intimal Hyperplasia Following Balloon Catheter-Induced Vascular Injury
  1361. Fatty acid-induced NF-κB activation and insulin resistance in skeletal muscle are chain length dependent
  1362. Molecular determinants of the cardiometabolic phenotype
  1363. Association of the polymorphisms in the PSMA6 (rs1048990) and PSMB5 (rs2230087) genes with type 2 diabetes in Korean subjects
  1364. Strategies to counteract ß-cell loss in pancreatic islet transplantation
  1365. Secretory vesicle analysis for discovery of low abundance plasma biomarkers
  1366. Salsalate may have broad utility in the prevention and treatment of vascular disorders and the metabolic syndrome
  1367. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease
  1368. Diabetic cardiomyopathy-to take a long story serious
  1369. Presence of p-synephrine in teas commercialized in Porto Alegre (RS/Brazil)
  1370. Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria
  1371. Interscapular brown adipose tissue metabolic reprogramming during cold acclimation: Interplay of HIF-1α and AMPKα
  1372. The effect of aspirin (ASA) given in cardiovascular therapeutic doses on glycemic control in type II diabetes
  1373. Design and Testing of an Infrared Temperature System to Test the Effects of Chemical Stimulation on Heat Production in Cell Cultures
  1374. When NRF2 talks, who’s listening?
  1375. Proteomic Study of the Effect ofBerberine on the Adipose Tissue ofdb/db Mice and 3T3-L1 Adipocytes
  1376. Age-associated development of inflammation in Wistar rats: effects of caloric restriction
  1377. The role of immunogenicity in cardiovascular disease
  1378. The Relationship Between the Insulin Receptor Substrates and Metabolic Disease
  1379. Palmitoylation of prohibitin at cysteine 69 facilitates its membrane translocation and interaction with Eps 15 homology domain protein 2 (EHD2)
  1380. Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats
  1381. Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet
  1382. A study of non-alcoholic fatty liver disease (NAFLD) in South African patients and analysis of candidate genes in insulin resistance and fatty acid oxidation.
  1383. Elucidation of mechanisms of insulin resistance in human skeletal muscle
  1384. Advances in the development of AMPK-activating compounds
  1385. Comparative genome analysis of PHB gene family reveals deep evolutionary origins and diverse gene function
  1386. Health promoting elementary schools in British Columbia: an analysis of school websites
  1387. Molecular aspects of genetic predisposition to type 2 diabetes mellitus and its monogenic forms
  1388. Transcriptional responses of insulin resistance and mechanisms of drug action
  1389. Saturated fatty acid-induced NF-κB activation and insulin resistance in skeletal muscle are chain length dependent
  1390. Pro-inflammatory cytokines in Omani type 2 diabetic patients presenting anxiety and depression
  1391. Genetic predisposition to diabetic nephropathy
  1392. In vitro and in vivo assessment of the genotoxic activity of aloesin
  1393. 5 Flavanols and NF-κB Activation: Relevance for Inflammation and Associated Diseases
  1394. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize …
  1395. Diabetische Kardiomyopathie–eine lang währende und ernstzunehmende Erkrankung
  1396. ω-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial enzymes despite no change in …
  1397. Comparative proteome study of apoptosis induced by As4S4 in retinoid acid resistant human acute promyelocytic leukemia NB4-R1 cells
  1398. Regulation of Insulin and CHOP Gene Expression in Pancreatic Beta Cells
  1399. Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin–inducer peptides
  1400. Toll-like receptors, their ligands, and atherosclerosis
  1401. Novel pathways regulating glucose and lipid metabolism in human skeletal muscle
  1402. Prohibitin inhibits TNFα-induced NF-κB nuclear translocation via the novel mechanism of decreasing importin α3 expression Arianne L. Theiss,* Aaron K. Jenkins …
  1403. Prohibitins and the functional compartmentalization of mitochondrial membranes
  1404. Prohibitins in human diseases: diagnostic and therapeutic applications
  1405. DOES ASPIRIN PRETREATMENT PREVENT DIABETES IN RATS?
  1406. Subchronic toxicity evaluation of aloesin
  1407. Role of cytokines in the pathogenesis of acute and chronic kidney disease, glomerulonephritis, and end-stage kidney disease
  1408. Prestin up-regulation in chronic salicylate (aspirin) administration: an implication of functional dependence of prestin expression
  1409. Effect of early insulin therapy on nuclear factor κB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats
  1410. Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells
  1411. Beyond receptor expression levels: the relevance of target accessibility in ligand-directed pharmacodelivery systems
  1412. Depot-Specific Gene Expression Programs of Adipocytes: Physiological and Developmental Implications
  1413. Engineered apoptosis-inducing peptides with enhanced mitochondrial localization and potency
  1414. Global IRS-1 phosphorylation analysis in insulin resistance
  1415. Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo
  1416. Adeno-associated viral vectors and their redirection to cell-type specific receptors
  1417. The Influence of Energy Expenditure on Mitochondrial Functions, Oxidative Stress and Insulin Resistance under Metabolic Oversupply Conditions
  1418. Isolation of specific peptides that home to dorsal root ganglion neurons in mice
  1419. Development of peptides as potential drugs for cancer therapy
  1420. Identification of a Cardiac Specific Protein Transduction Domain by In Vivo Biopanning Using a M13 Phage Peptide Display Library in Mice
  1421. Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications
  1422. Vascular-targeting antioxidant therapy in a model of hypertension and stroke
  1423. Combinatorial targeting and nanotechnology applications
  1424. Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective high-throughput analysis
  1425. A repressive role for prohibitin in estrogen signaling
  1426. Cationic and tissue-specific protein transduction domains: identification, characterization, and therapeutic application
  1427. Detection of selective cationic amphipatic antibacterial peptides by Hidden Markov models
  1428. Interaction between O-GlcNAc Modification and Tyrosine Phosphorylation of Prohibitin: Implication for a Novel Binary Switch
  1429. The Interleukin-11 Receptor
  1430. Effect of salicylic acid and diclofenac on the medium‐chain and long‐chain acyl‐CoA formation in the liver and brain of mouse
  1431. Regulation of pyruvate dehydrogenase kinase 4 (PDK4) through protein-protein interaction and its role in apoptosis
  1432. FEDERICO II
  1433. Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system
  1434. Successful Expansion but Not Complete Restriction of Tropism of Adeno-Associated Virus by In Vivo Biopanning of Random Virus Display Peptide Libraries
  1435. Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid
  1436. The diabetogenic effects of excessive ethanol: reducing β-cell mass, decreasing phosphatidylinositol 3-kinase activity and GLUT-4 expression in rats
  1437. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises
  1438. A subset of host B-lymphocytes control melanoma metastasis through a MCAM/MUC18-dependent interaction: Evidence from mice and humans
  1439. Direct covalent modification as a strategy to inhibit nuclear factor-kappa B
  1440. Ligand-directed profiling: applications to target drug discovery in cancer
  1441. Lytic peptide-mediated sensitization of TRAIL-resistant prostate cancer cells to death receptor agonists
  1442. Prohibitin expression and function in ethanol treated pancreatic beta-cells
  1443. Drug delivery in acute myeloid leukemia
  1444. Screening phage‐display peptide libraries for vascular targeted peptides
  1445. The unsolved problem of diabetes mellitus type 2 and associated complications
  1446. Mass transport via cellular barriers and endocytosis
  1447. Phage display and experimental brain therapeutics
  1448. Angiogenesis in Development, Disease, and Regeneration
  1449. β-Arrestins: multifunctional signaling adaptors in type 2 diabetes
  1450. In vitro phage display in a rat beta cell line: a simple approach for the generation of a single-chain antibody targeting a novel beta cell-specific epitope
  1451. Ligand-directed cancer gene therapy to angiogenic vasculature
  1452. Machine learning study for the prediction of transdermal peptide
  1453. Proteomic mapping of the vascular endothelium in vivo for vascular targeting
  1454. An FPGA implementation to detect selective cationic antibacterial peptides
  1455. Uptake and Intracellular Dynamics of Proteins Internalized by Cell‐Penetrating Peptides
  1456. A ligand peptide motif selected from a cancer patient is a receptor-interacting site within human interleukin-11
  1457. Drugs targeting integrins for cancer therapy
  1458. Intracellular Targets of Sphingosine-1-phosphate
  1459. An FPGA Implementation to Detect Selective Cationic Antibacterial
  1460. Insulin Action in Peripheral Glucose Uptake-The Molecular Perspective
  1461. Emerging role of flavonoids in inhibition of NF-κB-mediated signaling pathway: A review
  1462. Tumor targeting reagents: the road from ligand selections to clinical reagents
  1463. Successful Expansion but Not Complete Restriction of Tropism of Adeno
  1464. Next-Generation Phage Display: Integrating and Comparing Available Molecular Tools
  1465. Engineering functional blood vessels in vivo
  1466. NF‐κB Mechanism, Tumor Biology, and Inhibitors
  1467. Studies on Matrix Metalloproteinase (MMP-2,-9 and-14) and β2 Integrin Targeting as Potential Anticancer Therapeutics
  1468. Application of phage display technology for the study of cholangiocarcinoma associated with consumption of fluke infected food
  1469. Targeting the heart using in vivo phage display
  1470. Pilot randomized trial demonstrating reversal of obesity-related abnormalities in reward system responsivity to food cues with a behavioral intervention
  1471. Reversal of obesity-induced hypertriglyceridemia by (R)-α-lipoic acid in ZDF (fa/fa) rats
  1472. Partial reversal of obesity-induced insulin resistance owing to anti-inflammatory immunomodulatory potential of flaxseed oil
  1473. Brown adipose tissue thermogenesis in the resistance to and reversal of obesity: a potential new mechanism contributing to the metabolic benefits of proglucagon …
  1474. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models
  1475. Dietary restriction reverses obesity-induced anhedonia
  1476. Reversal of obesity and metabolic disorders by exercise in high-fat diet-induced obese c57bl/6 mice
  1477. New pharmacological perspectives for the leptin receptor in the treatment of obesity
  1478. Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids
  1479. Animal models of dietary-induced obesity
  1480. IL-33 reverses an obesity-induced deficit in visceral adipose tissue ST2+ T regulatory cells and ameliorates adipose tissue inflammation and insulin resistance
  1481. Weight loss reversed obesity-induced HGF/c-Met pathway and basal-like breast cancer progression
  1482. Steps to Growing Up Healthy: a pediatric primary care based obesity prevention program for young children
  1483. Inhalation of carbon monoxide is ineffective as a long-term therapy to reduce obesity in mice fed a high fat diet
  1484. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications
  1485. Hypothalamic gliosis associated with high-fat diet feeding is reversible in mice: a combined immunohistochemical and magnetic resonance imaging study
  1486. The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes
  1487. Bile acid signaling: mechanism for bariatric surgery, cure for NASH?
  1488. A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication
  1489. ATRIAL FIBRILLATION AND OBESITY: CHARACTERIZATION OF ELECTRO-STRUCTURAL ATRIAL SUBSTRATE WITH SUSTAINED OBESITY AND …
  1490. Systemic VEGF-A neutralization ameliorates diet-induced metabolic dysfunction
  1491. Exercise treatment of obesity
  1492. Chronic Treatment with Carbon Monoxide Releasing Molecule Reverses Dietary Induced Obesity in Mice
  1493. Reduction in inflammation and the expression of amyloid precursor protein and other proteins related to Alzheimer’s disease following gastric bypass surgery
  1494. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity
  1495. Atrial fibrillation and obesity: characterization of electro-structural atrial substrate with sustained obesity and reversal upon weight reduction.
  1496. Therapeutic assessment of cytochrome C for the prevention of obesity through endothelial cell-targeted nanoparticulate system
  1497. Role of obesity in the pathogenesis and progression of Barrett’s esophagus
  1498. Recombinant murine fibroblast growth factor 21 ameliorates obesity-related inflammation in monosodium glutamate-induced obesity rats
  1499. Energy balance modulates mouse skin tumor promotion through altered IGF-1R and EGFR crosstalk
  1500. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance
  1501. Resveratrol inhibits the deleterious effects of diet-induced obesity on thymic function
  1502. From abject eating to abject being: Representations of obesity in ‘Supersize vs. Superskinny’
  1503. Enhancement of brown fat thermogenesis using chenodeoxycholic acid in mice
  1504. Hepatic cannabinoid‐1 receptors mediate diet‐induced insulin resistance by increasing de novo synthesis of long‐chain ceramides
  1505. Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects
  1506. Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathy
  1507. Abstract IA45: Obesity and the microenvironment in basal-like breast cancer
  1508. Bariatric surgery to unload the stressed heart: a metabolic hypothesis
  1509. Physical exercise in overweight to obese individuals induces metabolic-and neurotrophic-related structural brain plasticity
  1510. Social Aspects as Maintenance Factors of the Obesity Condition: The Somatic Marker Hypothesis
  1511. Caffeic acid phenethyl ester reduces the activation of the nuclear factor κB pathway by high-fat diet-induced obesity in mice
  1512. Glutamate mediates the function of melanocortin receptor 4 on Sim1 neurons in body weight regulation
  1513. APpEaLINg therapeutic target for obesity cardiomyopathy?
  1514. What every hospitalist should know about the post‐bariatric surgery patient
  1515. Animal Models for the Study of Human Disease: Chapter 13. Animal Models of Dietary-Induced Obesity
  1516. Immune regulation in obesity-associated adipose inflammation
  1517. The impact of cash transfers to poor women in Colombia on BMI and obesity: prospective cohort study
  1518. Prognosis of morbid obesity patients with advanced heart failure
  1519. Two contrasting outcomes of weight loss surgery: Positive impact on the heart, negative impact on the liver
  1520. 39. Adolescent Bariatric Surgery
  1521. Feeding Management of the Neutered Cat
  1522. DIEtAry CONtrOL Of OBESIty AND LAMINItIS rISk
  1523. Drug targeting of leptin resistance
  1524. Healthy Alberta Communities: Impact of a three-year community-based obesity and chronic disease prevention intervention
  1525. Leptin, a mediator of cardiac damage associated with obesity
  1526. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
  1527. Role of Adiponectin in the Metabolic Effects of Cannabinoid Receptor-1 Blockade in Mice with Diet-Induced Obesity
  1528. Measuring success: a comparison of weight loss calculations
  1529. Treatment of obesity as a potential complementary approach to cancer therapy
  1530. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice
  1531. Browning of white adipose tissue by melatonin
  1532. A review on obesity and its management
  1533. Effects of an intensive short-term diet and exercise intervention: comparison between normal-weight and obese children
  1534. Endospanin 1 silencing in the hypothalamic arcuate nucleus contributes to sustained weight loss of high fat diet obese mice
  1535. Cytokine profiling of young overweight and obese female African American adults with prediabetes
  1536. A neuron-specific deletion of the microRNA-processing enzyme DICER induces severe but transient obesity in mice
  1537. Chaperoning to the metabolic party: the emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes
  1538. Subcutaneous adipose tissue transplantation in diet‐induced obese mice attenuates metabolic dysregulation while removal exacerbates it
  1539. Cichoric acid reverses insulin resistance and suppresses inflammatory responses in the glucosamine-induced HepG2 cells
  1540. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions
  1541. Curcumin promotes browning of white adipose tissue in a norepinephrine-dependent way
  1542. The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease
  1543. Polysome profiling in liver identifies dynamic regulation of endoplasmic reticulum translatome by obesity and fasting
  1544. Effects of metformin on weight loss: potential mechanisms
  1545. The neuropathology of obesity: insights from human disease
  1546. A role for sphingolipids in the pathophysiology of obesity-induced inflammation
  1547. Role of interleukins in obesity: implications for metabolic disease
  1548. Cardioprotective modulation of cardiac adiponectin and adiponectin receptors by omega-3 in the high-fat fed rats
  1549. Influence of circular stapler diameter on postoperative stenosis after laparoscopic gastrojejunal anastomosis in morbid obesity
  1550. Insulin inhibits IL-10–mediated regulatory T cell function: implications for obesity
  1551. Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol
  1552. Diabetes and cancer: placing the association in perspective
  1553. Hypothalamic endoplasmic reticulum stress and insulin resistance in offspring of mice dams fed high-fat diet during pregnancy and lactation
  1554. Stomach Following Bariatric Surgery
  1555. Obesity and cholangiocarcinoma
  1556. The adipose organ at a glance
  1557. Role of free fatty acid receptor 2 (FFAR2) in the regulation of metabolic homeostasis
  1558. Pregnancy is a critical period for prevention of obesity and cardiometabolic risk
  1559. Insulin resistance and impaired adipogenesis
  1560. The brown fat secretome: metabolic functions beyond thermogenesis
  1561. Sex differences during the course of diet-induced obesity in mice: adipose tissue expandability and glycemic control
  1562. HealthSTEPS: An Evidence-Based Program to Prevent Obesity and Related Diseases in Young Children
  1563. Adipose tissue inflammation in the pathogenesis of type 2 diabetes
  1564. Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery
  1565. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies
  1566. Effects of voluntary running on oxygen consumption, RQ, and energy expenditure during primary prevention of diet-induced obesity in C57BL/6N mice
  1567. Obesity and Weight Regulation
  1568. The bright-nights and dim-days of the urban photoperiod: implications for circadian rhythmicity, metabolism and obesity
  1569. Obesity, a health burden of a global nature
  1570. Physiotherapists’ perceptions of their role in the rehabilitation management of individuals with obesity
  1571. Fat cells directly sense temperature to activate thermogenesis
  1572. Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis
  1573. Mechanisms of insulin resistance in obesity
  1574. Vitamin C in the treatment and/or prevention of obesity
  1575. Inflammation-induced microvascular insulin resistance is an early event in diet-induced obesity
  1576. Metabolic heterogeneity of obesity: role of adipose tissue
  1577. Effects of dietary history on energy metabolism and physiological parameters in C57BL/6J mice
  1578. Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota?
  1579. Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development of obesity and insulin resistance
  1580. Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKε and TBK1
  1581. Role of T cells in malnutrition and obesity
  1582. Causes and consequences of obesity: the contribution of recent twin studies
  1583. Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
  1584. Constitutive activation of IKKβ in adipose tissue prevents diet-induced obesity in mice
  1585. TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis
  1586. Origins, purpose and future of Sure Start children’s centres
  1587. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s disease
  1588. Maternal hyperglycemia during pregnancy predicts adiposity of the offspring
  1589. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD …
  1590. Bariatric surgery-effects on obesity and related co-morbidities
  1591. The cellular and signaling networks linking the immune system and metabolism in disease
  1592. Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients
  1593. Human brown adipose tissue: what we have learned so far
  1594. Impact of abdominal obesity and ambulatory blood pressure in the diagnosis of left ventricular hypertrophy in never treated hypertensives
  1595. Age and obesity promote methylation and suppression of 5α-reductase 2: implications for personalized therapy of benign prostatic hyperplasia
  1596. Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-κB
  1597. GH improves spatial memory and reverses certain anabolic androgenic steroid-induced effects in intact rats
  1598. Vaspin inhibited proinflammatory cytokine induced activation of nuclear factor-kappa B and its downstream molecules in human endothelial EA. hy926 cells
  1599. Biliopancreatic diversion: the effectiveness of duodenal switch and its limitations
  1600. Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice
  1601. Mechanisms in endocrinology: white, brown and pink adipocytes: the extraordinary plasticity of the adipose organ
  1602. Oxidative stress and inflammation interactions in human obesity
  1603. High-fat load: mechanism (s) of insulin resistance in skeletal muscle
  1604. Recruitment of brown adipose tissue as a therapy for obesity-associated diseases
  1605. Depletion of white adipocyte progenitors induces beige adipocyte differentiation and suppresses obesity development
  1606. Metabolic inflammation: connecting obesity and insulin resistance
  1607. High-Fat Diet-Induced Obesity Exacerbates Inflammatory Bowel Disease in Genetically Susceptible Mdr1a−/− Male Mice
  1608. The impact of generation status on weight of immigrant and non-immigrant school-aged children living in minority situation: Preliminary results
  1609. Autophagy regulates inflammation in adipocytes
  1610. Populus balsamifera L.(Salicaceae) mitigates the development of obesity and improves insulin sensitivity in a diet-induced obese mouse model
  1611. Doxorubicin treatment inhibits PPARγ and may induce lipotoxicity by mimicking a type 2 diabetes-like condition in rodent models
  1612. From farm to fat cell: why aren’t we all fat?
  1613. Dietary polyphenols suppress elevated levels of proinflammatory mediators and aromatase in the mammary gland of obese mice
  1614. The combined effects of physical exercise training and detraining on adiponectin in overweight and obese children
  1615. The effect of exercise training in water on serum adiponectin and insulin resistance in obese children and adolescents
  1616. Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)
  1617. Methods of a Multidisciplinary, Community-based Treatment Program for Overweight and Obese Preschoolers: A Family-Oriented, Healthy Eating, Activity, and …
  1618. Bacteria, viruses, and hypothalamic inflammation: Potential new players in obesity
  1619. Satisfaction, satiation and food behaviour
  1620. Describing the Intrapersonal Influences on Eating Behaviours of Adolescent Girls in Saudi Arabia
  1621. Free Fatty Acids Induce Lhb mRNA but Suppress Fshb mRNA in Pituitary LβT2 Gonadotropes and Diet-Induced Obesity Reduces FSH Levels in Male Mice and …
  1622. Insulin and IGFs in obesity-related breast cancer
  1623. Recent advances in obesity-induced inflammation and insulin resistance
  1624. Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer
  1625. Dichotomous effects of VEGF-A on adipose tissue dysfunction
  1626. Inflammation during obesity is not all bad: evidence from animal and human studies
  1627. Longitudinal assessment of food intake, fecal energy loss, and energy expenditure after Roux-en-Y gastric bypass surgery in high-fat-fed obese rats
  1628. Endocrine changes in obesity
  1629. Peripheral targets in obesity treatment: a comprehensive update
  1630. Versatile functions for IL-6 in metabolism and cancer
  1631. Adipose tissue-related proteins locally associated with resolution of inflammation in obese mice
  1632. Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype
  1633. Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis
  1634. The By-Band study: gastric bypass or adjustable gastric band surgery to treat morbid obesity: study protocol for a multi-centre randomised controlled trial with …
  1635. Impact of wheat aleurone structure on metabolic disorders caused by a high-fat diet in mice
  1636. The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake
  1637. AMPK: mediating the metabolic effects of salicylate-based drugs?
  1638. Obesity alters the gustatory perception of lipids in the mouse: plausible involvement of lingual CD36
  1639. White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma
  1640. Impact of Roux-en-Y gastric bypass versus sleeve gastrectomy on vitamin D metabolism: short-term results from a prospective randomized clinical trial
  1641. Bariatric surgery and the kidney—much benefit, but also potential harm
  1642. Obesity, but not ethanol, promotes tumor incidence and progression in a mouse model of hepatocellular carcinoma in vivo
  1643. Implication of inflammatory signaling pathways in obesity-induced insulin resistance
  1644. Marine natural product des-O-methyllasiodiplodin effectively lowers the blood glucose level in db/db mice via ameliorating inflammation
  1645. Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure
  1646. The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival
  1647. Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment
  1648. BBS-induced ciliary defect enhances adipogenesis, causing paradoxical higher-insulin sensitivity, glucose usage, and decreased inflammatory response
  1649. New Onset of Left Ventricular Dysfunction Associated with Selenium, Zinc and Copper Deficiency Presenting Late after Gastric Bypass Surgery: Case Report …
  1650. The role of ghrelin in the control of energy balance
  1651. The role of specific chaperons in pathogenesis of obesity and related diseases
  1652. Fas (CD 95) expression in myeloid cells promotes obesity‐induced muscle insulin resistance
  1653. Influence of the core circadian gene “Clock” on obesity and leptin resistance in mice
  1654. Function and control of adipose tissue regulatory T cells: implications for obesity
  1655. Antiangiogenic nanotherapy for the control of obesity
  1656. Updates on gastric electrical stimulation to treat obesity: Systematic review and future perspectives
  1657. Protein tyrosine phosphatase 1B (PTP1B) and obesity
  1658. Salicylate downregulates 11β-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitization
  1659. Inflammation, cytokines and insulin resistance: a clinical perspective
  1660. IKKβ links vascular inflammation to obesity and atherosclerosis
  1661. A ceramide-centric view of insulin resistance
  1662. Placental dysfunction in obese women and antenatal surveillance strategies
  1663. Double-stranded RNA-activated protein kinase is a key modulator of insulin sensitivity in physiological conditions and in obesity in mice
  1664. The whitening of brown fat and its implications for weight management in obesity
  1665. Role of saturated and polyunsaturated fat in obesity-related inflammation
  1666. Surgery for weight loss in adults
  1667. Be prepared to adjust dosing of psychotropics after bariatric surgery
  1668. Repurposing of metformin and aspirin by targeting AMPK-mTOR and inflammation for pancreatic cancer prevention and treatment
  1669. Leptin-mediated increases in catecholamine signaling reduce adipose tissue inflammation via activation of macrophage HDAC4
  1670. A platelet-activating factor (PAF) receptor deficiency exacerbates diet-induced obesity but PAF/PAF receptor signaling does not contribute to the development of …
  1671. Lipocalin 2 is a regulator of macrophage polarization and NF-κB/STAT3 pathway activation
  1672. Obesity, insulin resistance, and inflammaging
  1673. The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice
  1674. Vascular rarefaction mediates whitening of brown fat in obesity
  1675. Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective
  1676. Genetics and obesity
  1677. Two triterpeniods from Cyclocarya paliurus (Batal) Iljinsk (Juglandaceae) promote glucose uptake in 3T3-L1 adipocytes: The relationship to AMPK activation
  1678. Appetite and body weight regulation after bariatric surgery
  1679. White-to-brown metabolic conversion of human adipocytes by JAK inhibition
  1680. Connecting type 1 and type 2 diabetes through innate immunity
  1681. Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art
  1682. Presence of brown adipocytes in retroperitoneal fat from patients with benign adrenal tumors: relationship with outdoor temperature
  1683. Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity
  1684. Adipose tissue immunity and cancer
  1685. Avatars of Adipose Tissue–The Saga of Transformation of White Fat, the Villain into 3 Brown Fat, the Protector 4
  1686. Distinct time course of the decrease in hepatic AMP-activated protein kinase and Akt phosphorylation in mice fed a high fat diet
  1687. Reversion to a control balanced diet is able to restore body weight and to recover altered metabolic parameters in adult rats long-term fed on a cafeteria diet
  1688. Apparent histological changes of adipocytes after treatment with CL 316,243, a β-3-adrenergic receptor agonist
  1689. Inflammatory causes of obesity and metabolic diseases
  1690. Insulin sensitization via partial agonism of PPARγ and glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway by embelin in …
  1691. Blockade of the nuclear factor-κB pathway in the endothelium prevents insulin resistance and prolongs life spans
  1692. Weighing in on adipocyte precursors
  1693. Sphingolipid metabolism and obesity-induced inflammation
  1694. Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG)
  1695. Diabetes mellitus in dogs and its associated complications: A review
  1696. Obesity, inflammation, and insulin resistance
  1697. The adipose organ: white‐brown adipocyte plasticity and metabolic inflammation
  1698. Berberine activates thermogenesis in white and brown adipose tissue
  1699. Leucine signaling in the pathogenesis of type 2 diabetes and obesity
  1700. Effect of obesity on hepatic drug metabolism
  1701. Role of oxidative stress in endothelial insulin resistance
  1702. Zinc deficiency augments leptin production and exacerbates macrophage infiltration into adipose tissue in mice fed a high-fat diet
  1703. TGF-β/Smad3 signaling regulates brown adipocyte induction in white adipose tissue
  1704. B lymphocytes as emerging mediators of insulin resistance
  1705. Andropause: current concepts
  1706. IL-17 axis driven inflammation in non-alcoholic fatty liver disease progression
  1707. Prospects of use of nutrient fiber, applying different feeding manners, to reduce obesity in dogs.
  1708. Central inflammation and leptin resistance are attenuated by ginsenoside Rb1 treatment in obese mice fed a high-fat diet
  1709. Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high‐fat‐diet …
  1710. Truncation of Ube3a-ATS Unsilences Paternal Ube3a and Ameliorates Behavioral Defects in the Angelman Syndrome Mouse Model
  1711. Increased adipose tissue hypoxia and capacity for angiogenesis and inflammation in young diet-sensitive C57 mice compared with diet-resistant FVB mice
  1712. 4β-Hydroxywithanolide E isolated from Physalis pruinosa calyx decreases inflammatory responses by inhibiting the NF-κB signaling in diabetic mouse adipose tissue
  1713. A2B Adenosine Receptors Prevent Insulin Resistance by Inhibiting Adipose Tissue Inflammation via Maintaining Alternative Macrophage Activation
  1714. Isolation and differentiation of stromal vascular cells to beige/brite cells
  1715. Flurbiprofen ameliorated obesity by attenuating leptin resistance induced by endoplasmic reticulum stress
  1716. Hypothalamic gene transfer of BDNF inhibits breast cancer progression and metastasis in middle age obese mice
  1717. MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16
  1718. Vascular Targeting of Adipose Tissue
  1719. Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary …
  1720. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis
  1721. Endoscopic treatment of metabolic syndrome
  1722. Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese mice
  1723. Global correlation analysis for microRNA and gene expression profiles in human obesity
  1724. Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice
  1725. Fibrosis and adipose tissue dysfunction
  1726. Acute pancreatitis due to diabetes: the role of hyperglycaemia and insulin resistance
  1727. Targeted delivery using peptide-functionalised gold nanoparticles to white adipose tissues of obese rats
  1728. The regulation of muscle protein turnover in diabetes
  1729. Role of the adipocyte in metabolism and endocrine function
  1730. Brown adipose tissue: what have we learned since its recent identification in human adults
  1731. Endocrine and metabolic signaling in retroperitoneal white adipose tissue remodeling during cold acclimation
  1732. Toll-like receptor 2/4 links to free fatty acid-induced inflammation and β-cell dysfunction
  1733. PI3K/Akt is involved in brown adipogenesis mediated by growth differentiation factor-5 in association with activation of the Smad pathway
  1734. Effects of an in-patient treatment program based on regular exercise and a balanced diet on high molecular weight adiponectin, resistin levels, and insulin resistance …
  1735. Inflammation, oxidative stress and metabolic syndrome: dietary modulation
  1736. Local macrophage proliferation in adipose tissue is a characteristic of obesity-associated inflammation: A dissertation
  1737. Food cue reactivity, obesity, and impulsivity: are they associated?
  1738. Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice
  1739. (−)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress
  1740. PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis
  1741. The different shades of fat
  1742. Salsalate, an old, inexpensive drug with potential new indications: a review of the evidence from 3 recent studies
  1743. Peripherally restricted CB1 receptor blockers
  1744. NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action
  1745. Adipocytokines in relation to cardiovascular disease
  1746. Metabolic adaptation of white adipose tissue to nutritional and environmental challenges
  1747. Opposite cross-talk by oleate and palmitate on insulin signaling in hepatocytes through macrophage activation
  1748. Rapid and weight-independent improvement of glucose tolerance induced by a peptide designed to elicit apoptosis in adipose tissue endothelium
  1749. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease
  1750. The role of chronic inflammation in obesity-associated cancers
  1751. Stromal cells derived from visceral and obese adipose tissue promote growth of ovarian cancers
  1752. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances …
  1753. Exercise prevents Western diet-associated erectile dysfunction and coronary artery endothelial dysfunction: response to acute apocynin and sepiapterin treatment
  1754. Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression
  1755. Role and function of macrophages in the metabolic syndrome
  1756. Brown and Beige Fat: Therapeutic Potential in Obesity
  1757. Oligopeptide complex for targeted non-viral gene delivery to adipocytes
  1758. Emerging role of JNK in insulin resistance
  1759. C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling
  1760. Adipokines and cardiovascular risk in Cushing’s syndrome
  1761. Insulin resistance and atherosclerosis
  1762. Energy metabolism of inbred mouse strains and its modulation by diet
  1763. Role of NKG2D in obesity-induced adipose tissue inflammation and insulin resistance
  1764. Laparoscopic Duodenal Switch
  1765. CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance
  1766. Type 2 Diabetes: Disease Overview
  1767. Circulating levels of IL-1B+ IL-6 cause ER stress and dysfunction in islets from prediabetic male mice
  1768. GLP-1 based therapeutics: simultaneously combating T2DM and obesity
  1769. Novel risk factors of cardiovascular disease and their associations between obesity, physical activity and physical fitness
  1770. Third ventricular coinjection of subthreshold doses of NPY and AgRP stimulate food hoarding and intake and neural activation
  1771. Herbal and microbial products for the management of obesity
  1772. Adiponectin, resistin, and visfatin in childhood obesity and exercise
  1773. Nuclear factor κB–inducing kinase activation as a mechanism of pancreatic β cell failure in obesity
  1774. Molecular mechanisms affected by n-3 polyunsaturated fatty acids
  1775. Insulin resistance
  1776. Development of a receptor targeted nanotherapy using a proapoptotic peptide
  1777. Development of an innovative drug delivery system targeted to adipose vessel utilizing novel nucleic acid aptamer for control of obesity
  1778. Prohibitin ligands in cell death and survival: mode of action and therapeutic potential
  1779. p107 is a crucial regulator for determining the adipocyte lineage fate choices of stem cells
  1780. TGF-B/Smad3 signaling regulates brown adipocyte induction in white adipose tissue
  1781. Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity
  1782. Growth differentiation factor-5 promotes brown adipogenesis in systemic energy expenditure
  1783. AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and …
  1784. Lipid-overloaded enlarged adipocytes provoke insulin resistance independent of inflammation
  1785. Sodium salicylate prevents inflammation-associated decreases in phosphorylated-enosser1177 in human aortic endothelial cells through an AMPK …
  1786. Macrophage polarization in metabolism and metabolic disease
  1787. Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes
  1788. Role of nuclear factor (erythroid-derived 2)-like 2 in metabolic homeostasis and insulin action: a novel opportunity for diabetes treatment?
  1789. The lipocalin-type prostaglandin D2 synthase knockout mouse model of insulin resistance and obesity demonstrates early hypothalamic-pituitary-adrenal axis …
  1790. Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic
  1791. Metabolic inflexibility of white and brown adipose tissues in abnormal fatty acid partitioning of type 2 diabetes
  1792. Regulation of UCP1 in the Browning of Epididymal Adipose Tissue by β3-Adrenergic Agonist: A Role for MicroRNAs
  1793. Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance
  1794. The expression of genes involved in NF-κB activation in peripheral blood mononuclear cells of patients with gestational diabetes
  1795. Obesity-related glomerulopathy and podocyte injury: a mini review
  1796. Do parental coronary heart disease risk factors (non-modifiable) effect their young ones?
  1797. Metabolic syndrome, insulin resistance, and roles of inflammation–mechanisms and therapeutic targets
  1798. Paraoxonases and chemokine (C–C Motif) ligand-2 in noncommunicable diseases
  1799. Molecular imaging of brown adipose tissue in health and disease
  1800. Ciliary neurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing beta cell mass and reducing insulin clearance
  1801. Both linoleic and α-linolenic acid prevent insulin resistance but have divergent impacts on skeletal muscle mitochondrial bioenergetics in obese Zucker rats
  1802. Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin
  1803. Mechanisms of disease: role of neurotrophins in diabetes and diabetic neuropathy
  1804. Salsalate and adiponectin improve palmitate-induced insulin resistance via inhibition of selenoprotein P through the AMPK-FOXO1α pathway
  1805. Glucagon-like peptide 1 regulates adipogenesis in 3T3-L1 preadipocytes
  1806. Physical inactivity, insulin resistance, and the oxidative-inflammatory loop
  1807. Why does obesity increase the risk for cardiovascular disease?
  1808. Association of ALOX15 gene polymorphisms with obesity-related phenotypes in Chinese nuclear families with male offspring
  1809. Inflammatory markers in pediatric obesity: health and physical activity implications
  1810. Inhibition of ghrelin O-acyltransferase attenuates food deprivation-induced increases in ingestive behavior
  1811. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis
  1812. CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH)
  1813. Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis
  1814. Age impact on weight loss and glycolipid profile after laparoscopic sleeve gastrectomy: experience with 308 consecutive patients
  1815. Prohibitins are involved in protease‐activated receptor 1‐mediated platelet aggregation
  1816. Berries in Prevention of Metabolic Disease–focus on obesity, diabetes and gut microbiota
  1817. Astragalus Polysaccharide Improves Palmitate-Induced Insulin Resistance by Inhibiting PTP1B and NF-κB in C2C12 Myotubes
  1818. Obesity & the Workplace: Direct, Indirect Costs & the Role of Wellness Education
  1819. Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity
  1820. Influence of vitamin D treatment on transcriptional regulation of insulin-sensitive genes
  1821. Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases
  1822. Proteomic identification of target proteins of thiodigalactoside in white adipose tissue from diet-induced obese rats
  1823. Biomarkers for cardiovascular risk in children
  1824. Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo
  1825. Serum cytokine, chemokine and hormone levels in Saudi adults with pre-diabetes: a one-year prospective study
  1826. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses
  1827. Oxidative stress in diabetes
  1828. Neural innervation of white adipose tissue and the control of lipolysis
  1829. Role of adipose cells in tumor microenvironment
  1830. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
  1831. The total phenolic fraction of Anemarrhena asphodeloides inhibits inflammation and reduces insulin resistance in adipocytes via regulation of AMP-kinase activity
  1832. DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity
  1833. Sumona Ghosh Lester, Simona S. Ghanem, and Sonia M. Najjar
  1834. Inactivation of NF-κB p65 (RelA) in liver improves insulin sensitivity and inhibits cAMP/PKA pathway
  1835. Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus
  1836. Dietary Factors in the Etiology of Gallstones
  1837. T2D@ ZJU: a knowledgebase integrating heterogeneous connections associated with type 2 diabetes mellitus
  1838. KSRP ablation enhances brown fat gene program in white adipose tissue through reduced miR-150 expression
  1839. Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity
  1840. Comparing physical activity programs for managing osteoarthritis in overweight or obese patients
  1841. Role of renin–angiotensin–aldosterone system in adipose tissue dysfunction
  1842. Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways
  1843. Pathophysiology of NASH: perspectives for a targeted treatment
  1844. Age and genetic determinants of variation of circulating levels of the receptor for advanced glycation end products (RAGE) in the general human population
  1845. The Relationship Among Obesity, Inflammation, and Insulin Resistance
  1846. Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoids
  1847. Interactions between the gut, the brain and brown adipose tissue function
  1848. Cell penetrating peptides and cationic antibacterial peptides: two sides of the same coin
  1849. Anti diabetic effect of CL 316,243 (a β3-adrenergic agonist) by down regulation of tumour necrosis factor (TNF-α) expression
  1850. Identification of microRNAs as a potential novel regulatory mechanism in HSD11B1 expression
  1851. Linoleic and α-linolenic acid both prevent insulin resistance but have divergent impacts on 1 skeletal muscle mitochondrial bioenergetics in obese Zucker rats 2
  1852. Pathological role of adipose tissue dysfunction in cardio-metabolic disorders
  1853. Nutrigenomic Approaches to Understanding the Transcriptional and Metabolic Responses of Phytochemicals to Diet‐Induced Obesity and its Complications
  1854. Dynamic interplay between metabolic syndrome and immunity
  1855. Apoptotic pathways in adipose tissue
  1856. Review on the effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for the treatment of non-alcoholic fatty liver disease
  1857. Adipokines and adipose tissue angiogenesis in obesity
  1858. Taking diabetes to heart—deregulation of myocardial lipid metabolism in diabetic cardiomyopathy
  1859. Cis-9, trans-11, trans-13-conjugated linolenic acid induces apoptosis and sustained ERK phosphorylation in 3T3-L1 preadipocytes
  1860. Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
  1861. Type 2 diabetes: pathogenesis and natural history
  1862. Roles and tissue source of adiponectin involved in lifestyle modifications
  1863. The platform for adipose tissue expansion during positive energy balance
  1864. Brown adipose tissue harbors a distinct sub-population of regulatory T cells
  1865. Understanding nutritional interventions and physical exercise in non-alcoholic fatty liver disease
  1866. Populus balsamifera Extract and Its Active Component Salicortin Reduce Obesity and Attenuate Insulin Resistance in a Diet-Induced Obese Mouse Model
  1867. Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
  1868. CYP2E1 potentiates toxicity in obesity and after chronic ethanol treatment
  1869. The Potential Epigenetic Modulation of Diabetes Influenced by Nutritional Exposures In Utero
  1870. Immune cells and metabolic dysfunction
  1871. Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazone
  1872. How brown is brown fat that we can see?
  1873. How metabolism generates signals during innate immunity and inflammation
  1874. Prognosis of patients treated for Cushing syndrome
  1875. The Poisoning of Our Children: Fighting the Obesity Epidemic in America
  1876. Efficacy of commercial weight-loss programs: an updated systematic review
  1877. Loss of prohibitin induces mitochondrial damages altering β-cell function and survival and is responsible for gradual diabetes development
  1878. Do obese children have chronic inflammation & could this contribute to future CVD risk?
  1879. The influence of endotoxemia on the molecular mechanisms of insulin resistance
  1880. Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk
  1881. INFLUENCES ON TYPE 2 DIABETES AND OBESITY
  1882. Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2
  1883. Myocardin-related transcription factor A regulates conversion of progenitors to beige adipocytes
  1884. Activated Kupffer cells inhibit insulin sensitivity in obese mice
  1885. Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man
  1886. Chaperoning to the metabolic party
  1887. Two types of brown adipose tissue in humans
  1888. Epigenetic influences on type 2 diabetes and obesity
  1889. The effect of a lifestyle intervention on metabolic health in young women
  1890. Extracellular signal-regulated protein kinase activation in spinal cord contributes to pain hypersensitivity in a mouse model of type 2 diabetes
  1891. Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice
  1892. Targeting inflammation in diabetes: Newer therapeutic options
  1893. Long-term effects of an inpatient weight-loss program in obese children and the role of genetic predisposition-rationale and design of the LOGIC-trial
  1894. DHA and α-ethyl DHA ethyl ester improve hepatic glucose and lipid metabolism via central leptin regulation in HFD male mice
  1895. O-GlcNAcylation and inflammation: a vast territory to explore
  1896. Niclosamide ethanolamine improves blood glycemic control and reduces hepatic steatosis in mice
  1897. The immune system as a sensor of the metabolic state
  1898. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD)
  1899. Stem cells from adipose tissue and breast cancer: hype, risks and hope
  1900. Mitochondriogenesis and apoptosis: possible cause of vitamin A-mediated adipose loss in WNIN/Ob-obese rats
  1901. Discrimination between brown and white adipose tissue using a 2-point Dixon water–fat separation method in simultaneous PET/MRI
  1902. Short term fat feeding rapidly increases plasma insulin but does not result in dyslipidaemia
  1903. Genetic deficiency of CD40 in mice exacerbates metabolic manifestations of diet-induced obesity: a dissertation
  1904. Energy metabolism in genetically fat and lean
  1905. The development mechanisms of overweight in young people
  1906. Duration of rise in free fatty acids determines salicylate’s effect on hepatic insulin sensitivity
  1907. Dietary ribonucleic acid suppresses inflammation of adipose tissue and improves glucose intolerance that is mediated by immune cells in C57BL/6 mice fed a high-fat …
  1908. Adipose tissue-derived serum amyloid A and adipose tissue macrophages in metabolic disease
  1909. Muscle inflammatory signaling in response to 9 days of physical inactivity in young men with low compared with normal birth weight
  1910. Bad Fat or Just More Fat? Murine Models of Metabolically Healthy Obesity
  1911. Dietary supplementation with evodiamine prevents obesity and improves insulin resistance in ageing mice
  1912. Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese …
  1913. Recombinant viral capsid protein VP1 suppresses migration and invasion of human cervical cancer by modulating phosphorylated prohibitin in lipid rafts
  1914. Growth hormone (GH) differentially regulates NF-kB activity in preadipocytes and macrophages: implications for GH’s role in adipose tissue homeostasis in obesity
  1915. Burn induces browning of the subcutaneous white adipose tissue in mice and humans
  1916. Role of macrophages in exercise-induced enhancement of insulin sensitivity in skeletal muscle
  1917. Mean platelet volume and red cell distribution width in hepatosteatosis
  1918. Turning off a viral/lipid sensor improves type 2 diabetes
  1919. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia
  1920. Effects of high vs. moderate exercise intensity during interval training on lipids and adiponectin levels in obese young females
  1921. The glucagon-like peptide-1 analogue liraglutide inhibits oxidative stress and inflammatory response in the liver of rats with diet-induced non-alcoholic fatty liver …
  1922. TNF-alpha and IL-6 inhibit apolipoprotein A-IV production induced by linoleic acid in human intestinal Caco2 cells
  1923. Correlated increase of omentin-1 and adiponectin by exenatide, avandamet and dietary change in diet-induced obese rats
  1924. Adipocyte-specific IKKβ signaling suppresses adipose tissue inflammation through an IL-13-dependent paracrine feedback pathway
  1925. INTERNATIONALJOURNALO FNUTRITION INTERNATIONALJOURNALO FNUTRITION
  1926. Fitness and adiposity are independently associated with cardiometabolic risk in youth
  1927. Advances in an active and passive targeting to tumor and adipose tissues
  1928. Adipose tissue biglycan as a potential anti-inflammatory target of sodium salicylate in mice fed a high fat diet
  1929. Elevated serum levels of cysteine and tyrosine: early biomarkers in asymptomatic adults at increased risk of developing metabolic syndrome
  1930. Flavanone naringenin: An effective antihyperglycemic and antihyperlipidemic nutraceutical agent on high fat diet fed streptozotocin induced type 2 diabetic rats
  1931. Salsalate, an Old, Inexpensive Drug with Potential New Indications: A Review of the Evidence from 3 Recent Studies
  1932. PI3K/AKT pathway in modulating glucose homeostasis and its alteration in diabetes
  1933. I Wayan Weta, IB Putra Manuaba 2, WP Sutirtayasa 2, Safarina G. Malik 3, W. Citrawulan Sucipta 4, Firman P. Sitanggang 5. Correspondence: wayan_weta06 …
  1934. Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus
  1935. PEDF-induced alteration of metabolism leading to insulin resistance
  1936. Palmitoleic acid prevents palmitic acid-induced macrophage activation and consequent p38 MAPK-mediated skeletal muscle insulin resistance
  1937. Men and alcohol: benefits and hazards
  1938. Spice up your life: adipose tissue and inflammation
  1939. ER stress in adipocytes and insulin resistance: Mechanisms and significance
  1940. Ascorbic acid: its role in immune system and chronic inflammation diseases
  1941. Salicylate acutely stimulates 5′-AMP-activated protein kinase and insulin-independent glucose transport in rat skeletal muscles
  1942. Comparative analysis of plasma metabolomics response to metabolic challenge tests in healthy subjects and influence of the FTO obesity risk allele
  1943. Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease?
  1944. Insulin Resistance-ECAB
  1945. Metabolic Control by Inflammation and Immunity: Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity
  1946. Expression of prohibitins on the surface of activated T cells
  1947. Compliance for Lifestyle Modification among Obese/Overweight School Children from 7-12 Years
  1948. Mice deficient in proglucagon-derived peptides exhibit glucose intolerance on a high-fat diet but are resistant to obesity
  1949. The effect of exercise on lipid profiles and inflammatory markers in lean male adolescents: a prospective interventional study
  1950. Targeting inflammation in the treatment of type 2 diabetes: time to start
  1951. The aberrant expression and localization of prohibitin during apoptosis of human cholangiocarcinoma Mz-ChA-1 cells
  1952. Central glucocorticoid administration promotes weight gain and increased 11β-hydroxysteroid dehydrogenase type 1 expression in white adipose tissue
  1953. Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis
  1954. Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets
  1955. Physical activity and cardiometabolic biomarkers in youths: A 2013 update
  1956. A peptide derived from G0/G1 switch gene 2 acts as noncompetitive inhibitor of adipose triglyceride lipase
  1957. Nonalcoholic fatty liver disease in childhood
  1958. Molecular Regulators of Metabolism and Cardiometabolic Disease
  1959. High-protein diets alters body composition and improves insulin resistance in a rat model of low birth weight
  1960. Novel aspects of metabolic regulation and inflammation in human adipocytes
  1961. Neonatal overnutrition in mice exacerbates high-fat diet-induced metabolic perturbations
  1962. Modulation of the Wnt/β-Catenin Pathway in Obesity: A Role for Bile Acid Metabolic Improvement
  1963. Manipulation of the gut microbiota in C57BL/6 mice changes glucose tolerance without affecting weight development and gut mucosal immunity
  1964. Rapid repression of ADP transport by palmitoyl-CoA is attenuated by exercise training in humans: a potential mechanism to decrease oxidative stress and improve …
  1965. Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis
  1966. Effects of the green tea polyphenol epigallocatechin-3-gallate on high-fat diet-induced insulin resistance and endothelial dysfunction
  1967. The browning of white adipose tissue: some burning issues
  1968. Lifestyle modification decreases arterial stiffness in overweight and obese men: dietary modification vs. exercise training
  1969. Effect of estrogen on expression of prohibitin in white adipose tissue and liver of diet-induced obese rats
  1970. Adipose tissue macrophages in obesity, inflammation, and cancer
  1971. The Genetic Mechanisms Underlying Human Obesity
  1972. Enhanced prereceptor glucocorticoid metabolism and lipogenesis impair insulin signaling in the liver of fructose-fed rats
  1973. Innovations in pediatric surgery
  1974. The ancient drug salicylate directly activates AMP-activated protein kinase
  1975. Development of an innovative drug delivery system targeted to
  1976. 20 Adipose Drug Targets
  1977. IκB kinase β (IKKβ) does not mediate feedback inhibition of the insulin signalling cascade
  1978. 2, 4-dinitrophenol downregulates genes for diabetes and fatty liver in obese mice
  1979. Current scenario for the hepatoprotective effects of Inchinkoto, a traditional herbal medicine, and its clinical application in liver surgery: A review
  1980. Effects of DAPT on Serum Vascular Endothelial Growth Factor and Its Soluble Receptor in Obese BALB/C Mice.
  1981. Insulin resistance and atherosclerosis
  1982. Docosahexaenoic acid supplementation improved lipocentric but not glucocentric markers of insulin sensitivity in hypertriglyceridemic men
  1983. AMPK activator-mediated inhibition of endoplasmic reticulum stress ameliorates carrageenan-induced insulin resistance through the suppression of selenoprotein P …
  1984. Metabolic characteristics and therapeutic potential of brown and? beige? adipose tissues
  1985. The role of CREB in the liver and adipose tissue
  1986. Attenuation of MTORC1-driven Secretion of Lipoproteins and Triacylglycerides by Short Chain Fatty Acids: Mechanistic Insight Into the Pathogenesis of …
  1987. Molecular aspects of glucose homeostasis in skeletal muscle–A focus on the molecular mechanisms of insulin resistance
  1988. Adipose Tissue-derived progenitor cells and cancer
  1989. Ablation of 3-phosphoinositide-dependent protein kinase 1 (PDK1) in vascular endothelial cells enhances insulin sensitivity by reducing visceral fat and suppressing …
  1990. Effect of six-month lifestyle intervention on adiponectin, resistin and soluble tumor necrosis factor-α receptors in obese adolescents
  1991. Physiology & pathophysiology of human brown adipose tissue
  1992. Selection of aptamers specific for adipose tissue
  1993. Salicylic acid: old and new implications for the treatment of type 2 diabetes?
  1994. The role of macrophage polarization in infectious and inflammatory diseases
  1995. Articles in PresS. Am J Physiol Cell Physiol (January 9, 2013). doi: 10.1152/ajpcell. 00312.2012
  1996. n-3 PUFA prevent metabolic disturbances associated with obesity and improve endothelial function in golden Syrian hamsters fed with a high-fat diet
  1997. Bcl10 links saturated fat overnutrition with hepatocellular NF-κB activation and insulin resistance
  1998. The vascular stem cell niche
  1999. The role of fatty acid metabolism and lipotoxicity in pancreatic β-cell injury: identification of potential therapeutic targets
  2000. G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome
  2001. The roles of diet and SirT3 levels in mediating signaling network changes in insulin resistance
  2002. Avatars of adipose tissue: the saga of transformation of white fat, the villain into brown fat, the protector. Focus on “Inflammation induced by RAW macrophages …
  2003. CGI-58/ABHD5-derived signaling lipids regulate systemic inflammation and insulin action
  2004. Reactive oxygen species in health and disease
  2005. Oligopeptide complex for targeted non-viral gene delivery to adipocytes
  2006. Dual actions of a novel bifunctional compound to lower glucose in mice with diet-2 induced insulin resistance 3
  2007. Unravelling the mechanism of ghrelin secretion and the effects of ghrelin reduction using a receptor decoy approach
  2008. Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic β cell fate in response to cytokines
  2009. Vibration stimuli and the differentiation of musculoskeletal progenitor cells: review of results in vitro and in vivo
  2010. Effects of interventions on adiponectin and adiponectin receptors
  2011. Peroxisome proliferator-activated receptor activating hypoglycemic effect of Gardenia jasminoides Ellis aqueous extract and improvement of insulin sensitivity …
  2012. Nutritional modulation of insulin resistance
  2013. Targeting inflammation through a physical active lifestyle and pharmaceuticals for the treatment of type 2 diabetes
  2014. Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice
  2015. Best practice dietetic management of overweight and obese children and adolescents: a 2010 update of a systematic review
  2016. Gastrointestinal surgery
  2017. Wild bitter gourd increased metabolic rate and up-regulated genes related to mitochondria biogenesis and UCP-1 in mice
  2018. A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance
  2019. Cell lysis-free quantum dot multicolor cellular imaging-based mechanism study for TNF-α-induced insulin resistance
  2020. Health Promotions 2.0: The Future of Wellness Programs in America
  2021. Low level of trans-10, cis-12 conjugated linoleic acid decreases adiposity and increases browning independent of inflammatory signaling in overweight Sv129 mice
  2022. Influences of the diabetes surgery on pancreatic B-cells mass
  2023. Type 2 diabetes mellitus: etiology, pathogenesis, and natural history
  2024. Increased Adiposity and Colorectal Cancer
  2025. 10 Ecological Approaches to Creating Healthy Local Food Environments in the United States
  2026. Novel anti-diabetic effect of SCM-198 via inhibiting the hepatic NF-κB pathway in db/db mice
  2027. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
  2028. Linking mitochondrial bioenergetics to insulin resistance via redox biology
  2029. Modified Si-Miao-San inhibits inflammation and promotes glucose disposal in adipocytes through regulation of AMP-kinase
  2030. T cell immunity and cardiovascular metabolic disorders: does metabolism fuel inflammation?
  2031. Browning of Adipose Organ
  2032. Research Article Endocrine and Metabolic Signaling in Retroperitoneal White Adipose Tissue Remodeling during Cold Acclimation
  2033. Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
  2034. Pharmacogenomics of cardiovascular complications in diabetes and obesity
  2035. The effect of salsalate on biochemical factors and endothelial dysfunction of prediabetic patients: A randomized clinical trial
  2036. Nuclear factor κB (NF-κB) suppresses food intake and energy expenditure in mice by directly activating the Pomc promoter
  2037. α-Lipoic acid as a triglyceride-lowering nutraceutical
  2038. The circulatory levels of irisin in response to acute and chronic resistance training in healthy humans
  2039. Anti-obesity mechanisms of conjugated linoleic acid (CLA): Role of inflammatory signaling and browning in white adipose tissue
  2040. Antihyperglycemic effect of carvacrol in combination with rosiglitazone in high-fat diet-induced type 2 diabetic C57BL/6J mice
  2041. Regulation of Adipose Tissue Function and Metabolic Homeostasis.
  2042. Nerium oleander distillate improves fat and glucose metabolism in high-fat diet-fed streptozotocin-induced diabetic rats
  2043. Does 8 weeks of strenuous bicycle exercise improve diabetes-related inflammatory cytokines and free fatty acids in type 2 diabetes patients and individuals at high …
  2044. Morphological and functional maturation of Leydig cells: from rodent models to primates
  2045. Effect of diclofenac on plasma glucose level, insulin resistance, inflammatory markers and hepatocytes in diabetic albino rats
  2046. Effectivity Combination of Bitter Melon (Momordica charantia) and Bitter (Andrographis paniculata) Extract to Suppress Proinflammatory Cytokines in Diabetic Mouse …
  2047. Effect of melatonin on obesity, low-grade inflamation and oxidative stress in diabetic fatty (ZDF) rats
  2048. Thermogenic ability of uncoupling protein 1 in beige adipocytes in mice
  2049. Heterozygous rho kinase2 deficinecy increases whole body insulin sensitivity in mice
  2050. Klotho ameliorates chemically induced endoplasmic reticulum (ER) stress signaling
  2051. Endothelial Driven Inflammation in Metabolic Disease: A Dissertation
  2052. Aspirin-induced inhibition of adipogenesis was p53-dependent and associated with inactivation of pentose phosphate pathway
  2053. Overweight in the military: causes and effects
  2054. Normalization of fasting hyperglycemia is beneficial for successful introduction of small amount of the GLP-1 analog liraglutide in an obese patient with type 2 diabetes …
  2055. AMP-activated protein kinase is activated by non-steroidal anti-inflammatory drugs
  2056. An Approach to Obesity as a Cardiometabolic Disease: Potential Implications for Clinical Practice
  2057. Inflammation induced by RAW macrophages suppresses UCP1 mRNA induction via ERK activation in 10T1/2 adipocytes
  2058. Novel link between inflammation, endothelial dysfunction, and muscle insulin resistance
  2059. Regulation of Fluid-phase Uptake in Podocytes by Albumin-associated Lipids and Role of NKG2D in Obesity-induced Adipose Tissue Inflammation and …
  2060. A continued saga of Boc5, the first non-peptidic glucagon-like peptide-1 receptor agonist with in vivo activities
  2061. Evolving therapies for non-alcoholic steatohepatitis
  2062. Opposite effects of quercetin, luteolin, and epigallocatechin gallate on insulin sensitivity under normal and inflammatory conditions in mice
  2063. The effects of stearidonic acid on 3T3-L1 adipocytes
  2064. Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity
  2065. Toll-like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high-fat diet
  2066. Insulin resistance, metabolic stress, and atherosclerosis
  2067. Understanding the regulation of adipogenesis and adipocyte metabolism in obesity
  2068. The adipose organ: morphological perspectives of adipose tissues
  2069. An intimate relationship between ROS and insulin signalling: implications for antioxidant treatment of fatty liver disease
  2070. Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy
  2071. PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases
  2072. Dynamic monitoring of β-cell injury with impedance and rescue by glucagon-like peptide-1
  2073. Correlation of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
  2074. Landmark studies on the glucagon subfamily of GPCRs: from small molecule modulators to a crystal structure
  2075. Systemic SIRT1 insufficiency results in disruption of energy homeostasis and steroid hormone metabolism upon high-fat-diet feeding
  2076. The role of serum albumin in the metabolism of Boc5: Molecular identification, species differences and contribution to plasma metabolism
  2077. Effects of exercise and elevated fatty acid availability on muscle lipid metabolism and insulin sensitivity
  2078. Progenitor cell mobilization from extramedullary organs
  2079. STUDIES ON THE REGULATION OF FGF21 GENE EXPRESSION BY (R)-α-LIPOIC ACID: MECHANISTIC INSIGHT INTO THE LIPID LOWERING PROPERTIES OF A …
  2080. A peptide probe for targeted brown adipose tissue imaging
  2081. Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor
  2082. Peroxisome Proliferator-Activated Receptor β/δ (PPAR β/δ) as a Potential Therapeutic Target for Dyslipidemia
  2083. Thyroid Hormone Receptor Regulation of Cholesterol and Lipid Metabolism
  2084. Can aging be’drugged’?
  2085. Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study
  2086. Insulin Sensitivity in Valproate Treated Epileptics.
  2087. Dietary regulation of glucose metabolism in metabolic syndrome
  2088. Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes
  2089. Heme Oxygenase 1 in Hepatocytes Drives Insulin Resistance in Mice and Men
  2090. Effect of natural compounds on insulin signaling
  2091. Activation of NF-κB drives the enhanced survival of adipose tissue macrophages in an obesogenic environment
  2092. Response to comment on “a peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys”
  2093. TGF-β and Metabolic Homeostasis
  2094. 4 Biomarkers of Inflammation and the Western Diet
  2095. Effect of medical nutrition therapy on outcomes of patients with pre-diabetes in a rural Nebraska primary care clinic: A pilot study
  2096. Dual actions of a novel bifunctional compound to lower glucose in mice with diet-induced insulin resistance
  2097. A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 …
  2098. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial
  2099. Expression of “brown-in-white” adipocyte biomarkers shows gender differences and the influence of early dietary exposure
  2100. Peroxisome Proliferator-Activated Receptor β/δ (PPAR β/δ) as a Potential Therapeutic Target for Dyslipidemia
  2101. Skeletal muscle-specific overproduction of constitutively activated c-Jun N-terminal kinase (JNK) induces insulin resistance in mice
  2102. Identification of novel regulators of mesenchymal stem cell commitment to the brown adipocyte lineage
  2103. Enhanced glucose tolerance and pancreatic beta cell function by low dose aspirin in hyperglycemic insulin-resistant type 2 diabetic Goto-Kakizaki (GK) rats
  2104. The effects of exercise-induced weight loss on ratio of acylated and unacylated ghrelin in obese adolescents
  2105. Technological discipline, obese bodies and gender: A sociological analysis of gastric banding surgery
  2106. Influence of feeding a fish oil-containing diet to young, lean, adult dogs: effects on lipid metabolites, postprandial glycaemia and body weight
  2107. Huang-lian-jie-du-tang protects rats from cardiac damages induced by metabolic disorder by improving inflammation-mediated insulin resistance
  2108. Practical prospects for boosting hepatic production of the “pro-longevity” hormone FGF21
  2109. Influencia de la cirugía de diabetes sobre la masa de células beta pancreáticas
  2110. Activation of hepatic CREBH and Insig signaling in the anti-hypertriglyceridemic mechanism of R-α-lipoic acid
  2111. Comparative assessments of crucial factors for a functional ligand-targeted nanocarrier
  2112. An antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosis
  2113. Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly
  2114. Multifaceted role of prohibitin in cell survival and apoptosis
  2115. Origin of White and Brown Adipose Cells From Vascular Endothelium: A Dissertation
  2116. A novel class of small molecule compounds that inhibit hepatitis C virus infection by targeting the prohibitin-CRaf pathway
  2117. Macronutrient activation of endothelium dependent leukocyte trafficking: Metabolic implications
  2118. Lipoic acid: its antioxidant and anti-inflammatory role and clinical applications
  2119. Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma
  2120. Evaluation of the CHANGES weight management programme: Prospective Patients
  2121. Air pollution as a risk factor for type 2 diabetes
  2122. Multifunctional envelope-type nano device: evolution from nonselective to active targeting system
  2123. From signal transduction to signal interpretation: an alternative model for the molecular function of insulin receptor substrates
  2124. Effects of a multi-component camp-based intervention on inflammatory markers and adipokines in children: a randomized controlled trial
  2125. An update on the pathogenesis of type 2 diabetes mellitus
  2126. Sodium salicylate treatment in early lactation increases whole-lactation milk and milk fat yield in mature dairy cows
  2127. Using RNA-seq technology to explore the impact of growth hormone on angiogenesis and other cellular pathways in subcutaneous and epididymal adipose tissue …
  2128. Pathogenesis of type 2 diabetes mellitus
  2129. Adipose tissue dysfunction and inflammation in cardiovascular
  2130. BMP7 reduces inflammation and oxidative stress in diabetic tubulopathy
  2131. Activating transcription factor 3 regulates immune and metabolic homeostasis
  2132. An ERP investigation of food cue responsivity in non-obese, weight gain prone individuals
  2133. High density lipoprotein is positively correlated with the changes in circulating total adiponectin and high molecular weight adiponectin during dietary and fenofibrate …
  2134. Current advances in ER stress intervention therapies
  2135. Sarcoplasmic reticulum phospholipid fatty acid composition and sarcolipin content in rat skeletal muscle
  2136. THE ROLE OF CGI-58/ABHD5 IN LIPID METABOLISM, INFLAMMATION, AND INSULIN ACTION
  2137. Interleukin 1β regulation of FoxO1 protein content and localization: evidence for a novel ceramide-dependent mechanism
  2138. Examining physiological roles of adipose derived VEGF: Consequences in substrate availability and endurance exercise capacity in adipocyte specific VEGF …
  2139. Targeting IL11 receptor in leukemia and lymphoma: a functional ligand-directed study and hematopathology analysis of patient-derived specimens
  2140. HMGB1 and Ceramides: Potential Mediators of Cigarette Smoke-induced Metabolic Dysfunction
  2141. Integrative and Translational Physiology: Integrative Aspects of Energy Homeostasis and Metabolic Diseases: Third ventricular coinjection of subthreshold …
  2142. Vascularization in Engineered Adipose Tissue
  2143. The culture and differentiation of human pluripotent cells into brown and white adipocytes
  2144. Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharide via inactivation of nuclear factor-κB
  2145. Inhibition of established micrometastases by targeted drug delivery via cell surface–associated GRP78
  2146. Lack of Association of Insulin Receptor Substrate Gene Polymorphisms with Obstructive Sleep Apnea Syndrome
  2147. Inhibition of the IKK pathway restores PI3-K activity in high-fat fed rodent skeletal muscles
  2148. Role of NF-Kappa B (NF-κB) in diabetes
  2149. Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients
  2150. Dietary docosahexaenoic acid supplementation reduces SERCA Ca2+ transport efficiency in rat skeletal muscle
  2151. Isoenergetic feeding of low carbohydrate-high fat diets does not increase brown adipose tissue thermogenic capacity in rats
  2152. Lasting Effects on Body Weight and Mammary Gland Gene Expression in Female Mice upon Early Life Exposure to n-3 but Not n-6 High-Fat Diets
  2153. New Mechanisms in Glucose Control
  2154. Effect of pioglitazone, quercetin and hydroxy citric acid on inflammatory markers in experimentally induced non alcoholic steatohepatitis (NASH)
  2155. Self-regulation and health
  2156. THE MECHANISMS OF INSULIN ACTION
  2157. Adipose tissue engineering: Obesity disease model and soft tissue regeneration
  2158. Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial …
  2159. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression …
  2160. Unravelling the link between insulin resistance and androgen excess
  2161. Mechanisms maintaining reduced appetite and normoglycaemia after metabolic surgery. The role of bile acids
  2162. The role of estrogens in the regulation of peripheral glucose dynamics
  2163. Protection of palmitic acid-mediated lipotoxicity by arachidonic acid via channeling of palmitic acid into triglycerides in C2C12
  2164. Hepatic expression of constitutively active IKKβ in mice induces low-grade inflammation, but does not cause insulin resistance: a protective role for A20?
  2165. Influence of metformin on lipid мetabolism and chronic inflammation in the liver тissues of mice on a diet rich in fructose
  2166. 13 Obesity and Diabetes
  2167. Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease
  2168. Lentiviral vector-mediated RNA interference targeted against prohibitin inhibits apoptosis of the retinoic acid-resistant acute promyelocytic leukemia cell line …
  2169. Mesenchymal stem cell pre-treatment with cytokines and hydrogen peroxide modifies their adhesion to cardiac endothelium and murine heart sections AND A …
  2170. Effect of alpha-lipoic acid supplementation on serum lipid profile in women with rheumatoid arthritis
  2171. Zinc signal in inflammation
  2172. The effect of endurance and resistance training on adiponectin in sedentary young woman
  2173. AMPK activators as a drug for diabetes, cancer and cardiovascular disease
  2174. Anti-inflammatory action of calorie restriction underlies the retardation of aging and age-related diseases
  2175. On the horizon: new oral therapies for type 2 diabetes mellitus
  2176. Oestrogen signalling in white adipose progenitor cells inhibits differentiation into brown adipose and smooth muscle cells
  2177. Evaluation of the Bariatric Care Pathway
  2178. Mechanisms Mediating Antidiabetic Effects of Serviceberry extracts, Curcumin, and Stilbenes
  2179. Cardiovascular Inflammation
  2180. Recent Advances in Histopathology: 23
  2181. Peptide-lipid interactions and functionalities
  2182. A Calcium-Deficient Diet in Rat Dams during Gestation and Nursing Affects Hepatic 11β-hydroxysteroid dehydrogenase-1 Expression in the Offspring
  2183. Loss of adipocyte VEGF impairs endurance exercise capacity in mice
  2184. Explanatory Models of Health and Disease among Elder Chinese Immigrants in the Bay Area
  2185. Impairments in glucose and lipid metabolism in breast cancer patients
  2186. A critical appraisal of brown adipose tissue metabolism in humans
  2187. Gene expression of sternohyoid and diaphragm muscles in type 2 diabetic rats
  2188. Nutritional and therapeutic Use of capsaicin in veterinary medicine
  2189. High fat diet increases tumor incidence in the intestine due to alterations in microbial communities and immune system
  2190. Peroxisome proliferator-activated receptor α in lipid metabolism and atherosclerosis
  2191. Palmitoleic acid prevents palmitic acid-induced macrophage activation
  2192. Insulin-and growth factor-resistance impairs vascular regeneration in diabetes mellitus
  2193. On the horizon: New oral therapies for type 2 diabetes mellitus
  2194. English version: influence of metformin on lipid metabolism and chronic inflammation in the liver tissues of mice on a diet rich in fructose
  2195. Bone mineral density is associated with total body weight loss ten years after Roux-en-Y gastric bypass
  2196. Do anti-angiogenic cancer therapies increase risk of significant weight loss?
  2197. Pathogenesis of diabetes-tuberculosis comorbidity, The
  2198. Suppression of adipogenesis by pathogenic seipin mutant is associated with inflammatory response
  2199. Impaired Innate Immune Responses in Phospholipase D ablated mice
  2200. ß-cell reserve in insulin resistant pregnant mice
  2201. Long term effect of extremely low frequency electromagnetic field on islet of pancreas structure
  2202. Research Article Nerium oleander Distillate Improves Fat and Glucose Metabolism in High-Fat Diet-Fed Streptozotocin-Induced Diabetic Rats
  2203. The role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancy
  2204. Omega 3 fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet
  2205. Periodontitis modulates insulin signaling, c-Jun N-terminal kinase activity, IKK activity, and insulin receptor substrate-1 ser 307 phosphorylation in muscle and …
  2206. Ahmed Bettaieb, Marcela A. Vazquez Prieto b, Cecilia Rodriguez Lanzi b
  2207. The impact of whey protein isolate on energy balance regulation
  2208. Cellular plasticity in white adipose tissue: in vivo identification of bipotent adipocyte progenitors in adult white adipose tissue
  2209. Pronóstico del paciente tratado de síndrome de Cushing
  2210. Towards Modeling of Metabolic Syndrome: Tissue Crosstalk in Lipid Spillover
  2211. Differential expression and subcellular localization of Prohibitin 1 are related to tumorigenesis and progression of non-small cell lung cancer
  2212. Effects of Exercise and Diet-Induced Weight Loss in Overweight/Obese Women on Characterization of Serum/White Blood Cells, microRNAs and Cytokine Gene …
  2213. A decade of RF ablation in children–a single centre experience
  2214. Insulin plant (Costus pictus) extract improves insulin sensitivity and ameliorates atherogenic dyslipidaemia in fructose induced insulin resistant rats: Molecular …
  2215. Evidence of endoplasmic reticulum stress and liver inflammation in the American mink Neovison vison with benign hepatic steatosis
  2216. CHANGES Weight Management Service Evaluation
  2217. Studies Defining The Local Function of Adipose Tissue IGF1 And The Role of Lipolysis in Adipose Tissue Macrophage Lipid Uptake
  2218. Modified Si-Miao-San () regulates adipokine expression and ameliorates insulin resistance by targeting IKKβ/Insulin receptor substrate-1 in mice.
  2219. The Role of Inflammatory Pathway Genetic Variation on Maternal Metabolic Phenotypes
  2220. GLP-1-based strategies: a physiological analysis of differential mode of action
  2221. The interrelationship between insulin resistane and Alzheimer development
  2222. Vascular-homing peptides for targeted drug delivery and molecular imaging: meeting the clinical challenges
  2223. Phage display—A powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications
  2224. Factors of Inflammation in Haitian Americans and African Americans with and without Type 2 Diabetes
  2225. The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer
  2226. Investigations into the Role of Inflammation in the Regulation of Glucose Homeostasis
  2227. Toll-Like Receptor 4 Knockout Mice Are Protected against Endoplasmic Reticulum Stress
  2228. Anti-inflammatory salicylate treatment alters the metabolic adaptations to lactation in 2 dairy cattle 3
  2229. Effects of maternal plane of nutrition and increased dietary selenium in first-parity ewes on inflammatory response in the ovine neonatal gut
  2230. Small molecule drug discovery at the glucagon-like peptide-1 receptor
  2231. Genome-wide profiling of peroxisome proliferator-activated receptor γ in primary epididymal, inguinal, and brown adipocytes reveals depot-selective binding …
  2232. Diabetes prevention education aimed at Dutch and Turkish relatives at risk: Development and evaluation of DiAlert
  2233. Antibacterial drugs—From basic concepts to complex therapeutic mechanisms of polymer systems
  2234. Activation of the bile acid receptor TGR5 enhances LPS-induced inflammatory responses in a human monocytic cell line
  2235. The effect of the anti-inflammatory drug sodium salicylate in mature periparturient dairy cattle and immortalized bovine mammary epitheilal (MAC-T) cells
  2236. The effects of organizational justice and exercise on the relationship between job stressors and employee health
  2237. 2013 RD PEAVY PAPERS
  2238. I Prostanoid Receptor–Mediated Inflammatory Pathway Promotes Hepatic Gluconeogenesis Through Activation of PKA and Inhibition of AKT
  2239. Identification of the NF-κB inhibitor A20 as a key regulator for human adipogenesis
  2240. R-α-lipoic acid does not reverse hepatic inflammation of aging, but lowers lipid anabolism, while accentuating circadian rhythm transcript profiles
  2241. The role of inflammation in lipid metabolism
  2242. Regulation of hepatic insulin receptor activity following injury
  2243. A meta-analysis of salicylates for type 2 diabetes mellitus
  2244. Regulation of Fluid-phase Uptake in Podocytes by Albumin-associated Lipids
  2245. Inflammation induced by RAW macrophages suppresses
  2246. Resveratrol and Metformin Combination Therapy in Prevention and Treatment of Insulin Resistance
  2247. The Effects of Low Dose Endotoxin on Glucose Homeostasis
  2248. Dietary enrichment with fish oil prevents high fat-induced metabolic dysfunction in skeletal muscle in mice
  2249. The altered gut microbiome in metabolic syndrome
  2250. Impact of Co-Administration of Salicylic Acid with Glibenclamide in a Rat Model of Type 2 Diabetes Mellitus
  2251. Antiinflammatory effects of aspirin in ACS: relevant to its cardio coronary actions?
  2252. Effects of Amino Acids on the Regulation of Insulin Sensitivity in Skeletal Muscle Cells
  2253. Current Topics in Pharmacogenomics
  2254. The regulation of sarco (endo) plasmic reticulum calcium-ATPases (SERCA)
  2255. Mitochondrial targeting functional peptides as potential devices for the mitochondrial delivery of a DF-MITO-Porter
  2256. Effects of Cyclosporine a and Sirolimus on Glucose and Lipid Metabolism: An in Vivo Rat Model
  2257. Detailed comparison of CPP’s uptake properties for pro-apoptotic cargo delivery
  2258. Tools from viruses: bacteriophage successes and beyond
  2259. Crosstalk between insulin and Toll-like receptor signaling pathways in the central nervous system
  2260. Oxidative stress-induced molecular and genetic mechanisms in human health and diseases
  2261. Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery
  2262. Moonlighting peptides with emerging function
  2263. Źŵ Ʋ Ʈſō ƶŝ LjŤŝř Ò (ŝ ŽƺĪƘƯ ƶƐŝřŹ ƹ ǀ Ʋ ƾĭŵŚƯō) Ʈſō ƶƘſƺţ Śŝ ƾƳŚưƀū ÏÔ
  2264. Cell Penetrating Peptides and Cationic
  2265. The Effects of Salsalate on Biochemical Factors of Serum and Endothelial Dysfunction in Patients with Newly Diagnosed Type 2 Diabetes
  2266. Two Days of Experiments in Vietnam: Asian Chemical Biology Initiative, Hanoi Meeting
  2267. Early events in chikungunya virus infection—from virus cell binding to membrane fusion
  2268. Novel players in rescue of β-cells from inflammation-mediated destruction in Type 2 Diabetes Mellitus
  2269. The development of the lifestyle and habits questionnaire-brief version: Relationship to quality of life and stress in college students
  2270. Non-steroidal anti-inflammatory drugs activate NADPH oxidase in adipocytes and raise the H2O2 pool to prevent cAMP-stimulated protein kinase a …
  2271. Activation of the Transcriptional Function of the NF-κB Protein c-Rel by O-GlcNAc Glycosylation
  2272. Prevention of osteopenia and dyslipidemia in rats after ovariectomy with combined aspirin and low-dose diethylstilbestrol
  2273. Targeting mammalian organelles with internalizing phage (iPhage) libraries
  2274. Anti-inflammatory salicylate treatment alters the metabolic adaptations to lactation in dairy cattle
  2275. Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors
  2276. New biomarkers in the retina and RPE under oxidative stress
  2277. Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells
  2278. Emergence of Chinese drug discovery research: impact of hit and lead identification
  2279. In vivo phage display—a discovery tool in molecular biomedicine
  2280. Remarkably reduced expression of FoxO3a in metaplastic colorectum, primary colorectal cancer and liver metastasis
  2281. Alteration in lymphocyte population and humoral immune response in type 2 diabetic Goto–Kakizaki rats
  2282. Rosiglitazone inhibits hepatic insulin resistance induced by chronic pancreatitis and IKK-β/NF-κB expression in liver
  2283. Complementary and Alternative Therapies for Liver Diseases 2014
  2284. Characterization of a gene encoding prohibitin in silkworm, Bombyx mori
  2285. Advances in phage display technology for drug discovery
  2286. Chikungunya virus: emerging targets and new opportunities for medicinal chemistry
  2287. Fish oil supplementation, resting blood flow and markers of cellular metabolism during incremental exercise
  2288. The scaffold protein prohibitin is required for antigen-stimulated signaling in mast cells
  2289. prevents vascular endothelial dysfunction in a type 2 diabetic rat model
  2290. The proteome of the murine presynaptic active zone
  2291. The Beneficial Effects of Calcium Supplementation Plus Low-Dose Aspirin on Metabolic Profiles in Pregnant Women at Risk for Pre-Eclampsia: Randomized, Double …
  2292. Peptide based molecules as protein-protein interaction inhibitors: Tools for chemical genetics and therapy
  2293. The interferon-inducible mouse apolipoprotein L9 and prohibitins cooperate to restrict Theiler’s virus replication
  2294. Aspirin regulates hepatocellular lipid metabolism by activating AMPK signaling pathway
  2295. Drug design strategies for the treatment of prostate cancer
  2296. High dose of aspirin moderates diabetes-induced changes of heart glycogen/glucose metabolism in rats
  2297. Dengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein
  2298. Chemical Proteomics: A Global Study of Protein-Small Molecule Interactions
  2299. Identification of tissue-specific targeting peptide
  2300. The synaptic proteome
  2301. Investigation of the Cry4B–Prohibitin Interaction in Aedes aegypti Cells
  2302. Insulin transcytosis across adipose microvascular endothelial cells: Mechanism and physiological implications
  2303. The Contribution of Prohibitin 1 to Prostate Cancer Chemoresistance
  2304. Integrative and Translational Physiology: Inflammation and Immunity in Organ System Physiology: Anti-inflammatory salicylate treatment alters the metabolic …
  2305. Early Events in Chikungunya Virus Infection–From Virus Cell Binding to Membrane Fusion.
  2306. Sustained NF-κB activation and inhibition in β-cells have minimal effects on function and islet transplant outcomes
  2307. The Role of Lipid Raft-Translocation of Prohibitin in Regulation of Akt and Raf-Protected Apoptosis of HaCaT Cells upon Ultraviolet B Irradiation
  2308. Delivery and Targeting of Therapeutic Cells
  2309. Discovery and investigation of a novel role for mitochondrial prohibitin in mitigating acute heart failure in endotoxic shock
  2310. Sustained NF-kB Activation and Inhibition in b-Cells Have Minimal Effects on Function and
  2311. Efeito do consumo isocalórico da ração hiperlipídica e da administração da erva-mate (Ilex paraguariensis) sobre a expressão de proteínas envolvidas na via …
  2312. Phage Display Library Screening for PSA-/lo Prostate Cancer Cell-Binding Peptides
  2313. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin
  2314. Reversal of obesity and liver steatosis in mice via inhibition of aryl hydrocarbon receptor and altered gene expression of CYP1B1, PPARα, SCD1, and osteopontin
  2315. Adipose tissue supports normalization of macrophage and liver lipid handling in obesity reversal
  2316. Obesity-related perivascular adipose tissue damage is reversed by sustained weight loss in the rat
  2317. Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, β-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse …
  2318. Reversal of obesity: The quest for the optimum dietary regimen
  2319. Nanotechnology advances towards development of targeted-treatment for obesity
  2320. Inhibiting glycogen synthase kinase 3 reverses obesity-induced white adipose tissue inflammation by regulating apoptosis inhibitor of macrophage/CD5L-mediated …
  2321. Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, colon cancer, obesity and insulin resistance
  2322. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin
  2323. Resveratrol reverses the adverse effects of a diet-induced obese murine model on oocyte quality and zona pellucida softening
  2324. Obesity-linked PPARγ S273 phosphorylation promotes insulin resistance through growth differentiation factor 3
  2325. Obesity-related epigenetic changes after bariatric surgery
  2326. Blood-brain barriers in obesity
  2327. To be or not to be obese: Impact of obesity on lymphatic function
  2328. Anti-obesity and insulin-sensitising effects of a glycosaminoglycan mix
  2329. SUN-543 Real World Evidence of Successful Weight Management for the Obese Population: Complete Reversal of Obesity Related Metabolic Co-Morbidities …
  2330. Simvastatin has anti-tumorigenic effects in endometrial cancer via reversal of obesity-driven upregulation of lipid biosynthesis
  2331. Attenuation of Obesity, Hepatic Steatosis and Reversal of Atherosclerosis by the Flavonoids Naringenin and Nobiletin
  2332. Mild suppression of hyperinsulinemia to treat obesity and insulin resistance
  2333. Vascular targeted nanotherapeutic approach for obesity treatment
  2334. Dietary options for rodents in the study of obesity
  2335. Role of innate and adaptive immunity in obesity-associated metabolic disease
  2336. Dynamic energy balance and obesity prevention
  2337. A single combination gene therapy treats multiple age-related diseases
  2338. Caloric restriction recovers impaired β-cell-β-cell gap junction coupling, calcium oscillation coordination, and insulin secretion in prediabetic mice
  2339. Genetic variants for personalised management of very low carbohydrate ketogenic diets
  2340. Genetics of obesity: can an old dog teach us new tricks?
  2341. Milestone weight loss goals (weight normalization and remission of obesity) after gastric bypass surgery: long-term results from the University of Michigan
  2342. Obesity and breast cancer–what’s new?
  2343. Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects
  2344. Dual inhibition of cannabinoid CB1 receptor and inducible NOS attenuates obesity‐induced chronic kidney disease
  2345. The neuroprotective effect of dark chocolate in monosodium glutamate-induced nontransgenic Alzheimer disease model rats: biochemical, behavioral, and …
  2346. Hypothalamic Pomc‐deficiency Impairs the Function of Leptin to Decrease Food Intake and Bodyweight
  2347. How does exercise support dietary approaches to weight loss and better health?
  2348. Comment on: Five-year changes in dietary intake and body composition in adolescents with severe obesity undergoing laparoscopic Roux-en-Y gastric bypass …
  2349. Long-term remission of type 2 diabetes—two roads to the elusive goal
  2350. Bariatric surgery prior to living donor nephrectomy: a solution to expand the living donor kidney pool–a retrospective study
  2351. Naltrexone/bupropion for the treatment of obesity and obesity with Type 2 diabetes
  2352. Dietary management of obesity: a review of the evidence
  2353. Time-dependent reversal of diet-induced metabolic syndrome in rats switched to a corn starch diet
  2354. Studies of perivascular adipose tissue function in obesity and following diet-induced weight loss
  2355. The obesity epidemic in the face of homeostatic body weight regulation: What went wrong and how can it be fixed?
  2356. Evidence-Based Guidelines for the Treatment of Obesity
  2357. Animal models of obesity and diabetes mellitus
  2358. Appetite control with relevance to mitochondrial biogenesis and activation of post-prandial lipid metabolism in obesity linked diabetes
  2359. Effect of obesity on bladder cancer and renal cell carcinoma incidence and survival
  2360. The effects of bariatric surgery on gut microbiota in patients with obesity: a review of the literature
  2361. Turbo Metabolism: 8 Weeks to a New You: by Pankaj Vij, MD, FACP, and Joel Fuhrman, MD
  2362. Whole-Food Plant-Based Lifestyle Program and Decreased Obesity: A 10-Year Follow-up
  2363. Comprehensive molecular characterization of surgical vs. dietary weight loss: impact on mammary tumor burden
  2364. Promises of nanotherapeutics in obesity
  2365. Decreases in neprilysin and vasoconstrictors and increases in vasodilators following bariatric surgery
  2366. Bilobalide abates inflammation, insulin resistance and secretion of angiogenic factors induced by hypoxia in 3T3-L1 adipocytes by controlling NF-κB and JNK …
  2367. The possible factors affecting microglial activation in cases of obesity with cognitive dysfunction
  2368. Vascular risk reduction in obesity through reduced granulocyte burden and improved angiogenic monocyte content following bariatric surgery
  2369. Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes
  2370. Akkermansia muciniphila-Derived Extracellular Vesicles as a Mucosal Delivery Vector for Amelioration of Obesity in Mice
  2371. Caloric Restriction recovers impaired β-cell-β-cell coupling, calcium oscillation coordination and insulin secretion in prediabetic mice
  2372. Targeting IκB kinase β in adipocyte lineage cells for treatment of obesity and metabolic dysfunctions
  2373. Profound and redundant functions of arcuate neurons in obesity development
  2374. Angiogenesis in obesity
  2375. Understanding human physiological limitations and societal pressures in favor of overeating helps to avoid obesity
  2376. Inflammation and the metabolic syndrome: the tissue-specific functions of NF-κB
  2377. Obesity in older people: A new scenario and a new challenger
  2378. Potential role of aryl hydrocarbon receptor signaling in childhood obesity
  2379. The impact of age and sex on body composition and glucose sensitivity in C57BL/6J mice
  2380. Childhood obesity plans already show progress, minister claims
  2381. Long-term exercise-secreted extracellular vesicles promote browning of white adipocytes by suppressing miR-191a-5p
  2382. Gastric bypass surgery in lean adolescent mice prevents diet-induced obesity later in life
  2383. Dietary nitrite reverses features of postmenopausal metabolic syndrome induced by high-fat diet and ovariectomy in mice
  2384. Dibenzazepine-loaded nanoparticles induce local browning of white adipose tissue to counteract obesity
  2385. Sleeve gastrectomy reversed obesity-induced hypogonadism in a rat model by regulating inflammatory responses in the hypothalamus and testis
  2386. Cyanidin-3-O-glucoside ameliorates palmitate-induced insulin resistance by modulating IRS-1 phosphorylation and release of endothelial derived vasoactive factors
  2387. TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl) purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway
  2388. Attenuation of obesity and insulin resistance by fish oil supplementation is associated with improved skeletal muscle mitochondrial function in mice fed a high-fat diet
  2389. Differential effects of diet and weight on taste responses in diet‐induced obese mice
  2390. Potential relationship between dietary long-chain saturated fatty acids and hypothalamic dysfunction in obesity
  2391. Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles
  2392. Perioperative course, weight loss and resolution of comorbidities after primary sleeve gastrectomy for morbid obesity: are there differences between adolescents and …
  2393. Prohibitin–At the crossroads of obesity-linked diabetes and cancer
  2394. THE PERCEPTION OF PHYSIOTHERAPISTS OF KARACHI IN THEIR ROLE TO REHABILITATE AND MANAGE OBESITY
  2395. Gut-brain cross-talk in metabolic control
  2396. Systemic TNF-α blockade attenuates anxiety and depressive-like behaviors in db/db mice through downregulation of inflammatory signaling in peripheral …
  2397. Resolution of refractory iron deficiency anemia following sleeve gastrectomy in an adolescent with severe obesity
  2398. Persistent microbiome alterations modulate the rate of post-dieting weight regain
  2399. Legend of weight loss: a crosstalk between the bariatric surgery and the brain
  2400. Zfp423 maintains white adipocyte identity through suppression of the beige cell thermogenic gene program
  2401. Trained immunity: linking obesity and cardiovascular disease across the life-course?
  2402. Expression and activity of the cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 is tissue and species-specific
  2403. Long-term atorvastatin or the combination of atorvastatin and nicotinamide ameliorate insulin resistance and left ventricular diastolic dysfunction in a murine model of …
  2404. The gut microbiome, energy homeostasis, and implications for hypertension
  2405. Exploring the impact of obesity on skeletal muscle function in older age
  2406. Downregulation of IL-10 secretion by Treg cells in osteoarthritis is associated with a reduction in Tim-3 expression
  2407. An eclectic cast of cellular actors orchestrates innate immune responses in the mechanisms driving obesity and metabolic perturbation
  2408. ASK1 (MAP3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity, molecularly defining a human dys-metabolic obese phenotype
  2409. Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy
  2410. Beiging of white adipose tissue as a therapeutic strategy for weight loss in humans
  2411. Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance
  2412. Obesity, body weight regulation and the brain: insights from fMRI
  2413. Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: a review
  2414. Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr−/− mice
  2415. The correlation between cardiorespiratory fatigue and lower extremity joint moments in obese individuals and the associated reverse causation
  2416. Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero
  2417. Downward trends in the prevalence of childhood overweight in two pilot towns taking part in the VIASANO community‐based programme in B elgium: data from a …
  2418. DNA methylation changes more slowly than physiological states in response to weight loss in genetically diverse mouse strains
  2419. The Effects of Diet Induced Obesity and Metabolic Irregularities on Hippocampal-Based Cognition and Neuroplasticity in Young Female and Male Rat
  2420. Turning the tables on obesity: young people, IT and social movements
  2421. Laparoscopic sleeve gastrectomy improves nonalcoholic fatty liver disease–related liver damage in adolescents by reshaping cellular interactions and hepatic …
  2422. Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue
  2423. Diet and gut microbiome interactions in gynecologic cancer
  2424. Skeletal muscle inflammation and insulin resistance in obesity
  2425. New therapeutic approaches for the treatment of obesity
  2426. Transcriptional dysregulation of adipose tissue autophagy in obesity
  2427. The effect of increasing body mass index on laparoscopic surgery for colon and rectal cancer
  2428. Deletion of the glutaredoxin-2 gene protects mice from diet-induced weight gain, which correlates with increased mitochondrial respiration and proton leaks in skeletal …
  2429. Exercise, adipokines and pediatric obesity: a meta-analysis of randomized controlled trials
  2430. Pharmacotherapy of obesity: limits and perspectives
  2431. The role of WIC in obesity prevention
  2432. Neutrophil elastase regulates emergency myelopoiesis preceding systemic inflammation in diet-induced obesity
  2433. Obesity in adolescents and youth: the case for and against bariatric surgery
  2434. Association between exercise and treatment with liraglutide in obese rats by cafeteria diet
  2435. Cytokines and fatty liver diseases
  2436. Adipose tissue heterogeneity-development and application of nonlinear microscopy methods
  2437. G protein-coupled receptor kinase 2 (GRK2) as an integrative signalling node in the regulation of cardiovascular function and metabolic homeostasis
  2438. Imaging of the parathyroid glands in primary hyperparathyroidism
  2439. Portrayal of bariatric surgery in the New Zealand print news media
  2440. Obesity prevention in a city state: lessons from New York City during the Bloomberg Administration
  2441. Link between chemerin, central obesity, and parameters of the Metabolic Syndrome: findings from a longitudinal study in obese children participating in a lifestyle …
  2442. Obesity and associated comorbidities in people and companion animals: a one health perspective
  2443. An Extract of Russian Tarragon Prevents Obesity‐Related Ectopic Lipid Accumulation
  2444. The association of chronic kidney disease and waist circumference and waist-to-height ratio in Chinese urban adults
  2445. Transgenerational epigenetics, paternal obesity, and insulin resistance
  2446. Post-dieting weight gain: the role of persistent microbiome changes
  2447. Vascular endothelial regulation of obesity-associated insulin resistance
  2448. Selective activation of Gs signaling in adipocytes causes striking metabolic improvements in mice
  2449. TrkB-expressing neurons in the dorsomedial hypothalamus are necessary and sufficient to suppress homeostatic feeding
  2450. Prohibitin: A new player in immunometabolism and in linking obesity and inflammation with cancer
  2451. How do structurally distinct compounds exert functionally identical effects in combating obesity?
  2452. Should bariatric surgery be performed in adolescents?
  2453. Peptide-functionalized quantum dots for potential applications in the imaging and treatment of obesity
  2454. Targeted proapoptotic peptides depleting adipose stromal cells inhibit tumor growth
  2455. A systematic review of studies of DNA methylation in the context of a weight loss intervention
  2456. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell
  2457. Targeting ceramide metabolism in obesity
  2458. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes
  2459. Food for thought: reward mechanisms and hedonic overeating in obesity
  2460. Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages
  2461. The gut microbiome, obesity, and weight control in women’s reproductive health
  2462. Capsaicin in attenuating metabolic syndrome
  2463. Carotenoids and carotenoid conversion products in adipose tissue biology and obesity: Pre-clinical and human studies
  2464. A transcriptomic analysis reveals novel patterns of gene expression during 3T3-L1 adipocyte differentiation
  2465. Effect of resveratrol on adipokines and myokines involved in fat browning: Perspectives in healthy weight against obesity
  2466. Visceral adipose tissue macrophage-targeted TACE silencing to treat obesity-induced type 2 diabetes
  2467. Food cues and obesity: overpowering hormones and energy balance regulation
  2468. The role of the Nrf2 signaling in obesity and insulin resistance
  2469. Plant hormones: key players in gut microbiota and human diseases?
  2470. Activation of neuregulin-4 in adipocytes improves metabolic health by enhancing adipose tissue angiogenesis
  2471. Mouse modeling of obese lung disease. Insights and caveats
  2472. Steroid metabolomic signature of insulin resistance in childhood obesity
  2473. Cardiovascular outcomes following adolescent bariatric surgery
  2474. PDGFRβ regulates adipose tissue expansion and glucose metabolism via vascular remodeling in diet-induced obesity
  2475. Microbial medicine: prebiotic and probiotic functional foods to target obesity and metabolic syndrome
  2476. P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions
  2477. Brown adipose tissue imaging using the TSPO tracer [18F] fluoromethyl-PBR28-d2: A comparison with [18F] FDG
  2478. Deletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle
  2479. Thyme oxymel by improving of inflammation, oxidative stress, dyslipidemia and homeostasis of some trace elements ameliorates obesity induced by high …
  2480. Obesity and cardiovascular disease: a risk factor or a risk marker?
  2481. Wnt signaling mediates TLR pathway and promote unrestrained adipogenesis and metaflammation: therapeutic targets for obesity and type 2 diabetes
  2482. Adipocyte dysfunction, inflammation, and insulin resistance in obesity
  2483. Association of oxytocin with glucose intolerance and inflammation biomarkers in metabolic syndrome patients with and without prediabetes
  2484. Vascular risk in obesity: Facts, misconceptions and the unknown
  2485. Development of pulmonary hypertension in heart failure with preserved ejection fraction
  2486. Triglyceride and glucose (TyG) index is an effective biomarker to identify severe acute pancreatitis
  2487. Central leptin resistance and hypothalamic inflammation are involved in letrozole-induced polycystic ovary syndrome rats
  2488. Investigating the Role of LRG1 in Obesity and Adipose Tissue Remodelling
  2489. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
  2490. Adipose natural killer cells regulate adipose tissue macrophages to promote insulin resistance in obesity
  2491. Mast cell stabilizers obviate high fat diet-induced renal dysfunction in rats
  2492. 10 Mechanisms Mediating Obesity-Induced Inflammation and Insulin Resistance
  2493. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes
  2494. High fat diet and associated changes in the expression of micro‐RNAs in tissue: Lessons learned from animal studies
  2495. Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome
  2496. Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [11C] DASB positron emission tomography study
  2497. Adiposity as a full mediator of the influence of cardiorespiratory fitness and inflammation in schoolchildren: The FUPRECOL Study
  2498. Weight management and physical activity throughout the cancer care continuum
  2499. Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness
  2500. Obesity and the acute respiratory distress syndrome
  2501. An integrated view of immunometabolism
  2502. Saturated fatty acids, obesity, and the nucleotide oligomerization domain–like receptor protein 3 (NLRP3) inflammasome in asthmatic patients
  2503. Hypoglycemic activity of 6-bromoembelin and vilangin in high-fat diet fed-streptozotocin-induced type 2 diabetic rats and molecular docking studies
  2504. Inflammatory signaling and brown fat activity
  2505. Targeting innate immune mediators in type 1 and type 2 diabetes
  2506. Brassinin, a phytoalexin in cruciferous vegetables, suppresses obesity‐induced inflammatory responses through the Nrf2‐HO‐1 signaling pathway in an adipocyte …
  2507. Treatment of insulin resistance in obesity-associated type 2 diabetes mellitus through adiponectin gene therapy
  2508. Training motor responses to food: A novel treatment for obesity targeting implicit processes
  2509. Obesity 13 of Diabetes
  2510. Levels of metabolic markers in drug-naive prediabetic and type 2 diabetic patients
  2511. (p‐ClPhSe)2 Reduces Hepatotoxicity Induced by Monosodium Glutamate by Improving Mitochondrial Function in Rats
  2512. Obesity as a Disease
  2513. Diabetes Mellitus and Glucose Metabolism
  2514. Anti-inflammatory actions of (−)-epicatechin in the adipose tissue of obese mice
  2515. Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction
  2516. A phytoestrogen secoisolariciresinol diglucoside induces browning of white adipose tissue and activates non-shivering thermogenesis through AMPK pathway
  2517. Effects of mixed carotenoids on adipokines and abdominal adiposity in children: a pilot study
  2518. Cellular aging contributes to failure of cold-induced beige adipocyte formation in old mice and humans
  2519. 2-OHOA supplementation reduced adiposity and improved cardiometabolic risk to a greater extent than n-3 PUFA in obese mice
  2520. Effect of bariatric surgery on plasma GDF15 in humans
  2521. CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance
  2522. Obesity causes irreversible mitochondria failure in visceral adipose tissue despite successful anti-obesogenic lifestyle-based interventions
  2523. Effect of 8 weeks sprint interval training on serum levels of Adiponectin and insulin in overweight children
  2524. Role of mitochondria in the skeletal muscle metabolism in obesity and type 2 diabetes
  2525. Regulation of metabolism by the innate immune system
  2526. Insulin-sparing and fungible effects of E4orf1 combined with an adipocyte-targeting sequence in mouse models of type 1 and type 2 diabetes
  2527. Curcumin prevents inflammatory response, oxidative stress and insulin resistance in high fructose fed male Wistar rats: Potential role of serine kinases
  2528. IKKβ is essential for adipocyte survival and adaptive adipose remodeling in obesity
  2529. Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice
  2530. MS-275, a class 1 histone deacetylase inhibitor augments glucagon-like peptide-1 receptor agonism to improve glycemic control and reduce obesity in diet-induced …
  2531. Neuroinflammation and white matter alterations in obesity assessed by diffusion basis spectrum imaging
  2532. Exercise-induced adaptations to white and brown adipose tissue
  2533. DHA reduces hypothalamic inflammation and improves central leptin signaling in mice
  2534. The colors of adipose tissue
  2535. Outcomes of adolescents compared with young adults after bariatric surgery: an analysis of 227,671 patients using the MBSAQIP data registry
  2536. Evaluation of Oxidative Stress Biomarkers in Patients after Bariatric Surgery of the Fobi Capella Type
  2537. Lysimachia Capillipes inhibit adipogenesis via angiogenesis inhibition
  2538. Neural vulnerability factors that increase risk for future weight gain.
  2539. Study of waist circumference in school children
  2540. Obesity, estrogens and adipose tissue dysfunction–implications for pulmonary arterial hypertension
  2541. Human adenovirus Ad36 and its E4orf1 gene enhance cellular glucose uptake even in the presence of inflammatory cytokines
  2542. Intermittent fasting and ‘metabolic switch’: Effects on metabolic syndrome, prediabetes and type 2 diabetes
  2543. Mean Platelet Volume (MPV) as an inflammatory marker in type 2 diabetes mellitus and obesity
  2544. Regulatory roles of invariant natural killer T cells in adipose tissue inflammation: defenders against obesity-induced metabolic complications
  2545. Metabolic inflammation-differential modulation by dietary constituents
  2546. Reinforced POSE: the 18-plication solution
  2547. Glucose-6-phosphate dehydrogenase deficiency improves insulin resistance with reduced adipose tissue inflammation in obesity
  2548. Hypothalamic insulin-sensitizing effect of exenatide in dietary induced rat model of obesity
  2549. Long-term pharmacotherapy considerations in the bariatric surgery patient
  2550. Metabolic Abnormalities and Adipose Tissue Leukocyte Dynamics in a Murine Model of Obesity, Weight Loss, and Weight Regain
  2551. Luteolin reduces adipose tissue macrophage inflammation and insulin resistance in postmenopausal obese mice
  2552. Glucagon-based therapy: past, present and future
  2553. Central leptin and tumor necrosis factor-α (TNFα) in diurnal control of blood pressure and hypertension
  2554. Adipose tissue inflammation in insulin resistance: review of mechanisms mediating anti-inflammatory effects of omega-3 polyunsaturated fatty acids
  2555. Peptides and peptidomimetics as potential antiobesity agents: overview of current status
  2556. The cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in the pathogenesis of the metabolic syndrome
  2557. Sex differences in sympathetic innervation and browning of white adipose tissue of mice
  2558. Brown adipose tissue: The heat is on the heart
  2559. The stability of children’s weight status over time, and the role of television, physical activity, and diet
  2560. Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Insulin Resistance
  2561. Adipokines: potential therapeutic targets for vascular dysfunction in type II diabetes mellitus and obesity
  2562. Repeatability of brown adipose tissue measurements on FDG PET/CT following a simple cooling procedure for BAT activation
  2563. Association of high-fat diet with neuroinflammation, anxiety-like defensive behavioral responses, and altered thermoregulatory responses in male rats
  2564. Promising therapies for treatment of nonalcoholic steatohepatitis
  2565. Mechanisms of Obesity Induced Impairment of Reproduction
  2566. Physical Exercise and White Adipose Tissue Plasticity in the Context of Obesity
  2567. Effect of short‐term probiotic Enterococcus faecium SF68 dietary supplementation in overweight and obese cats without comorbidities
  2568. Effects of microalgal polyunsaturated fatty acid oil on body weight and lipid accumulation in the liver of C57BL/6 mice fed a high fat diet
  2569. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review
  2570. Corn oil versus lard: Metabolic effects of omega-3 fatty acids in mice fed obesogenic diets with different fatty acid composition
  2571. Obesity, NASH, and HCC
  2572. Articles in PresS. Am J Physiol Heart Circ Physiol (April 15, 2016). doi: 10.1152/ajpheart. 00698.2015
  2573. Laparoscopic Duodenal Switch
  2574. Nanomedicine for obesity treatment
  2575. Obesity accelerates age defects in mouse and human B cells
  2576. Differential expression of six chicken genes associated with fatness traits in a divergently selected broiler population
  2577. Structured Physical Activity and Dietary Education Program for Obese Adolescents: An Evaluation of a Quality Improvement Project at a Rural Primary Care Clinic
  2578. Alteration of adipose tissue immune cell milieu towards the suppression of inflammation in high fat diet fed mice by flaxseed oil supplementation
  2579. Differential modulation of white adipose tissue endocannabinoid levels by n-3 fatty acids in obese mice and type 2 diabetic patients
  2580. Genistein Ameliorates Non-alcoholic Fatty Liver Disease by Targeting the Thromboxane A2 Pathway
  2581. Dietary supplementation with purified citrus limonin glucoside does not alter ex vivo functions of circulating T lymphocytes or monocytes in overweight/obese human …
  2582. Current mechanisms in obesity and tumor progression
  2583. The role of ceramides in insulin resistance
  2584. Endothelial cells: new players in obesity and related metabolic disorders
  2585. Fructose-enriched diet induces inflammation and reduces antioxidative defense in visceral adipose tissue of young female rats
  2586. Availability of vending machines and school stores in California schools
  2587. Exendin-4 modifies adipogenesis of human adipose-derived stromal cells isolated from omentum through multiple mechanisms
  2588. Clinical Manifestations of Insulin Resistance in Youth
  2589. Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
  2590. The Aryl Hydrocarbon Receptor and Diet-Induced Obesity: An Investigation of How the Canonical Toxicant Receptor Modulates the Obese State via Activation and …
  2591. Catabolic and anabolic faces of insulin resistance and their disorders: a new insight into circadian control of metabolic disorders leading to diabetes
  2592. Feeding obese diabetic mice a genistein diet induces thermogenic and metabolic change
  2593. Plasma acylcarnitines and amino acid levels as an early complex biomarker of propensity to high-fat diet-induced obesity in mice
  2594. Aegeline inspired synthesis of novel β3-AR agonist improves insulin sensitivity in vitro and in vivo models of insulin resistance
  2595. Adolescent Metabolic/Bariatric
  2596. Functional and molecular adaptations of enteroendocrine L-cells in male obese mice are associated with preservation of pancreatic α-cell function and prevention of …
  2597. Roles of daily diet and beta-adrenergic system in the treatment of obesity and diabetes
  2598. Type II diabetes mellitus and obesity: Common links, existing therapeutics and future developments
  2599. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes
  2600. Meta-inflammation and cardiometabolic disease in obesity: Can heat therapy help?
  2601. Stromal cell-derived factor 1 (SDF1) attenuates platelet-derived growth factor-B (PDGF-B)-induced vascular remodeling for adipose tissue expansion in obesity
  2602. Targeted hyaluronate–hollow gold nanosphere conjugate for anti-obesity photothermal lipolysis
  2603. Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF …
  2604. Stem cell and obesity: current state and future perspective
  2605. Regulation of 11β-hydroxysteroid dehydrogenase type 1 following caloric restriction and re-feeding is species dependent
  2606. Peroxisome proliferator-activated receptor γ in white and brown adipocyte regulation and differentiation
  2607. Evaluation of Urolithin, a Pomegranate Metabolite as an Inhibitor of Obesity Driven Endoplasmic Reticulum Stress and Inflammation
  2608. The protective effects of Chinese yam polysaccharide against obesity-induced insulin resistance
  2609. Urtica dioica Whole Vegetable as a Functional Food Targeting Fat Accumulation and Insulin Resistance-a Preliminary Study in a Mouse Pre-Diabetic Model
  2610. ÔØ Å ÒÙ× Ö ÔØ
  2611. Effects of growth hormone on uncoupling protein 1 in white adipose tissues in obese mice
  2612. Clinical application potential of small molecules that induce brown adipose tissue thermogenesis by improving fat metabolism
  2613. Health benefits attributed to 17α-estradiol, a lifespan-extending compound, are mediated through estrogen receptor α
  2614. Effect of an 8-week individualized training program on blood biomarkers, adipokines and endothelial function in obese young adolescents with and without metabolic …
  2615. ASK1 (MAP3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity, molecularly defining a human dys-metabolic obese phenotype
  2616. Insulin resistance in HIV-patients: causes and consequences
  2617. Non-glycanated decorin is a drug target on human adipose stromal cells
  2618. Foundations of immunometabolism and implications for metabolic health and disease
  2619. The effect of saffron on weight and lipid profile: A systematic review, meta‐analysis, and dose–response of randomized clinical trials
  2620. Browning of white adipose tissue induced by the ß3 agonist CL-316,243 after local and systemic treatment-PK-PD relationship
  2621. Pituitary pars intermedia dysfunction
  2622. Bitter Orange (Citrus aurantium Linné) Improves Obesity by Regulating Adipogenesis and Thermogenesis through AMPK Activation
  2623. The aryl hydrocarbon receptor in energy balance: the road from dioxin-induced wasting syndrome to combating obesity with ahr ligands
  2624. CREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance
  2625. PPARβ/δ and lipid metabolism in the heart
  2626. Flaxseed oil alleviates chronic HFD-induced insulin resistance through remodeling lipid homeostasis in obese adipose tissue
  2627. Premature ejaculation in type II diabetes mellitus patients: association with glycemic control
  2628. Secoisolariciresinol diglucoside inhibits adipogenesis through the AMPK pathway
  2629. ASK1 (MAP3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity
  2630. Endoscopic Primary Bariatric Procedures
  2631. Beneficial Health Effect of Aquarobics (Role of Adiponectin on Women with Obesity)
  2632. Essential roles for the non-canonical IκB kinases in linking inflammation to cancer, obesity, and diabetes
  2633. Intake of a Western diet containing cod instead of pork alters fatty acid composition in tissue phospholipids and attenuates obesity and hepatic lipid accumulation in …
  2634. Dietary Supplementation with Dunaliella Tertiolecta Prevents Whitening of Brown Fat and Controls Diet-Induced Obesity at Thermoneutrality in Mice
  2635. Muscle insulin resistance and the inflamed microvasculature: fire from within
  2636. Obesity and inflammation: Role of adipokines
  2637. Metabolic syndrome.
  2638. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders
  2639. MKK6 controls T3-mediated browning of white adipose tissue
  2640. CCL2/CCR2 signaling in cancer pathogenesis
  2641. A Retrospective Comparative Analysis on the Effectiveness of Pharmacologic Weight Loss
  2642. Macrophage infiltration into obese adipose tissues suppresses the induction of UCP1 level in mice
  2643. Latent inflammation and insulin resistance in adipose tissue
  2644. Influences of nutritional food label understanding in African-American Women with obesity
  2645. Classifying the linkage between adipose tissue inflammation and tumor growth through cancer-associated adipocytes
  2646. Effects of recombinant irisin on body mass index, serum insulin, luteinizing hormone and testosterone levels in obese female BALB/c mice
  2647. Fibroblast Growth Factor 21 Expression in Mice with Altered Growth Hormone Action: Links to Obesity, Type 2 Diabetes Mellitus, and Increased Longevity
  2648. Comprehensive functional screening of miRNAs involved in fat cell insulin sensitivity among women
  2649. (-)-Epicatechin and its metabolites prevent palmitate-induced NADPH oxidase upregulation, oxidative stress and insulin resistance in HepG2 cells
  2650. Metabolic and molecular mechanisms of macrophage polarisation and adipose tissue insulin resistance
  2651. Alterations in the transcriptional profile of the liver tissue and the therapeutic effects of Propolis extracts in alcohol-induced steatosis in rats
  2652. Application of Nanomaterials in Treatment of Endocrine Diseases
  2653. Cardiovascular risk factors after adolescent bariatric surgery
  2654. Citrus flavonoids as regulators of lipoprotein metabolism and atherosclerosis
  2655. Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus
  2656. Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance [S]
  2657. Humans and mice display opposing patterns of “browning” gene expression in visceral and subcutaneous white adipose tissue depots
  2658. Salsalate (salicylate) uncouples mitochondria, improves glucose homeostasis, and reduces liver lipids independent of AMPK-β1
  2659. Macrophage polarization: the link between inflammation and related diseases
  2660. Gender difference in NASH susceptibility: Roles of hepatocyte Ikkβ and Sult1e1
  2661. Influences of Nutritional Food Label Understanding on African American Women with Obesity
  2662. PI3Ka-Akt1-mediated Prdm4 induction in adipose tissue increases energy expenditure, inhibits weight gain, and improves insulin resistance in diet-induced …
  2663. Using neuroimaging to investigate the impact of Mandolean® training in young people with obesity: a pilot randomised controlled trial
  2664. Pro-inflammatory macrophages coupled with glycolysis remodel adipose vasculature by producing platelet-derived growth factor-B in obesity
  2665. Hypoglycaemic effect and mechanism of an RG-II type polysaccharide purified from Aconitum coreanum in diet-induced obese mice
  2666. Weight gain is associated with changes in neural response to palatable food tastes varying in sugar and fat and palatable food images: a repeated-measures fMRI …
  2667. Managing the Obese Living Kidney Donor
  2668. The role of the immune system in metabolic health and disease
  2669. Emerging therapeutic targets for NASH: key innovations at the preclinical level
  2670. Clinical guide to popular diets
  2671. Supplementation with Combined Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 Across Development Reveals Sex Differences in Physiological …
  2672. Drugs involved in dyslipidemia and obesity treatment: focus on adipose tissue
  2673. SP prevents T2DM complications by immunomodulation
  2674. Exercise regulation of adipose tissue
  2675. Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind …
  2676. Corosolic acid inhibits adipose tissue inflammation and ameliorates insulin resistance via AMPK activation in high-fat fed mice
  2677. Obesity and Exercice: Effects of different Chronic Exercise Models on visceralapipose tissue from obese animals.
  2678. Audiovestibular evaluation after bariatric surgery
  2679. Prohibitin in adipose and immune functions
  2680. Linking chronic inflammation with cardiovascular disease: from normal aging to the metabolic syndrome
  2681. Fibroblast growth factor 21 and the adaptive response to nutritional challenges
  2682. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease
  2683. Effect of selective expression of dominant-negative PPARγ in pro-opiomelanocortin neurons on the control of energy balance
  2684. Does physical activity-based intervention improve systemic proinflammatory cytokine levels in overweight or obese children and adolescents? Insights from a meta …
  2685. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease
  2686. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds
  2687. Nutritional properties of protein sources on diet-induced obesity, hepatic lipid accumulation, and fatty acid composition in mice
  2688. Innate obesity, revealed by selection markers, confers significant imprint of hypothalamic genes controlling energy expenditure
  2689. Type 2 diabetes and its impact on the immune system
  2690. Low dose doxycycline decreases systemic inflammation and improves glycemic control, lipid profiles, and islet morphology and function in db/db mice
  2691. TNF-alpha regulates alternative splicing of genes participating in pathways of crucial metabolic syndromes; a transcriptome wide study
  2692. Molecular mechanisms of insulin resistance: An update
  2693. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout …
  2694. Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue
  2695. Chenodeoxycholic acid attenuates high‑fat diet‑induced obesity and hyperglycemia via the G protein‑coupled bile acid receptor 1 and proliferator‑activated …
  2696. Heat therapy improves glucose tolerance and adipose tissue insulin signaling in polycystic ovary syndrome
  2697. EPA and DHA elicit distinct transcriptional responses to high-fat feeding in skeletal muscle and liver
  2698. Pentamethylquercetin induces adipose browning and exerts beneficial effects in 3T3-L1 adipocytes and high-fat diet-fed mice
  2699. (–)-Epicatechin in the control of glucose homeostasis: Involvement of redox-regulated mechanisms
  2700. Adipose tissue: a safe haven for parasites?
  2701. GNB3 overexpression causes obesity and metabolic syndrome
  2702. PAQR3 regulates phosphorylation of FoxO1 in insulin-resistant HepG2 cells via NF-κB signaling pathway
  2703. Endometrial cancer—is our knowledge changing?
  2704. Antisense oligonucleotide and thyroid hormone conjugates for obesity treatment
  2705. Searching for evidence of an anti-inflammatory diet in children: a systematic review of randomized controlled trials for pediatric obesity interventions with a focus on …
  2706. Weight suppression increases odds for future onset of anorexia nervosa, bulimia nervosa, and purging disorder, but not binge eating disorder
  2707. Aspirin mitigated tumor growth in obese mice involving metabolic inhibition
  2708. Obese adipose tissue secretion induces inflammation in preadipocytes: Role of Toll-like receptor-4
  2709. NAFLD and diabetes mellitus
  2710. Metabolic syndrome causes recognition impairments and reduced hippocampal neuronal plasticity in rats
  2711. Efficacy of weight loss intervention can be predicted based on early alterations of fMRI food cue reactivity in the striatum
  2712. Mitochondrial Damage Accumulation in Oocytes-A Potential Link Between Maternal Obesity and Increased Cardiometabolic Disease Risk in Offspring
  2713. Salsalate activates skeletal muscle thermogenesis and protects mice from high-fat diet induced metabolic dysfunction
  2714. Potential role of free fatty acids in the pathogenesis of periodontitis and primary Sjögren’s syndrome
  2715. Control of brown and beige fat development
  2716. A possible Role of Salicylates in Diabetes Type II
  2717. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to …
  2718. Peptide-functionalized nanoparticles for the selective induction of apoptosis in target cells
  2719. Metabolic health, insulin, and breast cancer: why oncologists should care about insulin
  2720. Nonalcoholic fatty liver disease induced by high-fat diet in C57bl/6 models
  2721. MANAGEMENT OF ENDOCRINE DISEASE: the impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of …
  2722. Different and unequal: a qualitative evaluation of salient factors influencing energy intake in adults with overweight and obesity
  2723. Pulmonary targeting of adeno-associated viral vectors by next-generation sequencing-guided screening of random capsid displayed peptide libraries
  2724. Improvement of mTORC1-driven overproduction of apoB-containing triacylglyceride-rich lipoproteins by short-chain fatty acids, 4-phenylbutyric acid and (R)-α-lipoic …
  2725. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?
  2726. Layperson-led vs professional-led behavioral interventions for weight loss in pediatric obesity: a systematic review and meta-analysis
  2727. Renal insulin sensitizing effect of exenatide in a high-fat diet obesity rat model
  2728. Inflammation in human adipose tissues–Shades of gray, rather than white and brown
  2729. Differential expression network analysis for diabetes mellitus type 2 based on expressed level of islet cells
  2730. Hypocaloric versus Ad Libitum Diet on Cardiometabolic Markers and Microbiota of Overweight Individuals Performing Intense Exercise
  2731. Adropin deficiency worsens HFD-induced metabolic defects
  2732. Viral and nonviral transfer of genetic materials to adipose tissues: Toward a gold standard approach
  2733. Lung endothelial cell-targeted peptide-guided bFGF promotes the regeneration after radiation induced lung injury
  2734. Adipose stromal cell expansion and exhaustion: mechanisms and consequences
  2735. Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in …
  2736. The GAMMA concept (gastrointestinal activity manipulation to modulate appetite) preliminary proofs of the concept of local vibrational gastric mechanical stimulation
  2737. Hypertension in diabetes and the risk of cardiovascular disease
  2738. Pleasure: an under-utilised ‘P’in social marketing for healthy eating
  2739. The mechanism by which safflower yellow decreases body fat mass and improves insulin sensitivity in HFD-induced obese mice
  2740. Postnatal leptin surge is critical for the transient induction of the developmental beige adipocytes in mice
  2741. The effects of metformin on high-fat diet-induced neuroinflammation and cognitive impairment
  2742. A calcium-deficient diet in rat dams during gestation decreases HOMA-β% in 3 generations of offspring
  2743. Aberrant DNA methylation of Tgfb1 in diabetic kidney mesangial cells
  2744. Unsaturated fatty acids from flaxseed oil and exercise modulate GPR120 but not GPR40 in the liver of obese mice: a new anti-inflammatory approach
  2745. Influence of smoking, body mass index, and other factors on the preventive effect of nonsteroidal anti-inflammatory drugs on colorectal cancer risk
  2746. Preliminary report of inflammatory markers, oxidative stress, and insulin resistance in adolescents of different ethnicities
  2747. Adipocyte-secreted chemerin is processed to a variety of isoforms and influences MMP3 and chemokine secretion through an NFkB-dependent mechanism
  2748. TonEBP in macrophages and adipocytes contributes to obesity and type 2 diabetes
  2749. CL 316, 243 mediated reductions in blood glucose are enhanced in RIP140−/− mice independent of alterations in lipolysis
  2750. Periapical lesions increase macrophage infiltration and inflammatory signaling in muscle tissue of rats
  2751. Diet-derived fatty acids, brain inflammation, and mental health
  2752. Ageing, colonic health, obesity and the gut microbiota
  2753. TNF-α as an adipokine
  2754. Implications of Agonizing and Antagonizing Stearoyl-CoA Desaturase-1
  2755. Parental Self-Efficacy, Feeding Practices and Styles, and Obesity in Mexican American Children
  2756. Fruits, vegetables, and health: A comprehensive narrative, umbrella review of the science and recommendations for enhanced public policy to improve intake
  2757. Bcl11b regulates arterial stiffness by regulating vascular smooth muscle contractility
  2758. Environmental obesogens and their impact on susceptibility to obesity: new mechanisms
  2759. An efficient route to bispecific antibody production using single-reactor mammalian co-culture
  2760. Chronic ephedrine administration decreases brown adipose tissue activity in a randomised controlled human trial: implications for obesity
  2761. Dietary intake, nutritional status and energy metabolism in adolescents with severe obesity-Effects of gastric bypass surgery
  2762. Sustained anti-obesity effects of life-style change and anti-inflammatory interventions after conditional inactivation of the activin receptor ALK7
  2763. Signalling networks governing metabolic inflammation
  2764. Scholars Archiv e
  2765. Melatonin alleviates glucose and lipid metabolism disorders in Guinea pigs caused by different artificial light rhythms
  2766. Impact of n-3 Polyunsaturated Fatty Acids on Adipose Tissue Inflammation and Metabolic Control in Severely Obese Patients
  2767. Exercise-induced adaptations to adipose tissue thermogenesis
  2768. Lack of TRPV 2 impairs thermogenesis in mouse brown adipose tissue
  2769. High-density lipoprotein ameliorates palmitic acid-induced lipotoxicity and oxidative dysfunction in H9c2 cardiomyoblast cells via ROS suppression
  2770. Trends in research and development of phenolic phytochemicals as potential antidiabetic therapeutics
  2771. Liraglutide and insulin have contrary effects on adipogenesis of human adipose-derived stem cells via wnt pathway
  2772. Linseed oil improves hepatic insulin resistance in obese mice through modulating mitochondrial quality control
  2773. The role of HMGB1 in the pathogenesis of type 2 diabetes
  2774. Antidiabetic, lipid normalizing, and nephroprotective actions of the strawberry: A potent supplementary fruit
  2775. LOSS OF SKELETAL MUSCLE PKCθ PROTECTS AGAINST THE PATHOGENESIS OF INSULIN RESISTANCE
  2776. Glucagon-like peptide-2 treatment improves glucose dysmetabolism in mice fed a high-fat diet
  2777. Weight loss management in client-owned horses
  2778. Metabolic syndrome
  2779. Reduced number of adipose lineage and endothelial cells in epididymal fat in response to omega-3 PUFA in mice fed high-fat diet
  2780. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation
  2781. Identification of a rhodanine derivative BML-260 as a potent stimulator of UCP1 expression
  2782. Harmine induces adipocyte thermogenesis through RAC1-MEK-ERK-CHD4 Axis
  2783. Mapping the response of human fibroblast growth factor 21 (FGF21) promoter to serum availability and lipoic acid in HepG2 hepatoma cells
  2784. The Use of CHS-131, a selective PPAR-γ modulator to treat NAFLD/NASH
  2785. Association of Atp2a1 Rs3888190 Single Nucleotide Polymorphism with Obesity and Allergic Conditions among Utar Kampar Campus Students
  2786. Schistosoma Infection and Schistosoma-Derived Products Modulate the Immune Responses Associated with Protection against Type 2 Diabetes
  2787. Culinary medicine: advancing a framework for healthier eating to improve chronic disease management and prevention
  2788. Micronutrient supplementation to improve the impact of paternal obesity on subsequent generations
  2789. Saponins from Boussingaultia gracilis prevent obesity and related metabolic impairments in diet-induced obese mice
  2790. Interplay between dietary sugars and fats and insulin resistance
  2791. INTERNATIONALJOURNALO FNUTRITION
  2792. Inhibition of inflammatory signaling pathways in 3T3‐L1 adipocytes by apolipoprotein A‐I
  2793. Therapeutic effect of metformin in the treatment of endometrial cancer
  2794. The Role of Christine A Saponins Molecules in the Control of Mild Chronic Inflammation in Obesity Related with Type-II Diabetes Mellitus
  2795. Eosinophil function in adipose tissue is regulated by Krüppel-like factor 3 (KLF3)
  2796. Type 2 diabetes mellitus: Prevalence and risk factors
  2797. Modulation of glucose metabolism by leaf tea constituents: a systematic review of recent clinical and pre-clinical findings
  2798. Can dietary intervention be an auxiliary therapy for Rheumatoid Arthritis?
  2799. Inflammation in chronic kidney disease
  2800. Potent antihyperglycemic and hypoglycemic effect of Tamarix articulata Vahl. in normal and streptozotocin-induced diabetic rats
  2801. Low-intensity exercise in the prevention of cardiac insulin resistance-related inflammation and disturbances in NOS and MMP-9 regulation in fructose-fed …
  2802. Alterations in niban gene expression as a response to stress conditions in 3T3-L1 adipocytes
  2803. CD8+ T cell/adipocyte inflammatory cross talk and ensuing M1 macrophage polarization are reduced by fish-oil-derived n-3 polyunsaturated fatty acids, in part by a …
  2804. Articles in PresS. Am J Physiol Endocrinol Metab (February 16, 2016). doi: 10.1152/ajpendo. 00028.2015
  2805. Autophagy-mediated metabolic effects of aspirin
  2806. β-adrenergic receptor signaling evokes the PKA-ASK axis in mature brown adipocytes
  2807. IKK/NF-κB-regulated Inflammatory Pathway in Human Adipocytes: Implication in Subsequent Contribution to Insulin Resistance and Atherosclerosis
  2808. Systems biology will direct vascular-targeted therapy for obesity
  2809. Remodeling of rat stromal-vascular cells to brite/beige adipocytes by prolyl-hydroxyproline
  2810. Insulin signaling and reduced glucocorticoid receptor activity attenuate postprandial gene expression in liver
  2811. Protein kinase A induces UCP1 expression in specific adipose depots to increase energy expenditure and improve metabolic health
  2812. Omega-3 fatty acids and adipose tissue biology
  2813. Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseases
  2814. Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy
  2815. THE LONG PENTRAXIN 3 PLAYS A KEY ROLE IN THE IMMUNOMODULATION OF DIET-INDUCED OBESITY
  2816. The immune deficiency pathway regulates metabolic homeostasis in Drosophila
  2817. NLRP3 inflammasome mediate palmitate-induced endothelial dysfunction
  2818. Protectin DX ameliorates palmitate-or high-fat diet-induced insulin resistance and inflammation through an AMPK-PPARα-dependent pathway in mice
  2819. Browning of white fat: agents and implications for beige adipose tissue to type 2 diabetes
  2820. Investigation of mechanisms of insulin-regulated lipolysis via ABHD15.
  2821. Effects of vaspin on insulin resistance in rats and underlying mechanisms
  2822. Deficiency of adipocyte IKKβ affects atherosclerotic plaque vulnerability in obese LDLR deficient mice
  2823. 11β-HSD1 Modulates the Set Point of Brown Adipose Tissue Response to Glucocorticoids in Male Mice
  2824. Study on development of brown and beige adipocytes in mice: effect of age and diet-induced obesity
  2825. Celastrol attenuates mitochondrial dysfunction and inflammation in palmitate-mediated insulin resistance in C3A hepatocytes
  2826. Obesity and Type 2 Diabetes Mellitus: Adipocytokines as Markers of Insulin Resistance
  2827. Saturated fatty acids engage an IRE1α-dependent pathway to activate the NLRP3 inflammasome in myeloid cells
  2828. Platelet count and 8-year incidence of diabetes: The Korean Genome and Epidemiology Study
  2829. Articles in PresS. Am J Physiol Endocrinol Metab (July 5, 2016). doi: 10.1152/ajpendo. 00133.2016
  2830. Association between serum C-reactive protein and serum gamma-glutamyl transferase with type 2 diabetes in the Kuopio Ischaemic Heart Disease Risk Factor …
  2831. Probiotic mixture VSL# 3: An overview of basic and clinical studies in chronic diseases
  2832. Mitochondrial quality control as a therapeutic target
  2833. Molecular mechanisms of insulin resistance
  2834. The Adipose Organ: Cold Acclimation
  2835. An update on screening and prevention for breast and gynecological cancers in average and high risk individuals
  2836. The Intestine of Drosophila melanogaster: An Emerging Versatile Model System to Study Intestinal Epithelial Homeostasis and Host-Microbial Interactions in Humans
  2837. Exercise, heat shock proteins and insulin resistance
  2838. NF-κB-IKKβ pathway as a target for drug development: realities, challenges and perspectives
  2839. NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia
  2840. Micronutrient deficiency, a novel nutritional risk factor for insulin resistance and Syndrom X
  2841. Anti-inflammatory agents in the treatment of diabetes and its vascular complications
  2842. NF-κB; the Critical Link between Immune and Metabolic Pathways: Could NF-κB be Used as a Novel Diagnostic and Prognostic Biomarker for Non-Alcoholic …
  2843. Effect of dietary pretreatment and obesity on (-)-epigallocatechin-3-gallate (EGCG) mediated hepatotoxicity and the underlying mechanism
  2844. Effects of intermittent dietary supplementation with conjugated linoleic acid and fish oil (EPA/DHA) on body metabolism and mitochondrial energetics in mice
  2845. Dietary flaxseed: What we know and don’t know about its effects on cardiovascular disease
  2846. Inflammation is not a contributing factor in the development of insulin resistance in diet induced obesity in rats
  2847. Consequences of exposure to maternal diabetes on offspring puberty and adiposity
  2848. Browning and Beiging of Adipose Tissue: Its Role in the Regulation of Energy Homeostasis and as a Potential Target for Alleviating Metabolic Diseases …
  2849. Uncoupling Lipid Metabolism from Inflammation in Adipose Tissue
  2850. RESEARCH ON TYPE 2 DIABETES, INSULIN RESISTANCE, AND THE IMMUNE SYSTEM
  2851. Artemisinin mimics nitric oxide to reduce adipose weight by targeting mitochondrial complexes
  2852. Caloric restriction and its effect on blood pressure, heart rate variability and arterial stiffness and dilatation: a review of the evidence
  2853. Senoinflammation: A major mediator underlying age-related metabolic dysregulation
  2854. Dlgap1 negatively regulates browning of white fat cells through effects on cell proliferation and apoptosis
  2855. The interaction between prohibitin-1 and sex steroid hormones in adipogenesis
  2856. Association Between Single Nucleotide Polymorphisms (SNPs) in the Promoter of Adiponectin Gene, Hypoadiponectinemia, and Diabetes
  2857. Adipocyte Gi signaling is essential for maintaining whole-body glucose homeostasis and insulin sensitivity
  2858. Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by …
  2859. Theoretical review: Effect of caffeine intake on food consumption patterns and body weight gain
  2860. The UPRER: sensor and coordinator of organismal homeostasis
  2861. A PRDM16-driven metabolic signal from adipocytes regulates precursor cell fate
  2862. HOMA-estimated insulin resistance as an independent prognostic factor in patients with acute pancreatitis
  2863. w Adherence to Weight Loss and Physical Activity
  2864. IKKβ is a β-catenin kinase that regulates mesenchymal stem cell differentiation
  2865. Oxidised metabolites of the omega-6 fatty acid linoleic acid activate dFOXO
  2866. Huma Younus Faisal R. Khan
  2867. Berberine hydrochloride protects against cytokine-induced inflammation through multiple pathways in undifferentiated C2C12 myoblast cells
  2868. Transcriptional, Epigenetic and Lipidomic Responses to Metabolic Interventions: Implications for Human Obesity
  2869. A mixed-methods study: Self-efficacy and barriers to participation in workplace wellness programs
  2870. Rosiglitazone elicits an adiponectin-mediated insulin-sensitizing action at the adipose tissue-liver axis in Otsuka Long-Evans Tokushima fatty rats
  2871. Repeated ozone exposure exacerbates insulin resistance and activates innate immune response in genetically susceptible mice
  2872. Identifying a Role for the ER Stress Sensor IRE1α in Fatty Acid-Induced Inflammation
  2873. Omega-3 fatty acids as feed supplement modulates blood formation and body weight in Rattus norvegicus model
  2874. Scientific Plenary V: The Farr Nezhat Surgical Innovation Session Tuesday, March 14, 2017
  2875. MKK6 controls T3-mediated browning of white adipose tissue
  2876. The Cardiovascular Risk in Cushing’s Syndrome
  2877. From cultivation to consumption: Linking Urban agriculture, nutritional sciences, environmental sciences, and telehealth to food deserts and the social …
  2878. Associations of brain reactivity to food cues with weight loss, protein intake and dietary restraint during the PREVIEW intervention
  2879. IRS proteins and diabetic complications
  2880. EFFECT OF SALICYLATE ON ALBINO RATS BY STUDY OF SERUM GLOBULIN PATTERN
  2881. Food cravings: Associations with dietary intake and metabolic health
  2882. Intestinal microbial metabolites in human metabolism and type 2 diabetes
  2883. Periapical Lesions Increase Macrophage Infiltration and Inflammatory Signaling in Muscle Tissue of Rats
  2884. Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort
  2885. Leptin Repolarizes Tumor-Associated Macrophages to Boost Immunotherapy Efficacy in Obesity
  2886. Protective effects of Ficus carica leaves on glucose and lipids levels, carbohydrate metabolism enzymes and β-cells in type 2 diabetic rats
  2887. Targeted molecular magnetic resonance imaging detects brown adipose tissue with ultrasmall superparamagnetic iron oxide
  2888. PHB in cardiovascular and other diseases: present knowledge and implications
  2889. The potent antioxidant alpha lipoic acid
  2890. Diabetes and sepsis: risk, recurrence, and ruination
  2891. Omega-3 versus omega-6 polyunsaturated fatty acids in the prevention and treatment of inflammatory skin diseases
  2892. Beneficial effects of metformin and/or salicylate on palmitate-or TNFα-induced neuroinflammatory marker and neuropeptide gene regulation in immortalized …
  2893. Harnett, William (2017) Parasite excretory-secretory products and their effects on metabolic syndrome. Parasite Immunology. ISSN 0141-9838
  2894. Lysine-specific demethylase 1 promotes brown adipose tissue thermogenesis via repressing glucocorticoid activation
  2895. 3,5 Diiodo-l-Thyronine (T2) Promotes the Browning of White Adipose Tissue in High-Fat Diet-Induced Overweight Male Rats Housed at Thermoneutrality
  2896. Cross-talk between adipose tissue health, myocardial metabolism and vascular function: the adipose-myocardial and adipose-vascular axes
  2897. Adipose tissue: Development, physiology, and pathophysiology
  2898. Effect of High-Fat-Diets on Iron Homeostasis and Tissue Iron Deposition in Female Sprague-Dawley Rats
  2899. Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases
  2900. Flaxseed oil attenuates hepatic steatosis and insulin resistance in mice by rescuing the adaption to ER stress
  2901. Neural 3 Vulnerability Factors for Overeating Treatment Implications
  2902. Effects of α-lipoic acid on lipid metabolism and mitochondrial biogenesis in adipocytes: study of the molecular mechanisms involved
  2903. Bone Morphogenetic Protein 4 regulates white, beige and brown adipose tissue
  2904. Weight management in horses: relationships among digestible energy intake, body weight, and body condition
  2905. Thematic Review Series: Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death: Lipid signaling and lipotoxicity in metaflammation: indications for …
  2906. Beta 3 adrenergic receptor activation rescues metabolic dysfunction in female estrogen receptor alpha-null mice
  2907. Graphical abstract Chapter 3: PEDF-induced alteration of metabolism leading to insulin resistance
  2908. Genetically Dissecting Basal Forebrain Circuits Underlying Eating Disorders
  2909. The Effects of Interleukin-10 on Skeletal Muscle Insulin Resistance and Myogenesis
  2910. Duration of a” Brown-Like” Phenotype of White Adipose Tissue Induced by the β3 Agonist CL-316,243
  2911. The effects of physical activity on chronic subclinical systemic inflammation
  2912. The Anti-Obesogenic Effect of Lean Fish Species Is Influenced by the Fatty Acid Composition in Fish Fillets
  2913. Oxygen-Dependent Regulation of Fatty Acid Metabolism and Endoplasmic Reticulum Function in Adipocytes
  2914. Lowering effects of aspirin eugenol ester on blood lipids in rats with high fat diet
  2915. Current state of in vivo panning technologies: Designing specificity and affinity into the future of drug targeting
  2916. Fármacos usados no tratamento da dislipidemia e da obesidade: foco no tecido adiposo/Drugs involved in dyslipidemia and obesity treatment: focus on …
  2917. Astragaloside IV facilitates glucose transport in C2C12 myotubes through the IRS1/AKT pathway and suppresses the palmitate-induced activation of the IKK …
  2918. Amelioration of postprandial hyperglycemia by exercise with ultra-soft rubber bands: A non-crossover test.
  2919. Exercise training induces depot-specific adaptations to white and brown adipose tissue
  2920. Amelioration of high-insulin-induced skeletal muscle cell insulin resistance by resveratrol is linked to activation of AMPK and restoration of GLUT4 translocation
  2921. New advances in our understanding of the control and functions of brown adipose tissue thermogenesis
  2922. TSH promotes adiposity by inhibiting the browning of white fat
  2923. Association of daily home-based hot water bathing and glycemic control in ambulatory japanese patients with type 2 diabetes mellitus during the COVID-19 pandemic …
  2924. Changes in eating behaviour and meal patterns following vertical sleeve gastrectomy
  2925. Protein quality & amino acid requirements in relation to needs in India
  2926. Serum CXCL2 Level Can Predict High-Fat Diet-Induced Impairment of Bone Marrow Mesenchymal Stem Cells
  2927. Metabolomic response of skeletal muscle to aerobic exercise training in insulin resistant type 1 diabetic rats
  2928. Adipose Sensory Nerves: Functional and Neuroanatomical Evidence for Their Emerging Role in Energy Balance
  2929. Microbiome dynamics and their impact on the host
  2930. Lore of Nutrition: Challenging conventional dietary beliefs
  2931. Prohibitin as the molecular binding switch in the retinal pigment epithelium
  2932. Salutogenic design with healthcare approaches to indoor environment for office premises
  2933. DeepCPI: a deep learning-based framework for large-scale in silico drug screening
  2934. Small Ubiquitin-Like Modifier 4 (SUMO4) Gene M55V Polymorphism and Type 2 Diabetes Mellitus: A Meta-analysis Including 6,823 Subjects
  2935. Loss of TBK1 Kinase Function Improves Disease Outcome in Pancreatic Cancer and Metabolic Syndrome
  2936. The effect of concurrent aerobic and resistance exercises on glucose homeostasis and serum HS-CRP in overweight and obese anxious adolescent girls
  2937. Therapeutic methods against insulin resistance
  2938. Thyroid hormone status defines brown adipose tissue activity and browning of white adipose tissues in mice
  2939. Acute insulin deprivation results in altered mitochondrial substrate sensitivity conducive to greater fatty acid transport
  2940. Lifestyle and food habits impact on chronic diseases: Roles of PPARs
  2941. Autophagy-mediated metabolic effects of aspirin
  2942. Low-dose aspirin improves glucose uptake and attenuates inflammation in rats fed high-fat diet
  2943. Panx1 and Panx3 Regulate Adipocyte Development and Fat Accumulation in Vivo
  2944. Mechanisms of action of ginger in nuclear factor-kappaB signaling pathways in diabetes
  2945. Metabolic remodelling in heart failure
  2946. Adiposity and Health in Zoo African and Asian Elephants
  2947. CRISPR/Cas9 guided genome and epigenome engineering and its therapeutic applications in immune mediated diseases
  2948. The potential roles of artemisinin and its derivatives in the treatment of type 2 diabetes mellitus
  2949. Exploring Māori experiences of bariatric surgery
  2950. Transgenerational glucose intolerance of tumor necrosis factor with epigenetic alteration in rat perirenal adipose tissue induced by intrauterine hyperglycemia
  2951. “Bridge Proteins” Link Inflammation and Metabolic Diseases: Potential Targets for Therapeutics
  2952. Lipids, Low-Grade Chronic Inflammation and NAFLD: A Ménage À Trois?
  2953. PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes
  2954. Role of macrophages in depot-dependent browning of white adipose tissue
  2955. Aryl hydrocarbon receptor role in co-ordinating SARS-CoV-2 entry and symptomatology: linking cytotoxicity changes in COVID-19 and cancers; modulation by racial …
  2956. Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model
  2957. The Effect of Endurance Training on Adiponectin and Insulin Resistance in Overweight Female University Students.
  2958. Fármacos Usados no Tratamento da Dislipidemia e da Obesidade: Foco no Tecido Adiposo
  2959. Characterization of zebrafish Traf6 and Ikk2 mutants
  2960. In Vitro Effects of Oil’s Fatty Acids on T-Cell Function of Obese Men
  2961. TarNet: an evidence-based database for natural medicine research
  2962. Dietary genistein alleviates lipid metabolism disorder and inflammatory response in laying hens with fatty liver syndrome
  2963. Being big, becoming small: conversations with Māori women about weight loss surgery: a thesis presented in partial fulfilment of the requirements for the degree of …
  2964. Food-predicting stimuli differentially influence eye movements and goal-directed behavior in normal-weight, overweight, and obese individuals
  2965. Identification of T cell derived KLK1b22 as a novel regulator of systemic metabolism
  2966. Ligand-targeted theranostic nanomedicines against cancer
  2967. Oxidative stress and diabetes: antioxidative strategies
  2968. Type 2 Diabetes Mellitus Acts as a Risk Factor for the Development of Early Stage Alzheimer’s Disease
  2969. Dietary supplementation of epigallocatechin gallate but not catechin protects against diet-induced nonalcoholic steatohepatitis in mice to a similar extent as green tea …
  2970. Association between normal triglyceride and insulin resistance in US adults without other risk factors: a cross-sectional study from the US National Health and …
  2971. The regulation of FGF21 gene expression by metabolic factors and nutrients
  2972. Abscisic acid supplementation rescues high fat diet-induced alterations in hippocampal inflammation and IRSs expression
  2973. Expression, purification and characterization of a vascular endothelial growth factor fusion protein
  2974. Astragaloside IV Inhibits Adipose Lipolysis and Reduces Hepatic Glucose Production via Akt Dependent PDE3B Expression in HFD-Fed Mice
  2975. CCDC3: A new p63 target gene involved in regulation of liver lipid metabolism
  2976. Novel Adipose Tissue Targets to Prevent and Treat Atherosclerosis
  2977. Production and Management of Beverages: Volume 1. The Science of Beverages
  2978. SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models
  2979. Diabetic cardiomyopathy: an immunometabolic perspective
  2980. Fish and fish oil for cardiovascular disease in diabetes
  2981. Investigation of salicylate hepatic responses in comparison with chemical analogues of the drug
  2982. Effects of Aspirin on metabolic alterations in Type 2 Diabetic Rats
  2983. Peri-pubertal high caffeine exposure increases ovarian estradiol production in immature rats
  2984. Lactational metformin exposure programs offspring white adipose tissue glucose homeostasis and resilience to metabolic stress in a sex-dependent manner
  2985. Sources of vascular nitric oxide and reactive oxygen species and their regulation
  2986. MANAGEMENT OF LAPAROSCOPIC SLEEVE GASTRECTOMY
  2987. Interventions for sustainable weight loss in military families
  2988. Preventive effect of salicylate and pyridoxamine on diabetic nephropathy
  2989. A Review on Pharmacological and Clinical Aspects of Linum usitatissimum L.
  2990. HB-EGF and ADAM 12S directed cellular reprogramming results in metabolically active brown adipose tissue-like cells
  2991. Molecular remodeling of the insulin receptor pathway by thiazolidinediones in type 2 diabetes mellitus: A brief review
  2992. Salicylate suppresses the oncogenic hyaluronan network in metastatic breast cancer cells
  2993. The Immune Deficiency Pathway Regulates Metabolic Homeostasis in Drosophila
  2994. Influence of different oil sources on growth, disease resistance, immune response and immune-related gene expression on the hybrid grouper (♀ Epinephelus …
  2995. GR24, a synthetic analog of Strigolactones, alleviates inflammation and promotes Nrf2 cytoprotective response: In vitro and in silico evidences
  2996. CD24 is required for gene expression, but not glucose uptake, during adipogenesis in vitro
  2997. A novel small molecule A2A adenosine receptor agonist, indirubin-3′-monoxime, alleviates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes
  2998. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway
  2999. Monocyte Factors in Pathogenesis of Vascular Lesions in Diabetes
  3000. Transcriptome sequencing analysis of peripheral blood of type 2 diabetes mellitus patients with thirst and fatigue
  3001. Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-κB
  3002. A dietary anthocyanin cyanidin-3-O-glucoside binds to PPARs to regulate glucose metabolism and insulin sensitivity in mice
  3003. TO STUDY THE EFFECT OF LAPAROSCOPIC SLEEVE GASTRECTOMY ON BMI AND METABOLIC PARAMETERS IN MORBIDLY OBESE PATIENTS.
  3004. Importance of thorough tissue and cellular level characterization of targeted drugs in the evaluation of pharmacodynamic effects
  3005. Effect of metformin on global gene expression in liver of KKAy mice
  3006. Metabolic pathways at the crossroads of diabetes and inborn errors
  3007. Glycosaminoglycan from Apostichopus japonicus Improves Glucose Metabolism in the Liver of Insulin Resistant Mice
  3008. Siglec-7 restores β-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes
  3009. The brain renin-angiotensin system in metabolic and cardiovascular regulation
  3010. Associations between anthropometric traits, detailed body composition, fat fraction per adipose tissue and cardiometabolic risks: differences between children …
  3011. Rare variant associations with waist-to-hip ratio in European-American and African-American women from the NHLBI-Exome Sequencing Project
  3012. Anti-TNF-α antibody alleviates insulin resistance in rats with sepsis-induced stress hyperglycemia
  3013. Use of Bao Gui capsule in treatment of a polycystic ovary syndrome rat model
  3014. CIDEA transcriptionally regulates UCP1 for britening and thermogenesis in human fat cells
  3015. Co-expression of HB-EGF and ADAM 12S displays a brown adipose phenotype in mouse and human cell lines.
  3016. Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
  3017. Phosphorylation of the exocyst protein Exo84 by TBK1 promotes insulin-stimulated GLUT4 trafficking
  3018. Effects of sodium salicylate on glucose kinetics and insulin signaling in postpartum dairy cows
  3019. Metabolic syndrome, brain insulin resistance, and Alzheimer’s disease: Thioredoxin Interacting Protein (TXNIP) and inflammasome as core amplifiers
  3020. Retinoid X receptor ligands with anti-type 2 diabetic activity
  3021. The experiences of physicians who implement a whole food, plant-based diet as a treatment modality for chronic disease
  3022. Picture this: the role of mental imagery in induction of food craving–a theoretical framework based on the elaborated intrusion theory
  3023. SETDB2 links glucocorticoid to lipid metabolism through Insig2a regulation
  3024. Changing health behavior motivation from I-must to I-want
  3025. Učinci tjelesne aktivnosti na kroničnu subkliničku sustavnu upalu
  3026. Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story
  3027. LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding
  3028. Cardiovascular Health: How Conventional Wisdom is Failing Us
  3029. The role of inflammation in β-cell dedifferentiation
  3030. Srinivas R. Sripathi, O’Donnell Sylvester, Weilue He, Trevor Moser, Ji-Yeon Um, Folami Lamoke, Wusirika Ramakrishna
  3031. Complementary cholesterol-lowering response of a phytosterol/α-lipoic acid combination in obese zucker rats
  3032. Immunoglobulin free light chains: An inflammatory biomarker of diabetes
  3033. Climate-smart policy: The need for a coherent approach at food systems level
  3034. The Origin of Human White, Brown, and Brite/Beige Adipocytes
  3035. Passive heating and glycaemic control in non-diabetic and diabetic individuals: A systematic review and meta-analysis
  3036. Angiogenic factors in the white adipose tissue in childhood
  3037. Non-Steroidal Anti-Inflammatory Drugs, Chronic Inflammation and Colorectal Cancer Risk
  3038. Association between fat mass, adipose tissue, fat fraction per adipose tissue, and metabolic risks: a cross-sectional study in normal, overweight, and obese adults
  3039. Longitudinal trajectories of fasting plasma glucose and risks of cardiovascular diseases in middle age to elderly people within the general Japanese population: the …
  3040. Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents …
  3041. The Serum Level of KL-6 Is Associated with the Risk of Insulin Resistance and New-onset Diabetes Mellitus: The Tanno-Sobetsu Study
  3042. Utilising data for a better understanding of disease
  3043. Proinflammatory cytokine polarization in type 2 diabetes
  3044. In vitro and in vivo Activities of Allium-Derived Alk(En)Ylmercaptocysteines
  3045. Friend or foe? Recent strategies to target myeloid cells in cancer
  3046. Effect Of Ethanolic Extract Of Emblica Officinalis (Amla) On Intermediary Metabolism Of Albino Rats Fed With Hyperlipidemic Diet
  3047. Roles of NF-κB in cancer and inflammatory diseases and their therapeutic approaches
  3048. Ah receptor a regulace metabolismu mastných kyselin in vitro
  3049. Molecular markers of caspase-dependent and mitochondrial apoptosis: Role in the development of pathology and cellular senescence
  3050. Phenotypic characterization of a novel Ucp1-LUC-iRFP713 reporter mouse model for visualization and quantification of brown and beige fat recruitment
  3051. Effect of metabolic syndrome on fertility of male type 2 diabetic mice
  3052. Effective design of multifunctional peptides by combining compatible functions
  3053. Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats
  3054. Graphical abstract Chapter 2: Molecular aspects of glucose homeostasis in skeletal muscle–A focus on the molecular mechanisms of insulin resistance
  3055. XENOGRAFT OF MICROENCAPSULATED SERTOLI CELLS RESTORES GLUCOSE HOMEOSTASIS IN db/db MICE WITH SPONTANEOUS DIABETES …
  3056. The Immune Deficiency Pathway Attenuates Insulin Signaling to Protect Against Infection.
  3057. Alpha-lipoic acid alleviates acute inflammation and promotes lipid mobilization during the inflammatory response in white adipose tissue of mice
  3058. Normal Triglyceride is Associated with Insulin Resistance in the Absence of Risk Factors
  3059. Apoptose de neuronios hipotalamicos em ratos alimentados com dieta hiperlipidica
  3060. Phage-Mediated Immunomodulation
  3061. Immunometabolic cross-talk in the inflamed heart
  3062. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3—PBX1 and β-catenin—ABCG2 signaling
  3063. Prohibitin 1 in liver injury and cancer
  3064. Evidence-based psychotherapeutic interventions and mhealth for weight management in overweight: A biopsychosocial framework
  3065. Development and pilot testing of standardized food images for studying eating behaviors in children
  3066. The Development and Feasibility of a Culturally Tailored Malaysian Diabetes Education Intervention Using Motivational Interviewing (MY DEUMI) for People …
  3067. Mean platelet volume as a novel marker for increased cardiovascular risk in patients with non alcoholic fatty liver disease
  3068. Anti-diabetic effects of Inonotus obliquus polysaccharides in streptozotocin-induced type 2 diabetic mice and potential mechanism via PI3K-Akt signal pathway
  3069. Spinal cord injury induced cardiac decline and the limitations of exercise.
  3070. WJD
  3071. Regulation of glucose metabolism by TNF-α signalling and MIG1 gene switching
  3072. Exenatide Improves Endometrial Glands in PCOS Rats through AMPKα-SIRT1
  3073. Brunstrom, JM (2019). A review of evidence supporting current strategies, challenges, and opportunities in regards to portion-size reduction. Nutrition Reviews …
  3074. Sub-toxic exposure to lindane activates redox sensitive kinases and impairs insulin signaling in muscle cell culture: the possible mechanism of lindane-induced …
  3075. Dottorato in Scienze Farmacologiche Sperimentali e Cliniche
  3076. Electrochemolipolysis of human adipose tissue
  3077. Inhibition of Free fatty acid-Induced Insulin Resistance by Rosemary Extract: Investigation of the Mechanisms Involved
  3078. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein …
  3079. Effect of sub-toxic chlorpyrifos on redox sensitive kinases and insulin signaling in rat L6 myotubes
  3080. Mutation in Sortilin Identified in an Amish Population Results in Hypercholesterolemia and Insulin Resistance in Mice and Humans
  3081. Abstracts of the 10th Asia-Pacific Conference on Clinical Nutrition
  3082. Liver Macrophage Polarization and Function in Hepatotropic Viral Infection
  3083. A Role for TNMD in Adipocyte Differentiation and Adipose Tissue Function: A Dissertation
  3084. White paper: Brain scan research
  3085. MS-275 induces hepatic FGF21 expression via H3K18ac-mediated CREBH signal
  3086. Insulin Resistance and T1D: The Effect of Exercise on Skeletal Muscle Lipid Metabolism
  3087. THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD)
  3088. Additional attention to combination antiretroviral therapy-related lipodystrophy
  3089. Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective
  3090. Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells in vitro
  3091. Out of control? Managing baseline variability in experimental studies with control groups
  3092. Immunoglobulin Free Light Chains: A Biomarker of Diabetes
  3093. Tumor imaging using the pacifastin family of peptides
  3094. Omega-3 fatty acid supplementation combined with acute aerobic exercise does not alter the improved post-exercise insulin response in normoglycemic, inactive and …
  3095. 3, 5-Diiodo-L-thyronine affects structural and metabolic features of skeletal muscle mitochondria in high-fat-diet fed rats producing a co-adaptation to the …
  3096. Industrial uses of phospholipases: current state and future applications
  3097. The effect of the aerobic continues versus high-intensity interval training on IRE1 expression and its correlation with insulin resistance index of liver tissue in rats …
  3098. Flaxseed (Linum Usitatissimum L.) Supplementation in Patients Undergoing Lipoprotein Apheresis for Severe Hyperlipidemia—A Pilot Study
  3099. Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced …
  3100. Synthetic salicylates and/or pioglitazone ameliorative effect in type 2 induced diabetic rats
  3101. Metformin promotes beclin1-dependent autophagy to inhibit the progression of gastric cancer
  3102. Flavonoid-enriched extract from desert plant Warionia saharae improves glucose and cholesterol levels in diabetic rats
  3103. R-α-Lipoic Acid and 4-Phenylbutyric Acid Have Distinct Hypolipidemic Mechanisms in Hepatic Cells
  3104. Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis
  3105. Effects of diosgenin and its derivatives on atherosclerosis
  3106. Improvement of insulin signalling rescues inflammatory cardiac dysfunction
  3107. Evaluation of glucose and lipid lowering activity of Arganimide A in normal and streptozotocin-induced diabetic rats
  3108. Prospects of pharmacological interventions to organismal aging
  3109. Organ-based drug delivery
  3110. Phage-displayed peptides targeting specific tissues and organs
  3111. Compound C enhances the anticancer effect of aspirin in HER-2-positive breast cancer by regulating lipid metabolism in an AMPK-independent pathway
  3112. Characterization and functionality of two members of the SPFH protein superfamily, prohibitin 1 and 2 in Leishmania major
  3113. Predicting the vascular adhesion of deformable drug carriers in narrow capillaries traversed by blood cells
  3114. Antidiabetic effect of spearmint in streptozotocin-induced diabetic rats
  3115. Development of an alternative payment model (APM) for endometrial cancer: opportunities to reduce cost and improve quality
  3116. Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications
  3117. Aqueous extract of Argania spinosa L. fruits ameliorates diabetes in streptozotocin-induced diabetic rats
  3118. Insulin plant (Costus pictus) extract restores thyroid hormone levels in experimental hypothyroidism
  3119. Advances in antidiabetic drugs targeting insulin secretion
  3120. Metal-Free [2 + 2]-Photocycloaddition of (Z)-4-Aryliden-5(4H)-Oxazolones as Straightforward Synthesis of 1,3-Diaminotruxillic Acid Precursors: Synthetic Scope and …
  3121. Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-a
  3122. Treatment with carboplatin and taxane chemotherapy increases T-cell receptor (TCR) clonality in high-grade serous ovarian cancer (HGSOC)
  3123. Influence of High Frequency Electromagnetic Fields Produced by Antennas for Mobile Communication on the Structure of the Pancreas in Rats: Histological and …
  3124. Indicated presurgical testing is a priority to achieve high-quality, cost-effective oncologic health care delivery
  3125. Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases
  3126. β-catenin induces expression of prohibitin gene in acute leukemic cells
  3127. Salsalate treatment following traumatic brain injury reduces inflammation and promotes a neuroprotective and neurogenic transcriptional response with concomitant …
  3128. Prohibitin-2 depletion unravels extra-mitochondrial functions at the kidney filtration barrier
  3129. Gelam honey attenuates the oxidative stress-induced inflammatory pathways in pancreatic hamster cells
  3130. The Effects of Resistance and Aerobic Training Volume on Body Composition and Adipokines
  3131. A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo
  3132. Role of gamma glutamyl transferase levels in prediction of cardio vascular risk in patients with non-alcoholic fatty liver disease
  3133. Biomarkers and predictors of the chemopreventative capacity of non-steroidal anti-inflammatory drugs (NSAIDs).
  3134. Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells
  3135. Peripubertal caffeine exposure impairs longitudinal bone growth in immature male rats in a dose-and time-dependent manner
  3136. Genetically encoded, multivalent liquid glycan array (LiGA)
  3137. Mitochondria-targeting thermosensitive initiator with enhanced anticancer efficiency
  3138. New podolactones from the seeds of Podocarpus nagi and their anti-inflammatory effect
  3139. Peptide-conjugated nanoparticles as targeted anti-angiogenesis therapeutic and diagnostic in cancer
  3140. How Insider Trading Adds Confidence to Firm Product Innovation
  3141. Effect of aspirin on hyperlipidemia in rats
  3142. Regulation of cardiac sarco (endo) plasmic reticulum calcium-ATPases (SERCA2a) in response to exercise
  3143. Clinical decision-making when treating diabetic macular edema patients with dexamethasone intravitreal implants
  3144. Metformin alleviates neuronal and renal related stress signals in diabetic C57BL/6 mice.
  3145. A SCREEN FOR PEPTIDES TARGETING CHEMORESISTANT METASTATIC TRIPLE-NEGATIVE BREAST CANCER
  3146. Empowering the potential of cell-penetrating peptides for targeted intracellular delivery via molecular self-assembly
  3147. Targeting prohibitins at the cell surface prevents Th17‐mediated autoimmunity
  3148. Sustained NFjB inhibition improves insulin sensitivity but is detrimental to muscle health
  3149. Mechanical Regulation of Striated Muscle Nitric Oxide Signaling in Muscular Dystrophy
  3150. Reversal of obesity development in Ceacam1−/− male mice by bone marrow transplantation or introduction of the human CEACAM1 gene
  3151. White adipocyte-targeted dual gene silencing of FABP4/5 for anti-obesity, anti-inflammation and reversal of insulin resistance: Efficacy and comparison of …
  3152. Association of a self-paid medically supervised weight management program with reversal of obesity-associated impaired fasting glucose
  3153. Reciprocal control of obesity and anxiety–depressive disorder via a GABA and serotonin neural circuit
  3154. Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity
  3155. Trends in US adolescent physical activity and obesity: A 20‐year age‐period‐cohort analysis
  3156. Reversal of hypertriglyceridemia in diabetic BTBR ob/ob mice does not prevent nephropathy
  3157. FACI Is a Novel CREB-H–Induced Protein That Inhibits Intestinal Lipid Absorption and Reverses Diet-Induced Obesity
  3158. Swertiamarin ameliorates diet-induced obesity by promoting adipose tissue browning and oxidative metabolism in preexisting obese mice: Swertiamarin …
  3159. Obesity and chronic diarrhea: a new syndrome?
  3160. Peripheral blood mononuclear cells oxidative stress and plasma inflammatory biomarkers in adults with normal weight, overweight and obesity
  3161. Whole-food plant-based lifestyle program and decreased obesity
  3162. A Novel Symbiotic Formulation Reduces Obesity and Concomitant Metabolic Syndrome in Rats by Raising the Relative Abundance of Blautia
  3163. Dieting reverses histone methylation and hypothalamic AgRP regulation in obese rats
  3164. Effectiveness of a population‐scaled, school‐based physical activity intervention for the prevention of childhood obesity
  3165. Allograft inflammatory factor-1-like is a situational regulator of leptin levels, hyperphagia, and obesity
  3166. Essential Oil of Carvone Chemotype Lippia alba (Verbenaceae) Regulates Lipid Mobilization and Adipogenesis in Adipocytes
  3167. Reversing the genomic, epigenetic, and triple-negative breast cancer–enhancing effects of obesity
  3168. The impact of weight cycling on health outcomes in animal models: A systematic review and meta‐analysis
  3169. Metformin booster adipocyte-targeted gene therapy for the treatment of obesity and related metabolic syndromes
  3170. The gut-liver axis as a target of liver disease management
  3171. Obesity as a major health hazard
  3172. Duodenal Switch, SADI, and SIPS in Adolescent
  3173. 233-LB: Ranolazine Fails to Improve Glycemia in Obese Liver-Specific Pyruvate Dehydrogenase–Deficient Mice
  3174. Mechanism of action of acupuncture in obesity: a perspective from the hypothalamus
  3175. AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity
  3176. Precision nutrition, diet and gut-microbiota in obesity
  3177. Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus
  3178. Nanotechnology-Based Strategies for Treatment of Obesity, Cancer and Anti-microbial Resistance: Highlights of the Department of Science and Innovation/Mintek …
  3179. Fetal programming of obesity and type 2 diabetes
  3180. The insulin-sensitizer pioglitazone remodels adipose tissue phospholipids in humans
  3181. Association between visceral obesity, metformin use, and recurrence risk in early-stage colorectal cancer
  3182. Biomaterial-based therapeutic strategies for obesity and its comorbidities
  3183. Obesity and metabolic syndrome in atrial fibrillation: cardiac and noncardiac adipose tissue in atrial fibrillation
  3184. Impact of Surgical and Dietary Weight Loss Interventions on the Obesity—Gut Microbiome—Breast Cancer Links
  3185. Association of prior metabolic surgery with outcomes after cardiac operations
  3186. The Effects of Obesity and Bariatric Surgery on Rates of Upper Extremity Compression Neuropathies
  3187. Revised Protein Sparing Diet in Obesity and Type 2 Diabetes Mellitus
  3188. Stress granules determine the development of obesity-associated pancreatic cancer
  3189. The tumor promotional role of adipocytes in the breast cancer microenvironment and macroenvironment
  3190. Durability of cardiometabolic outcomes among adolescents after sleeve gastrectomy: first study with 9-year follow-up
  3191. Two-year skeletal effects of sleeve gastrectomy in adolescents with obesity assessed with quantitative CT and MR spectroscopy
  3192. Obesity, an independent predictor of pre and postoperative tumor grading disagreement in endometrial cancer
  3193. The anti-obesity effect of Allium cepa L. leaves on high fat diet induced obesity in male wistar rats
  3194. Turning the clock forward: New pharmacological and non pharmacological targets for the treatment of obesity
  3195. Role of bariatric surgery in a COVID-19 era: a review of economic costs
  3196. Association between socioeconomic positions and overweight/obesity in rural Nepal
  3197. Impact of digital monitoring on compliance and outcome of lifestyle-change measures in patients with coexistent atrial fibrillation and obesity
  3198. Obesity and dyslipidemia are associated with partially reversible modifications to DNA hydroxymethylation of apoptosis-and senescence-related genes in …
  3199. Tumor suppressor Par-4 regulates complement factor C3 and obesity
  3200. Obesity Hypertension: Clinical Aspects
  3201. Skeletal muscle non-shivering thermogenesis as an attractive strategy to combat obesity
  3202. Characterization of Allograft Inflammatory Factor-1-Like (AIF1L) in Diet-Induced Obesity
  3203. A novel dual-targeted rosiglitazone-loaded nanoparticle for the prevention of diet-induced obesity via the browning of white adipose tissue
  3204. Preventing ovariectomy-induced weight gain decreases tumor burden in rodent models of obesity and postmenopausal breast cancer
  3205. ELISA versus LUMINEX assay for measuring mouse metabolic hormones and cytokines: sharing the lessons I have learned
  3206. Obesity and bariatric surgery in kidney transplantation: a clinical review
  3207. Weight loss and/or sulindac mitigate obesity-associated transcriptome, microbiome, and protumor effects in a murine model of colon cancer
  3208. Are individual or group interventions more effective for long‐term weight loss in adults with obesity? A systematic review
  3209. The impact of school-based physical activity programs on obesity prevention
  3210. Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis
  3211. The potential mechanisms of white adipose tissue browning: a novel target for the treatment of obesity.
  3212. Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness
  3213. Childhood overweight and obesity abatement policies in Europe
  3214. Cyclin-dependent kinase 4/6 inhibitors require an arcuate-to-paraventricular hypothalamus melanocortin circuit to treat diet-induced obesity
  3215. Brown adipose tissue in adults as a study target in the development of new therapies for the management and treatment of obesity: an integrative review
  3216. The gut microbiota as a therapeutic target for obesity: a scoping review
  3217. Longitudinal gut microbial signals are associated with weight loss: insights from a digital therapeutics program
  3218. Actin related protein 2/3 complex subunit 1 up‐regulation in the hypothalamus prevents high‐fat diet induced obesity
  3219. Association between distinct body mass index trajectories according to the group‐based trajectory modeling and the risk of incident diabetes: A systematic review
  3220. D7. 4: Report on the cost effectiveness of the Healthy Lifestyle Intervention
  3221. Epicardial adipose tissue, obesity, and the occurrence of atrial fibrillation: an overview of pathophysiology and treatment methods
  3222. MPA alters metabolic phenotype of endometrial cancer-associated fibroblasts from obese women via IRS2 signaling
  3223. Gastrokine-1, an anti-amyloidogenic protein secreted by the stomach, regulates diet-induced obesity
  3224. Role of obesity-induced inflammation in the development of insulin resistance and type 2 diabetes: History of the research and remaining questions
  3225. Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects
  3226. Obese adipose tissue as a driver of breast cancer growth and development: Update and emerging evidence
  3227. Characteristic MicroRNAs linked to dysregulated metabolic pathways in qatari adult subjects with obesity and metabolic syndrome
  3228. Crosstalk between Melanin Concentrating Hormone and Endocrine Factors: Implications for Obesity
  3229. Combining a β3 adrenergic receptor agonist with alpha‐lipoic acid reduces inflammation in male mice with diet‐induced obesity
  3230. Regulation of body weight: lessons learned from bariatric surgery
  3231. An overview of epigenetics in obesity: The role of lifestyle and therapeutic interventions
  3232. Lycopene alleviates ionic disturbances and anaemia by improving iron homeostasis, insulin sensitivity, and ATPases activities in obese female rats
  3233. Deciphering biochemical and molecular signatures associated with obesity in context of metabolic health
  3234. Gintonin-enriched fraction protects against sarcopenic obesity by promoting energy expenditure and attenuating skeletal muscle atrophy in high-fat diet-fed …
  3235. Neuroimaging Investigations of Obesity: a Review of the Treatment of Sex from 2010
  3236. Fibroblast growth factor 21 as a potential master regulator in metabolic disorders
  3237. Evaluation of a group family-based intervention programme for adolescent obesity: the LITE randomised controlled pilot trial
  3238. Investigation of the anti-obesity effects of citrate-capped gold nanoparticles on 3T3-L1 cells and their genetic profiling
  3239. An Overview of Obstructive Sleep Apnea/Hypopnea with a Comparison of Existing Treatments
  3240. Update on pediatric metabolic and bariatric surgery
  3241. Zebrafish and flavonoids: adjuvants against obesity
  3242. The role of the gut microbiome in pediatric obesity and bariatric surgery
  3243. Lycopene abrogates obesity-provoked hyperactivity of neurosignalling enzymes, oxidative stress and hypothalamic inflammation in female Wistar rats
  3244. Diet-derived antioxidants and their role in inflammation, obesity and gut microbiota modulation
  3245. Enhancing fatty acids oxidation via l-carnitine attenuates obesity-related atrial fibrillation and structural remodeling by activating AMPK signaling and …
  3246. Role of obesity related inflammation in pathogenesis of peripheral artery disease in patients of type 2 diabetes mellitus
  3247. Potential therapeutic effect of medium chain triglyceride oil in ameliorating diabetic liver injury in a streptozotocin-induced diabetic murine model.
  3248. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases
  3249. New insights into adipose tissue macrophages in obesity and insulin resistance
  3250. Injectable cell-targeting fiber rods to promote lipolysis and inflammatory regulation for obesity treatment
  3251. Obesity and altered angiogenic-related gene expression in endometrial cancer
  3252. Clinical and metabolic characteristics of endometrial lesions in polycystic ovary syndrome at reproductive age
  3253. Photoacoustic molecular imaging-escorted adipose photodynamic–browning synergy for fighting obesity with virus-like complexes
  3254. Macrophage membrane-camouflaged lipoprotein nanoparticles for effective obesity treatment based on a sustainable self-reinforcement strategy
  3255. Involvement of TRP channels in adipocyte thermogenesis: An update
  3256. Improved outcomes in rheumatoid arthritis with obesity after a weight loss intervention: randomized trial
  3257. Does obesity put your brain at risk?
  3258. Transdermal photothermal-pharmacotherapy to remodel adipose tissue for obesity and metabolic disorders
  3259. Perillartine protects against metabolic associated fatty liver in high-fat diet-induced obese mice
  3260. The impacts of exercise on pediatric obesity
  3261. Neural vulnerability factors that predict future weight gain
  3262. CREG1 administration stimulates BAT thermogenesis and improves diet-induced obesity in mice
  3263. 4-Hydroxyisoleucine alleviates macrophage-related chronic inflammation and metabolic syndrome in mice fed a high-fat diet
  3264. Outcome of mini gastric bypass after failed vertical band gastroplasty in treatment of morbid obese patients
  3265. Circulating acyl and des-acyl ghrelin levels in obese adults: a systematic review and meta-analysis
  3266. Transcriptome sequencing of 3, 3′, 4, 4′, 5-Pentachlorobiphenyl (PCB126)-treated human preadipocytes demonstrates progressive changes in pathways …
  3267. Metformin Mitigated Obesity-Driven Cancer Aggressiveness in Tumor-Bearing Mice
  3268. Laparoscopic sleeve gastrectomy in adolescents: A retrospective case–controlled study
  3269. Trends in metabolic bariatric surgery in adolescents in France: a nationwide analysis on an 11-year period
  3270. Hepatokine Fetuin B expression is regulated by leptin-STAT3 signalling and associated with leptin in obesity
  3271. Adipose endothelial cells mastering adipose tissues metabolic fate
  3272. Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer
  3273. Restored TDCA and valine levels imitate the effects of bariatric surgery
  3274. Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
  3275. Effects of Obesogenic Environment on Body Weight Regulation: A Review
  3276. The physiologic and physiopathologic roles of perivascular adipose tissue and its interactions with blood vessels and the renin-angiotensin system
  3277. Liraglutide suppresses obesity and promotes browning of white fat via miR-27b in vivo and in vitro
  3278. Cell death and inflammation during obesity:“Know my methods, WAT (son)”
  3279. Adipokines, myokines, and hepatokines: crosstalk and metabolic repercussions
  3280. Positive effect of combined exercise on adipokines levels and pubertal signs in overweight and obese girls with central precocious puberty
  3281. Obesity as a premature aging phenotype—Implications for sarcopenic obesity
  3282. Astragalus mongholicus powder, a traditional Chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic mice
  3283. N-Trimethylated chitosan coating white adipose tissue vascular-targeting oral nano-system for the enhanced anti-obesity effects of celastrol
  3284. Optogenetic activation of UCP1-dependent thermogenesis in brown adipocytes
  3285. Piecing together human adult comparative pharmacokinetic trials and rodent studies: What happens to drug clearance in obesity?
  3286. Caloric restriction overcomes pre-diabetes and hypertension induced by a high fat diet and renal artery stenosis
  3287. Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies
  3288. Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming …
  3289. Insulin and insulin-like growth factor-1 associated cancers
  3290. Macrophages, chronic inflammation, and insulin resistance
  3291. Brown/Beige Adipose Tissue: Novel Players in the Fight Against Obesity
  3292. 3-N-butylphthalide protects against high-fat-diet-induced obesity in C57BL/6 mice and increases metabolism in lipid-accumulating cells
  3293. The effect of healthy lifestyle strategies on the management of insulin resistance in children and adolescents with obesity: a narrative review
  3294. Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
  3295. Deletion of the feeding-induced hepatokine TSK ameliorates the melanocortin obesity syndrome
  3296. Understanding Pericardial Adipose Tissue Mitochondrial Bioenergetics in the Context of Obesity
  3297. Adipocyte IRE1α promotes PGC1α mRNA decay and restrains adaptive thermogenesis
  3298. CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder
  3299. Induction of lipid catabolism and mitochondrial biogenesis in white adipose tissue as therapeutic target for obesity and associated metabolic disorders
  3300. Functionalized nanoformulation based on enriched-triterpenes fraction target adipose tissue, as a potential treatment to obesity and type-2 diabetes: preliminary data
  3301. Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A
  3302. World Journal of Food and Nutrition (WJFN)
  3303. Assessment of serum chemerin levels in acanthosis nigricans: A case–control study
  3304. Adipocyte phenotype flexibility and lipid dysregulation
  3305. A novel application of finite Gaussian mixture model (GMM) using real and simulated biomarkers of cardiovascular disease to distinguish adolescents with and without …
  3306. Revisiting the contribution of mitochondrial biology to the pathophysiology of skeletal muscle insulin resistance
  3307. Phosphorylation of STAT3 in hypothalamic nuclei is stimulated by lower doses of leptin than are needed to inhibit food intake
  3308. Genotypic analysis of the female BPH/5 mouse, a model of superimposed preeclampsia
  3309. Moving the Needle for Vegetable Consumption: Addressing Influences at Both Ends of the Social-Ecologic Model
  3310. Revisiting the Principles of Preservation in an Era of Pandemic Obesity
  3311. Progress toward molecular therapy for diabetes mellitus: a focus on targeting inflammatory factors
  3312. Encapsulated Peptides and Proteins with an Effect on Satiety
  3313. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
  3314. Prohibitin inactivation in adipocytes results in reduced lipid metabolism and adaptive thermogenesis impairment
  3315. Is overweight still a problem of rich in sub-Saharan Africa? Insights based on female-oriented demographic and health surveys
  3316. Genetic advancements in obesity management and CRISPR–Cas9-based gene editing system
  3317. Brain regulation of hunger and motivation: The case for integrating homeostatic and hedonic concepts and its implications for obesity and addiction
  3318. Sodium salicylate rewires hepatic metabolic pathways in obesity and attenuates IL-1β secretion from adipose tissue: The implications for obesity-impaired …
  3319. Role of insulin resistance in MAFLD
  3320. “Little more than a gut feeling?”—considerations when prescribing psychotropic medications to patients undergoing bariatric surgery
  3321. Bariatric surgery-associated myelopathy
  3322. Docosahexaenoic Acid Delivery Systems, Bioavailability, Functionality, and Applications: A Review
  3323. Targeting vascular zip codes: from combinatorial selection to drug prototypes
  3324. Antidiabetic and Antioxidant Activity of Zanthoxylum armatum DC. On Type 2 Diabetic Rats.(2022)
  3325. New Insights into Adipose Tissue Macrophages in Obesity and Insulin Resistance. Cells 2022, 11, 1424
  3326. Regenerative Medicine for Polycystic Ovary Syndrome: Stem Cell-Based Therapies and Brown Adipose Tissue Activation
  3327. Role of NF-κB in ageing and age-related diseases: Lessons from genetically modified mouse models
  3328. Obesity and Hepatocellular Carcinoma: Epidemiology and Mechanisms
  3329. Late life vascular risk factors and their association with dementia and Alzheimer’s disease
  3330. Impact of inflammasome inhibition on the development of insulin
  3331. Jean Himms-Hagen, D. Phil.(1933–2021): Pioneering research in brown adipose tissue thermogenesis
  3332. Excessive weight gain and poor growth
  3333. Durability of changes in biomarkers of cardiometabolic disease: 1-year family-based intervention in children with obesity
  3334. Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth
  3335. Benefits, risks and possibilities of strength training in school Physical Education: a brief review
  3336. Hematology and Oncology: Current Research
  3337. REDD1 promotes obesity-induced metabolic dysfunction via atypical NF-κB activation
  3338. Mechanistic target of rapamycin complex 1: from a nutrient sensor to a key regulator of metabolism and health
  3339. Inflammatory Mediators and Type 2 Diabetes Risk Factors before and in Response to Lifestyle Intervention among Latino Adolescents with Obesity
  3340. Cissus Quadrangularis enhances UCP1 mRNA, indicative of white adipocyte browning and decreases central obesity in humans in a randomized trial
  3341. Induction of aryl hydrocarbon receptor in granulosa cells by endoplasmic reticulum stress contributes to pathology of polycystic ovary syndrome
  3342. Uncoupling hepatic insulin resistance–hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in …
  3343. Leveraging variation in genetically diverse mouse strains to study Metabolic Syndrome phenotypes: genetic and genomic analyses in the Hybrid Mouse …
  3344. Effect of 8-Week Short-Term Sprint Interval Training on Serum Levels of Adipokines, Inflammatory Markers and Lipid Profile in Overweight Boys
  3345. Multifunctional gold nanoparticles for improved diagnostic and therapeutic applications: a review
  3346. Obesity protects against sepsis-induced and norepinephrine-induced white adipose tissue browning
  3347. What Happens to Adipokines and Cytokine in Overweight and Obese Girls with Central Precocious Puberty When They Exercise and Stop Exercising? A randomized …
  3348. Evaluation of serum irisin, retinol-binding protein-4 in human obesity
  3349. Gynecologic Cancers and Lifestyle Medicine
  3350. Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism
  3351. Browning epicardial adipose tissue: friend or foe?
  3352. Body Condition and Fertility in Dogs
  3353. The adipose organ is a unitary structure in mice and humans
  3354. The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth
  3355. A review on metabolic syndrome
  3356. Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects
  3357. Thermoregulatory responses, heart rate, and the susceptibility to anxiety in obese animals subjected to stress
  3358. Endothelial TrkA coordinates vascularization and innervation in thermogenic adipose tissue and can be targeted to control metabolism
  3359. Inflammation in metabolic and cardiovascular disorders—role of oxidative stress
  3360. Sodium salicylate induces browning of white adipocytes via M2 macrophage polarization by HO-1 upregulation
  3361. Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer
  3362. Obesity Induced Insulin Resistance, Type 2 Diabetes and Emerging Therapeutic Approaches
  3363. Deoxysphingolipids – atypical skeletal muscle lipids related to insulin resistance in humans that decrease insulin sensitivity in vitro
  3364. Bariatric Surgery-Associated Myelopathy
  3365. Effect of 8-weeks of Combined Exercise Training on Plasma Leptin and Adiponectin levels in Obese Boys
  3366. Hepatic Gadd45β promotes hyperglycemia and glucose intolerance through DNA demethylation of PGC-1α
  3367. The Influence of Aerobic Exercise on Extracellular Vesicles in Obesity
  3368. Peptide Adjuvant to Invigorate Cytolytic Activity of NK Cells in an Obese Mouse Cancer Model
  3369. Endothelial prohibitin mediates bidirectional long-chain fatty acid transport in white and brown adipose tissues
  3370. Healthy for My Baby Research Protocol-a Randomized Controlled Trial Assessing a Preconception Intervention to Improve the Lifestyle of Overweight Women …
  3371. Aspirin suppresses hepatic glucagon signaling through decreasing production of thromboxane A2
  3372. Effects of N-3 PUFA-Derived Epoxides Combined with sEH Inhibition on Brown Adipose Tissue and Brown Adipocytes in Obesity
  3373. Recent advances in understanding the role of IKKβ in cardiometabolic diseases
  3374. A Prospective Assessment of Bariatric Surgery Outcomes
  3375. Eicosapentaenoic Acid Ethyl Esters Prevent Obesity Associated Metabolic Impairments in Male and Female Mice
  3376. Weight Loss Strategies
  3377. Mechanisms of Action of Berry Bioactives on Obesity-induced Inflammation
  3378. Research Article Regulation of UCP1 in the Browning of Epididymal Adipose Tissue by 𝛽3-Adrenergic Agonist: A Role for MicroRNAs
  3379. Salsalate reduces atherosclerosis through AMPKβ1 in mice
  3380. Chronic tissue inflammation and metabolic disease.
  3381. Adipose‐specific ATGL ablation reduces burn injury‐induced metabolic derangements in mice
  3382. Pharmacokinetics and pharmacodynamics of peptidomimetics
  3383. Hypoglycemic effect of astragaloside IV via modulating gut microbiota and regulating AMPK/SIRT1 and PI3K/AKT pathway
  3384. Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy
  3385. Deconstructing adipose tissue heterogeneity one cell at a time
  3386. The impact of helminth infection on the incidence of metabolic syndrome: A systematic review and meta-analysis
  3387. Eating behavior modulates the sensitivity to the central effects of GLP-1 receptor agonist treatment: a secondary analysis of a randomized trial
  3388. Manipulation of growth conditions of cyanobacteria to potentiate the production of high value compounds for obesity treatment
  3389. Application in medicine: obesity and satiety control
  3390. The Role of Catechins in Regulating Diabetes: An Update Review
  3391. Inflammation in metabolic cardiomyopathy
  3392. Tissue-specific insulin sensitivity and changes in brain reward reactivity in overweight or obese pre-diabetic adults
  3393. Non-alcoholic fatty liver disease and steatohepatitis: risk factors and pathophysiology
  3394. Linseed oil supplementation improves altered lipid metabolism and insulin resistance in induced obese rats
  3395. Use of DREADD technology to identify novel targets for antidiabetic drugs
  3396. Salicylate Sodium Suppresses Monocyte Chemoattractant Protein-1 Production by Directly Inhibiting Phosphodiesterase 3B in TNF-α-Stimulated Adipocytes
  3397. Factors associated with choice of behavioural weight loss program by adults with obesity
  3398. Biotransformation and Gut Microbiota-Mediated Bioactivity of Flavonols
  3399. Yudi Zhang1†, Yuping Fu1†, Tiannan Jiang2†, Binghua Liu 3, Hongke Sun 1, Ying Zhang1, Boyuan Fan 1, Xiaoli Li1, Xinghua Qin3* and Qiangsun Zheng1
  3400. Endoplasmic reticulum stress: a new research direction for polycystic ovary syndrome?
  3401. Impact of inflammasome inhibition on the development of insulin resistance in the context of diet-induced obesity
  3402. Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative review
  3403. Sandalwood seed oil ameliorates hepatic insulin resistance by regulating the JNK/NF-κB inflammatory and PI3K/AKT insulin signaling pathways
  3404. The effect of early time-restricted feeding on glycemic profile in adults: a systematic review of interventional studies
  3405. Browning and Beiging of Adipose Tissue: Its Role in the Regulation of Energy Homeostasis and as a Potential Target for Alleviating Metabolic Diseases …
  3406. Impact of Lifestyle Interventions on Gynecologic Cancers: Beyond Diet and Exercise
  3407. An Evaluation of the Anti-Inflammatory Effects of a Thai Traditional Polyherbal Recipe TPDM6315 in LPS-Induced RAW264. 7 Macrophages and TNF-α …
  3408. Effects of ADIPOQ Gene Polymorphisms on Combined Training-induced Weight Loss of Obese Boys
  3409. Children With Asparaginase-associated Pancreatitis Present Elevated Levels of Insulin, Total Cholesterol, and HOMA-IR Before Starting Acute Lymphoblastic …
  3410. Metabolic syndrome and liver cancer
  3411. Insulin resistance and cancer: In search for a causal link
  3412. Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer
  3413. Cardiac transcriptomic remodeling in metabolic syndrome
  3414. Development of predictive models for successful weight loss in people living with obesity
  3415. EFFECT OF DAILY ADMINISTRATION OF MICROENCAPSULATED LIMOSILACTOBACILLUS REUTERI DSM 17938 ON THE INTESTINAL MICROBIOTA AND …
  3416. High-throughput mediation analysis of human proteome and metabolome identifies mediators of post-bariatric surgical diabetes control
  3417. Child and adolescent food insecurity in South Africa: A household-level analysis of hunger
  3418. Selective encapsulation of therapeutic mRNA in engineered extracellular vesicles by DNA aptamer
  3419. Beneficial effects of soybean-derived bioactive peptides
  3420. Targeting the vasculature in cardiometabolic disease
  3421. White adipose tissue depots respond to chronic beta-3 adrenergic receptor activation in a sexually dimorphic and depot divergent manner
  3422. Somatic ablation of IKKβ in liver and leukocytes is not tolerated in obese mice but hepatic IKKβ deletion improves fatty liver and insulin sensitivity
  3423. Chalobol Chalermsri,*, Shirin Ziaei, Eva-Charlotte Ekström, Weerasak Muangpaisan, Wichai Aekplakorn, Warapone Satheannopakao and Syed Moshfiqur Rahman
  3424. Closing the Mesenteric Defects
  3425. Glucose intolerance and cancer risk: A community-based prospective cohort study in Shanghai, China
  3426. Diabetes and Hypertension Prevention in Vanuatu: A Community Service Project
  3427. Fatty acid translocase: a culprit of lipid metabolism dysfunction in disease
  3428. Links between insulin resistance and periodontal bacteria: Insights on molecular players and therapeutic potential of polyphenols
  3429. Nanotechnology as a tool to mitigate the effects of intestinal microbiota on metabolization of anthocyanins
  3430. The β3 adrenergic receptor agonist CL316243 ameliorates the metabolic abnormalities of high-fat diet-fed rats by activating AMPK/PGC-1α signaling in skeletal …
  3431. Essential Minerals and Metabolic Adaptation of Immune Cells
  3432. The crucial role and mechanism of insulin resistance in metabolic disease
  3433. The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth
  3434. Flaxseed and its products improve glycemic control: a systematic review and meta-analysis
  3435. Tissue-specific regulation of 11β hydroxysteroid dehydrogenase type-1 mRNA expressions in Cushing’s syndrome mouse model
  3436. GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal …
  3437. Anthocyanins as promising molecules affecting energy homeostasis, inflammation, and gut microbiota in type 2 diabetes with special reference to impact of acylation
  3438. Divergence of Chemerin Reduction by an ATS9R Nanoparticle Targeting Adipose Tissue In Vitro vs. In Vivo in the Rat
  3439. Role of IKKε in the Metabolic Diseases: Physiology, Pathophysiology, and Pharmacology
  3440. Milled flaxseed-added diets ameliorated hepatic inflammation by reducing gene expression of TLR4/NF-κB pathway and altered gut microbiota in STZ …
  3441. Adiponectin synthesis, secretion and extravasation from circulation to interstitial space
  3442. Apolipoprotein A-IV reduced metabolic inflammation in white adipose tissue by inhibiting IKK and JNK signaling in adipocytes
  3443. Repurposing lenvatinib as a potential therapeutic agent against thyroid eye disease by suppressing adipogenesis in orbital adipose tissues
  3444. Shattering Glass Ceilings: Three Black Women Surgeons Ascend to Chairs of Departments of Surgery
  3445. Effects of a high-fat diet and global aryl hydrocarbon receptor deficiency on energy balance and liver retinoid status in male Sprague-Dawley rats
  3446. Role of the aryl hydrocarbon receptor and gut microbiota-derived metabolites indole-3-acetic acid in sulforaphane alleviates hepatic steatosis in mice
  3447. Fatty acids rescue the thermogenic function of sympathetically denervated brown fat
  3448. Regulatory modules of human thermogenic adipocytes: functional genomics of large cohort and Meta-analysis derived marker-genes
  3449. Endothelial cells induced progenitors into Brown fat to reduce atherosclerosis
  3450. Current Evidence in Water and Hydration Science
  3451. Calcium-deficiency during pregnancy affects insulin resistance in offspring
  3452. Novel biomarkers of inflammation for the management of diabetes: immunoglobulin-free light chains
  3453. Medication Rule and Mechanism of Action for the Treatment of Polycystic Ovary Syndrome Based on Data Mining and Network Pharmacology
  3454. Diabetes as a potential compounding factor in COVID-19-mediated male subfertility
  3455. Altered glucose-dependent secretion of glucagon and ACTH is associated with insulin resistance, assessed by population analysis
  3456. A comprehensive review of the role of hemogram derived inflammatory markers in gastrointestinal conditions
  3457. Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progression
  3458. Heart Uptake of [18F]Fluoro-4-Thia-Oleate in a Non-Alcoholic Fatty Liver Disease Mouse Model
  3459. A randomized placebo-controlled cross-over study on the effects of anthocyanins on inflammatory and metabolic responses to a high-fat meal in healthy …
  3460. Insulin resistance in children and adolescents: mechanisms and clinical effects
  3461. P. an der.(2023, anuar 26)
  3462. Glucagon shows higher sensitivity than insulin to grapeseed proanthocyanidin extract (GSPE) treatment in cafeteria-fed rats
  3463. Exploring the Definition of “Similar Toxicities”: Case Studies Illustrating Industry and Regulatory Interpretation of ICH S6 (R1) for Long-Term Toxicity Studies in One or …
  3464. Effects of anti-inflammatory therapies on glycemic control in type 2 diabetes mellitus
  3465. Evaluation of lifespan promoting effects of biofortified wheat in Drosophila melanogaster
  3466. Effects of a Diabetes Prevention Program among Latino Youth with Prediabetes
  3467. Emerging roles of myeloid-derived suppressor cells in diabetes
  3468. Characterization of peptides targeting metastatic tumor cells as probes for cancer detection and vehicles for therapy delivery
  3469. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line
  3470. Role of mitochondria-associated endoplasmic reticulum membranes in insulin sensitivity, energy metabolism, and contraction of skeletal muscle
  3471. Household environmental factors and childhood malnutrition
  3472. Decreased glucocorticoid signaling potentiates lipid-induced inflammation and contributes to insulin resistance in the skeletal muscle of fructose-fed male rats …
  3473. Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model
  3474. Complement component C3: A novel biomarker participating in the pathogenesis of non-alcoholic fatty liver disease
  3475. Short-Term Fasting and Autonomic Control
  3476. Suppression of estrogen receptor beta classical genomic activity enhances systemic and adipose-specific response to chronic beta-3 adrenergic receptor …
  3477. Orexin receptor type 2 agonism inhibits thermogenesis in brown adipose tissue by attenuating afferent innervation
  3478. A novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancer
  3479. Implications of Inflammation and Fibrosis in Pathophysiology Atrial Fibrillation
  3480. Berberine improves TNF-α-induced hepatic insulin resistance by targeting MEKK1/MEK pathway
  3481. Studies on Genotype-Phenotype Correlation in Type II Diabetics and Evaluation of Melatonin and DPP-IV inhibitor on Experimental Diabetic Models
  3482. Glucagon Shows Higher Sensitivity than Insulin to Grapeseed Proanthocyanidin Extract (GSPE) Treatment in Cafeteria-Fed Rats. Nutrients 2021, 13, 1084
  3483. Anti-and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
  3484. Achieving Food and Nutrition Security and Climate Change: Clash of the Titans or Alignment of the Stars?
  3485. Circulating Lipid-and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases …
  3486. ERRα Up-Regulates Invadopodia Formation by Targeting HMGCS1 to Promote Endometrial Cancer Invasion and Metastasis
  3487. Implementation of dietary methionine restriction using casein after selective, oxidative deletion of methionine
  3488. CXCL2 impairs functions of bone marrow mesenchymal stem cells and can serve as a serum marker in high-fat diet-fed rats
  3489. MLR-1023 treatment in mice and humans induces a thermogenic program, and menthol potentiates the effect
  3490. Assessing Metabolic Risk Factors for LVSI in Endometrial Cancer: A Cross-Sectional Study
  3491. The nutrition prescription: Guideline development for nutrition education in graduate nursing curriculum
  3492. A simple liking survey captures behaviors associated with weight loss in a worksite program among women at risk of type 2 diabetes
  3493. BF175 inhibits endometrial carcinoma through SREBP-regulated metabolic pathways in vitro
  3494. Down-regulating Interleukin-22/Interleukin-22 binding protein axis promotes inflammation and aggravates diet-induced metabolic disorders
  3495. Insights on the role of anti-inflammatory and immunosuppressive agents in the amelioration of diabetes
  3496. Insights into the development of insulin resistance: Unraveling the interaction of physical inactivity, lipid metabolism and mitochondrial biology
  3497. Plant Protein Consumption and Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis
  3498. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs
  3499. Adaptive mechanisms of tumor therapy resistance driven by tumor microenvironment
  3500. Prophylactic consequences of sodium salicylate nanoparticles in cisplatin-mediated hepatotoxicity
  3501. Unraveling Molecular Mechanisms Responsible for the Healthspan Benefits of 17α-Estradiol, a Lifespan-Extending Compound
  3502. Ursolic acid ameliorates adipose tissue insulin resistance in aged rats via activating the Akt‑glucose transporter 4 signaling pathway and inhibiting …
  3503. Effects of 8 Weeks of Combined Rehabilitation Training on Plasma Levels of Leptin, Adiponectin, and Resistin‎ in Middle-Aged Men after CABG
  3504. The Impact of Exercise on Serum Levels of Leptin and Adiponectin in Obese Children and Adolescents: A Systematic Review and Meta-Analysis
  3505. The Importance of Education in the Management of Diabetes
  3506. Tumor microenvironment and nanotherapeutics: intruding the tumor fort
  3507. Genistein enhances NAD+ biosynthesis by binding to Prohibitin 1 and upregulating nicotinamide phosphoribosyltransferase in adipocytes
  3508. The Antidiabetic Activities of Neocryptotanshinone: Screened by Molecular Docking and Related to the Modulation of PTP1B
  3509. A randomized placebo-controlled cross-over study on the effects of anthocyanins on inflammatory and metabolic responses to a high-fat meal in healthy subjects.
  3510. The Unity of Redox and Structural Remodeling of Brown Adipose Tissue in Hypothyroidism. Antioxidants 2021, 10, 591
  3511. Critical material designs for mucus-and mucosa-penetrating oral insulin nanoparticle development
  3512. Eating behavior modulates the sensitivity to the central effects of GLP-1 receptor agonist treatment: a secondary analysis of
  3513. The effect of grape products containing polyphenols on C-reactive protein levels: a systematic review and meta-analysis of randomised controlled trials
  3514. Hacking Health: The Only Book You’ll Ever Need to Live Your Healthiest Life
  3515. Chylomicron production is repressed by RPTOR knockdown, R-α-lipoic acid and 4-phenylbutyric acid in human enterocyte-like Caco-2 cells
  3516. RELA governs a network of islet-specific metabolic genes necessary for beta cell function
  3517. In Silico Prediction of Anti-Infective and Cell-Penetrating Peptides from Thalassophryne nattereri Natterin Toxins
  3518. TNFAIP3 Reduction-of-Function Drives Female Infertility and CNS Inflammation
  3519. Effects of Korean Food-based Dietary Inflammatory Index Potential on the incidence of diabetes and HbA1c level in Korean adults aged 40 years and older
  3520. Targeting Myeloid Protein Kinase C Signaling to Overcome Immune Suppression and Improve Immunotherapy in Cancer
  3521. NLRP3 inflammasome blocked the glycolytic pathway via targeting to PKLR in arsenic-induced hepatic insulin resistance
  3522. Structural Requirements for the Binding of a Peptide to Prohibitins on the Cell Surface of Monocytes/Macrophages
  3523. Recent Advances in Molecular Mechanism of Metformin against Gastrointestinal Cancer in Type 2 Diabetics
  3524. Antihyperglycemic and antihyperlipidemic effects of Lippia citriodora in rats
  3525. Vascular endothelial cells: heterogeneity and targeting approaches
  3526. Identification and validation of Sertoli cell homing peptides as molecular steering for testis targeted drug delivery
  3527. Modification of bacteriophages to increase their association with lung epithelium cells in vitro
  3528. Effects of a single transdermal administration of flunixin meglumine in early postpartum Holstein Friesian dairy cows: Part 1. Inflammatory and metabolic …
  3529. Novel Lung Targeting Cell Penetrating Peptides as Vectors for Delivery of Therapeutics
  3530. Novel Muscle-Homing Peptide FGF1 Conjugate Based on AlphaFold for Type 2 Diabetes Mellitus
  3531. Novel Lung Targeting Cell Penetrating Peptides as Vectors for Delivery of Therapeutics
  3532. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis
  3533. The prohibitins (PHB) gene family in tomato: Bioinformatic identification and expression analysis under abiotic and phytohormone stresses
  3534. Cross-Cultural Adaptation of the Brazilian Portuguese-translated version of the Mini Sarcopenia Risk Assessment (MSRA) Questionnaire in Cancer Patients
  3535. A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney …
  3536. Synthetic polypeptide crotamine: characterization as a myotoxin and as a target of combinatorial peptides
  3537. Endoscopic and Histopathological Findings of the Esophagus, Stomach, and Duodenum in Patients with Crohn’s Disease from a Reference Center in Bahia, Brazil
  3538. Transport of statins by human ABC efflux transporters in vitro
  3539. Vascular Endothelial Cells: Heterogeneity and Targeting Approaches. Cells 2021, 10, 2712

Related Posts

Shopping Cart
Scroll to Top